Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3004119	vb-hb	g/l (g/l)	13164	48632	0.00%
3004119	vb-thb	g/l (g/l)	11220	30890	0.00%
3004119	vb-hb	— (—)	962	2616	100.00%	Distribution not available
3004119	vb-hb-vt	g/l (g/l)	451	728	0.00%
3004119	vb-thb	— (—)	270	293	100.00%	Distribution not available
3004119	vb-hb-vt	— (—)	88	113	100.00%	Distribution not available
3004119	vb-hblask	g/l (g/l)	57	63	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Hypothyroidism (congenital or acquired)

910

1121

4.85

320.22

4.3

2.0

131.27

139.83

g/l

17.90

883

1107

Nausea and vomiting

1478

5069

3.10

317.63

5.9

3.4

125.05

128.28

g/l

6.15

1445

4956

Type 1 diabetes, wide definition

1232

3895

3.42

314.10

5.7

3.6

123.92

132.23

g/l

26.90

1196

3804

Erysipelas

2764

11754

2.27

314.04

4.7

2.7

124.88

131.59

g/l

40.97

2707

11474

Valvular heart disease excluding rheumatic fever

2563

7025

2.86

307.65

5.0

2.9

121.12

129.54

g/l

53.05

2486

6878

Anaemias

1285

1047

8.86

307.65

7.5

2.2

114.61

139.07

g/l

147.10

1253

1035

Implicit bacterial Sepsis

2639

8392

3.19

307.65

6.5

2.8

119.47

129.91

g/l

88.56

2556

8196

Codes for special purposes

3289

8885

4.15

307.65

4.6

3.5

130.16

129.58

g/l

0.74

3250

8659

Viral Sepsis

1246

3819

3.65

307.65

6.7

2.8

121.90

130.57

g/l

30.25

1202

3735

Angina pectoris

3322

9954

2.41

307.65

4.4

2.9

125.95

129.79

g/l

16.30

3231

9749

Explicit Sepsis

2677

9184

3.05

307.65

7.0

2.9

117.11

130.21

g/l

144.17

2604

8974

Bacterial Sepsis

2940

9300

3.09

307.65

6.4

2.8

119.60

130.23

g/l

101.50

2849

9092

Diseases of arteries, arterioles and capillaries (FINNGEN)

1444

2057

5.40

307.65

6.1

2.3

120.96

133.25

g/l

50.83

1404

2023

Septicaemia

2617

8877

3.11

307.65

7.1

2.8

116.82

130.56

g/l

153.80

2546

8647

Complications of surgical and medical care, not elsewhere classified

4678

17461

2.00

307.65

4.6

3.1

123.46

130.55

g/l

73.64

4549

17081

Implicit viral Sepsis

1243

3812

3.65

307.65

6.7

2.8

121.85

130.55

g/l

30.48

1199

3728

Non-rheumatic valve diseases

2538

6970

2.85

307.65

5.0

2.8

121.17

129.54

g/l

52.08

2461

6825

Pain in throat and chest

4222

11513

2.34

307.65

3.7

3.1

130.89

129.81

g/l

2.12

4121

11257

Biguanides

4616

14095

2.11

307.65

3.6

3.2

128.38

129.78

g/l

3.49

4511

13769

Any reimbursement code in KELA

2348

3904

3.13

307.65

4.3

2.1

130.61

136.50

g/l

22.67

2292

3824

Implicit Sepsis

4377

13343

2.74

307.65

5.4

2.8

123.03

131.02

g/l

84.00

4252

13066

Kidney transplant status

738

906

12.57

307.65

13.5

3.7

107.30

132.16

g/l

113.88

731

888

Fever of other and unknown origin

2939

10374

2.79

307.65

5.5

2.9

122.39

130.56

g/l

64.17

2876

10140

Condition for Implicit Sepsis (Organ dysfunction codes)

4666

14356

2.50

307.65

5.2

2.8

123.88

131.53

g/l

81.62

4530

14066

Certain infectious and parasitic diseases

4528

11700

2.00

307.65

4.6

2.7

126.53

132.62

g/l

51.57

4429

11434

Malaise and fatigue

2870

8519

3.02

307.65

4.7

2.9

126.11

129.77

g/l

13.58

2807

8323

Depression medications

1107

1196

4.84

307.65

3.5

1.8

134.45

140.64

g/l

11.83

1078

1180

Pneumonia, organism unspecified

4458

15508

2.18

307.65

4.9

3.1

124.47

131.22

g/l

63.66

4347

15184

Abnormalities of breathing

4243

11893

2.20

307.65

4.3

3.2

129.02

129.85

g/l

1.36

4129

11631

Type 2 diabetes

5087

13092

2.43

307.65

4.2

2.9

127.68

130.64

g/l

13.60

4962

12786

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

4681

15450

2.15

307.65

5.8

2.9

122.70

131.50

g/l

109.99

4554

15130

L04AD Calcineurin inhibitors

925

1887

5.98

307.65

12.6

3.6

110.31

132.12

g/l

126.07

909

1842

4671

13047

2.36

307.65

4.8

2.9

124.88

130.71

g/l

48.32

4546

12771

Bacterial infection, other or unspecified

3312

10748

3.03

307.65

6.6

2.8

118.81

130.89

g/l

158.64

3232

10487

Hypertensive diseases

4026

8456

2.84

307.65

5.0

2.7

127.72

132.59

g/l

26.10

3942

8265

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5294

13201

2.59

307.65

4.2

3.1

127.45

130.75

g/l

17.51

5176

12896

Renal tubulo-interstitial diseases

5537

14910

3.08

307.65

6.3

2.6

119.76

131.90

g/l

242.95

5411

14571

Dyspnoea

4477

16630

2.16

307.65

4.4

3.2

127.35

129.30

g/l

6.46

4371

16250

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4853

17104

2.13

307.65

5.7

3.0

117.48

132.41

g/l

308.57

4739

16716

Type 1 diabetes, wide definition, subgroup 1

1206

3547

3.71

307.65

5.7

3.4

124.00

132.52

g/l

27.52

1170

3465

Type 2 diabetes, definitions combined

4546

12739

2.23

307.65

3.8

2.9

128.67

130.49

g/l

5.19

4443

12446

Cardiovascular diseases (excluding rheumatic etc)

2965

4955

3.64

307.65

5.0

2.7

129.48

135.46

g/l

28.12

2904

4842

Covid-19 suspected case

1897

3379

6.69

307.65

3.8

3.4

134.88

130.66

g/l

12.18

1885

3296

All pneumoniae

5132

16584

2.24

307.65

4.9

3.1

124.80

131.23

g/l

65.59

4989

16235

Atrial fibrillation and flutter

2172

2645

5.95

307.65

4.5

2.1

133.68

134.17

g/l

0.32

2128

2594

Type 2 diabetes, definitions combined, including avohilmo

4553

12613

2.23

307.65

3.7

3.0

128.95

130.47

g/l

3.81

4450

12315

Dialysis, with operation codes

1480

2466

8.04

307.65

13.8

2.8

106.70

132.35

g/l

283.19

1461

2403

General symptoms and signs

5495

12625

2.27

307.65

4.3

2.9

128.47

131.26

g/l

13.10

5364

12340

Hard cardiovascular diseases

3903

12394

2.13

307.65

4.4

3.1

125.48

130.35

g/l

28.78

3806

12134

Influenza and pneumonia

5385

16378

2.27

307.65

4.9

3.1

125.29

131.35

g/l

60.92

5237

16030

Diabetes, varying definitions

5397

13664

2.48

307.65

4.3

3.1

127.97

130.76

g/l

12.99

5260

13350

Hypertensive heart and/or renal disease

1498

3669

3.46

307.65

5.4

2.6

123.50

129.40

g/l

15.31

1484

3594

Diabetes medication

5413

14307

2.42

307.65

4.1

3.2

127.63

130.60

g/l

14.92

5280

13975

Transplanted organ and tissue status

1003

1699

7.62

307.65

13.0

3.1

108.68

132.70

g/l

160.92

986

1655

Endocrine, nutritional and metabolic diseases

3737

7737

2.56

307.65

4.3

3.0

130.17

132.36

g/l

5.60

3640

7560

Ischemic heart diseases

3864

11916

2.13

307.65

4.5

3.0

125.54

130.36

g/l

28.11

3766

11671

Diabetes mellitus

5427

13673

2.49

307.65

4.3

3.1

127.97

130.78

g/l

13.22

5289

13358

Bleeding

4192

15304

2.09

307.65

4.6

3.3

123.55

130.09

g/l

54.45

4087

14970

Other (not insulin) diabetes medications

4710

13480

2.20

307.65

3.7

3.0

128.12

130.31

g/l

7.60

4603

13167

Non-invasive ventilation

1319

2183

6.29

307.65

6.5

2.8

118.92

130.57

g/l

44.77

1203

2152

Glucagon-like peptide-1 (GLP-1) analogues

3232

10663

2.70

307.65

4.3

3.2

125.40

128.93

g/l

13.51

3159

10402

Heart failure and antihypertensive medication

1723

2211

5.78

307.65

6.3

2.5

121.90

131.87

g/l

37.74

1673

2180

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4993

16592

2.22

307.65

4.9

3.2

124.59

131.17

g/l

67.22

4855

16239

Type 1 diabetes

1477

4573

3.51

307.65

5.8

3.5

123.83

132.01

g/l

29.94

1434

4462

Other septicaemia

2375

8067

3.18

307.65

7.3

2.8

116.46

130.35

g/l

142.00

2308

7858

Provisional assignment of new diseases of uncertain etiology

3284

8878

4.15

307.65

4.6

3.5

130.17

129.58

g/l

0.74

3245

8652

Cerebrovascular diseases (FINNGEN)

1620

2766

4.51

307.65

4.2

2.2

128.01

133.87

g/l

15.00

1582

2714

Ischaemic heart disease, wide definition

3825

11754

2.14

307.65

4.5

3.0

125.47

130.38

g/l

28.71

3727

11511

All-cause Heart Failure

3405

10445

2.54

307.65

5.3

3.0

122.03

129.43

g/l

56.35

3304

10202

Heart failure,strict

3251

8700

2.95

307.65

5.4

2.7

122.32

131.42

g/l

76.78

3155

8510

Acute tubulo-interstitial nephritis

3117

12012

2.43

307.65

5.2

2.7

122.87

131.04

g/l

71.32

3044

11717

Hypertension, essential

4004

8228

2.94

307.65

4.5

2.5

128.48

132.52

g/l

18.24

3918

8043

Other heart diseases, wide

4838

11578

2.74

307.65

4.7

3.0

129.57

131.05

g/l

3.58

4721

11338

Insulin, combination of fast acting with intermediate-acting or long-acting

3795

13987

2.70

307.65

5.1

3.2

124.77

129.85

g/l

31.89

3701

13661

Cardiovascular diseases

2547

4404

3.29

307.65

5.0

2.8

130.11

135.54

g/l

20.76

2493

4300

Diabetes, insulin treatment (Kela reimbursement)

5550

14499

2.47

307.65

4.1

3.2

127.32

130.43

g/l

16.51

5423

14155

Other bacterial diseases

5733

15224

2.79

307.65

5.7

2.8

121.86

132.17

g/l

177.01

5605

14873

Heart failure, not strict

4959

11694

3.20

307.65

6.0

2.7

121.38

131.99

g/l

151.56

4830

11459

Insulin, fast-acting or short human

2242

8408

2.90

307.65

5.8

3.5

124.00

130.16

g/l

28.30

2184

8202

Insulin, intermediate and long-acting

3492

13066

2.85

307.65

5.0

3.2

125.15

129.98

g/l

26.94

3407

12760

Care involving dialysis

1056

1374

11.20

307.65

14.3

3.2

105.67

131.56

g/l

186.68

1048

1329

Glomerular diseases

1299

3853

3.85

307.65

10.4

3.2

112.69

130.48

g/l

131.44

1279

3757

Type 2 diabetes, strict (exclude DM1)

4551

12824

2.21

307.65

3.8

3.0

128.65

130.45

g/l

5.10

4448

12527

Hypertensive diseases (excluding secondary)

2778

3985

4.33

307.65

5.4

2.5

127.98

135.10

g/l

34.69

2719

3895

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

4671

13047

2.36

307.65

4.8

2.9

124.88

130.71

g/l

48.32

4546

12771

Atrial fibrillation and flutter with reimbursement

1837

2091

6.33

307.65

4.0

2.2

134.27

133.09

g/l

0.96

1799

2055

Insulin medication

3784

11331

3.10

307.65

5.1

3.3

124.79

130.33

g/l

35.99

3690

11065

Insulin, fast-acting

2233

7883

3.09

307.65

5.8

3.4

124.06

130.58

g/l

31.21

2175

7691

Pneumonias (Asthma/COPD co-morbidities)

5112

16520

2.25

307.65

4.9

3.1

124.76

131.30

g/l

67.76

4973

16171

Infections, IBD-co-morbidities

920

1462

4.98

307.65

7.5

2.9

119.80

130.41

g/l

25.01

894

1435

Dental caries

1525

5240

3.14

307.65

8.7

3.1

120.36

131.42

g/l

54.27

1496

5116

STROKE

2835

7773

2.68

307.65

4.1

2.7

128.54

131.76

g/l

9.44

2767

7617

Chronic kidney disease

2495

6776

4.29

307.65

9.8

2.8

111.84

129.84

g/l

272.83

2440

6611

Secondary hypertension

577

823

8.11

307.65

9.9

2.8

113.26

133.85

g/l

61.26

568

810

Care involving use of rehabilitation procedures

3768

13377

2.87

307.65

4.5

2.9

127.53

131.23

g/l

18.53

3673

13059

Extracorporeal dialysis

814

1187

10.32

307.65

15.4

3.2

105.79

130.49

g/l

145.97

808

1152

Disorders of lipoprotein metabolism and other lipidaemias

4397

12103

2.42

307.65

4.1

2.9

127.97

130.15

g/l

6.92

4294

11828

Presence of cardiac and vascular implants and grafts

2686

8850

2.47

307.65

4.9

2.8

122.92

129.94

g/l

42.76

2594

8663

Metabolic disorders

5501

13364

2.72

307.65

4.7

3.0

127.11

130.48

g/l

18.76

5369

13056

Acute renal failure

1579

4430

4.14

307.65

7.9

2.8

114.20

130.31

g/l

118.64

1534

4317

Other arrhythmias

2807

9542

2.36

307.65

3.7

2.8

131.92

130.25

g/l

3.40

2745

9345

Dialysis

499

662

10.85

307.65

15.4

3.6

106.08

131.86

g/l

90.96

494

650

Hypertension

4018

8452

2.84

307.65

5.0

2.7

127.69

132.59

g/l

26.34

3934

8261

Glomerular disorders in diseases classified elsewhere

929

2332

4.73

307.65

10.7

3.1

110.38

130.53

g/l

118.55

916

2264

Type 2 diabetes, wide definition

4929

11678

2.97

307.65

4.4

3.0

125.82

130.21

g/l

27.97

4817

11410

Other heart diseases

2914

4083

5.12

307.65

5.3

2.7

129.88

135.14

g/l

19.46

2841

3993

Cardiac arrhythmias

3126

5796

3.79

307.65

4.1

2.8

133.14

131.66

g/l

2.42

3057

5674

Paroxysmal tachycardia

1025

2239

4.14

307.65

4.2

2.5

130.82

133.41

g/l

2.80

1003

2200

Other disorders of fluid, electrolyte and acid-base balance

2062

6027

3.70

307.65

5.8

2.9

122.24

128.21

g/l

25.73

2021

5878

Heart failure, strict

3467

10606

2.54

307.65

5.3

3.0

122.14

129.45

g/l

55.65

3365

10361

Nephropathy related operations

1498

2456

8.38

307.65

13.9

3.0

106.82

131.20

g/l

257.76

1478

2391

Speech therapy

2010

5824

3.94

307.65

3.9

3.5

129.62

128.14

g/l

2.14

1987

5683

Renal failure

3587

9698

3.88

307.65

8.2

2.7

113.99

130.32

g/l

298.50

3497

9456

Persons encountering health services for specific procedures and health care

6047

15335

2.58

307.65

5.3

2.8

124.42

132.00

g/l

101.00

5906

14976

Pure hypercholesterolaemia

3608

11380

2.24

307.65

4.0

2.9

127.23

129.83

g/l

8.20

3508

11123

Antihypertensive medication - note that there are other indications

2514

4773

3.00

307.65

4.4

2.7

130.53

134.73

g/l

13.17

2451

4681

Hypothyroidism, levothyroxine purchases

889

1115

4.77

307.22

4.0

2.0

131.22

139.79

g/l

17.83

864

1101

Hypothyroidism and >3 levothyroxin purchases

889

1115

4.77

307.22

4.0

2.0

131.22

139.79

g/l

17.83

864

1101

Parasetamol

3581

8986

2.10

304.23

4.0

2.9

129.56

132.91

g/l

12.59

3492

8801

Dentinal caries

1355

4616

3.19

303.39

8.1

3.1

120.53

131.54

g/l

47.03

1330

4511

Complications of medical and surgical care

3445

16777

2.04

303.11

4.9

3.2

123.04

129.72

g/l

51.23

3337

16412

Substance abuse, excluding more controls

2686

10943

2.25

301.76

3.7

3.4

130.17

130.31

g/l

0.11

2606

10689

Hypertensive Heart Disease

1295

3458

3.33

299.28

5.0

2.6

125.34

129.17

g/l

6.14

1285

3386

Other nutritional deficiencies

2834

13348

2.17

296.83

4.2

3.4

130.00

129.62

g/l

0.36

2764

13036

Covid-19 confirmed case

1539

5714

2.92

296.30

6.0

3.4

123.87

129.14

g/l

15.41

1510

5564

Symptoms and signs involving the circulatory and respiratory systems

4441

11935

1.92

294.68

3.9

3.2

131.03

129.90

g/l

2.35

4337

11671

Bacterial pneumoniae

2198

8513

2.43

290.43

5.3

3.0

123.48

130.06

g/l

31.66

2118

8311

Symptoms and signs involving the digestive system and abdomen

4693

12909

1.88

290.30

4.1

3.3

129.53

130.12

g/l

0.88

4579

12611

Hyperlipidaemia, other/unspecified

2050

8331

2.50

287.78

4.4

2.8

128.41

128.95

g/l

0.47

2025

8130

Headache

2711

10730

2.19

286.62

3.7

2.9

131.16

131.00

g/l

0.14

2647

10489

Complications of procedures, not elsewhere classified

3674

16846

1.96

286.53

4.5

3.2

123.54

130.35

g/l

55.07

3574

16483

Other diseases of intestines

4678

15214

1.84

282.58

4.3

3.3

128.38

130.66

g/l

8.46

4571

14863

Abdominal and pelvic pain

4632

12902

1.86

278.41

4.0

3.2

130.43

130.12

g/l

0.36

4520

12604

Bacterial pneumonia, not elsewhere classified

2086

8063

2.44

276.81

5.4

3.0

123.22

130.03

g/l

32.10

2007

7873

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1589

3664

2.85

276.32

4.4

2.2

128.47

134.57

g/l

18.02

1549

3582

GASTRO-related operations

3546

9030

2.03

275.04

4.4

2.5

127.55

134.37

g/l

49.96

3461

8840

Any gastric operation

3546

9030

2.03

275.04

4.4

2.5

127.55

134.37

g/l

49.96

3461

8840

Other CVD (FINNGEN)

621

991

5.48

270.49

4.9

2.0

124.97

131.80

g/l

9.09

602

974

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1225

4192

3.09

270.40

3.2

131.11

131.02

g/l

0.05

1186

4106

Asthma, unspecified (mode), excluding more controls

2251

7938

2.32

268.65

4.0

2.7

129.23

131.75

g/l

5.62

2198

7781

Asthma, excluding more controls

3242

8633

2.07

267.70

3.8

2.8

130.64

132.35

g/l

3.57

3168

8461

Obesity

2660

12924

2.13

266.31

4.2

3.3

130.20

129.61

g/l

0.62

2596

12627

Obesity and other hyperalimentation

2670

12989

2.13

265.83

4.2

3.3

130.15

129.60

g/l

0.58

2606

12689

Symptoms and signs involving cognition, perception, emotional state and behaviour

4301

16979

1.84

265.76

3.7

3.3

129.05

129.31

g/l

0.30

4188

16603

Diseases of arteries, arterioles and capillaries

3340

13074

2.00

265.21

5.1

3.1

121.65

129.53

g/l

65.96

3244

12783

Diarrhoea and gastroenteritis of presumed infectious origin

3192

15115

2.00

264.62

5.4

3.2

127.30

130.16

g/l

9.77

3104

14778

First line medication for Crohn's disease

4959

15655

1.78

263.29

5.2

3.0

125.60

131.45

g/l

51.80

4845

15307

ILD medications: prednisolone, methylprednisolone, prednisone

4899

16041

1.78

261.44

5.2

2.9

125.76

131.01

g/l

42.03

4783

15683

Diseases of oesophagus, stomach and duodenum

4726

16574

1.79

260.17

4.1

3.3

126.35

130.44

g/l

25.31

4609

16202

Poisoning by drugs, medicaments and biological substances

1197

4155

3.09

259.76

3.4

132.00

131.17

g/l

0.62

1160

4062

Intracranial trauma

2476

8711

2.20

259.51

3.6

3.4

130.31

129.19

g/l

1.54

2426

8519

Poisoning by medicine

1104

3679

3.24

257.86

3.4

3.5

132.12

131.31

g/l

0.57

1069

3596

ILD medications

5051

16244

1.76

257.37

5.3

3.0

125.94

131.08

g/l

41.05

4931

15883

Intestinal infectious diseases

4135

18247

1.82

254.58

5.2

3.2

126.82

129.99

g/l

15.01

4018

17839

Bacterial pneumonia (organism specified)

2302

9928

2.23

251.92

5.4

3.2

123.22

128.96

g/l

26.11

2220

9687

Non-ischemic cardiomyopathy

1563

5120

2.70

249.89

4.9

2.8

123.66

129.69

g/l

17.30

1519

5005

Tramadol

3548

12266

1.93

249.53

4.2

3.0

126.68

131.27

g/l

23.72

3463

12017

Hypo-osmolality and hyponatraemia

1031

3404

3.35

246.92

5.2

2.9

122.19

127.90

g/l

13.13

1016

3326

Syncope and collapse

2084

8460

2.29

244.64

3.8

2.9

127.86

129.79

g/l

3.32

2032

8267

Heart failure and bmi 25plus

1939

5866

2.46

243.48

5.3

2.9

122.24

129.88

g/l

33.45

1876

5714

Obesity due to excess calories

2020

9255

2.30

242.73

4.3

3.4

129.74

129.81

g/l

0.04

1974

9041

Mental and behavioural disorders due to psychoactive substance use

2760

13404

2.03

239.94

3.7

3.5

130.19

130.59

g/l

0.38

2679

13098

Aplastic and other anaemias

2305

10629

2.18

237.99

6.3

3.2

110.75

129.59

g/l

270.76

2250

10360

Hypothyroidism, drug reimbursement

522

689

5.69

237.10

3.9

1.9

128.63

138.19

g/l

14.01

503

682

Diverticular disease of intestine

3331

11911

1.94

236.82

3.9

3.1

126.59

129.43

g/l

9.54

3260

11645

Coronary atherosclerosis

3149

10738

1.98

235.74

4.5

2.9

123.58

130.10

g/l

41.02

3068

10515

Substance abuse

2686

13186

2.03

235.42

3.7

3.5

130.17

130.62

g/l

0.43

2606

12889

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1508

2798

2.79

235.12

3.7

2.6

130.97

133.51

g/l

3.11

1470

2735

Statin medication

2878

8138

2.05

234.96

4.6

2.8

128.33

132.10

g/l

12.83

2806

7963

Asthma

3379

9670

1.93

232.07

3.8

2.9

130.45

131.46

g/l

1.57

3302

9473

Pain in limb

3449

13726

1.88

231.48

4.5

3.3

127.91

129.42

g/l

3.37

3365

13424

Asthma (only as main-diagnosis), excluding more controls

2850

8633

2.03

230.63

3.8

2.8

130.16

132.35

g/l

5.09

2790

8461

COPD/asthma related infections

4487

13061

1.77

229.51

4.4

2.9

127.40

130.71

g/l

16.38

4379

12785

COPD/asthma/ILD related infections

4487

13061

1.77

229.51

4.4

2.9

127.40

130.71

g/l

16.38

4379

12785

Autoimmune diseases excluding thyroid diseases

4621

15171

1.74

228.12

4.5

3.2

126.33

130.90

g/l

30.97

4516

14828

Cardiodefibrillation

1997

9404

2.28

228.02

3.8

3.4

135.70

127.21

g/l

46.33

1962

9159

Major coronary heart disease event

3402

12485

1.90

227.87

4.4

3.1

123.99

129.75

g/l

36.66

3306

12230

Asthma, unspecified (mode)

2308

8887

2.14

226.86

4.0

2.8

129.04

130.80

g/l

3.09

2254

8705

Sub-endpoint used in defining T1D endpoints

1557

6479

2.51

226.29

5.7

3.6

123.75

130.19

g/l

21.59

1510

6331

Valvular operations

862

2741

3.49

220.94

5.7

3.0

115.71

129.55

g/l

49.05

813

2679

Autoimmune diseases excluding thyroid diseases, strict definition

4466

14721

1.74

220.52

4.5

3.2

126.27

130.83

g/l

29.64

4368

14395

Personality disorders, excluding more controls

1077

3857

2.95

218.76

3.3

3.2

131.71

131.91

g/l

0.11

1055

3785

Abnormalities of heart beat

1584

6801

2.43

217.09

3.6

3.1

131.95

128.23

g/l

9.00

1551

6639

Other soft tissue disorders, not elsewhere classified

3968

14192

1.78

216.84

4.4

3.3

128.69

129.63

g/l

1.70

3867

13877

L04AA Selective immunosuppressants

1119

4151

2.92

216.16

9.2

3.2

114.74

130.98

g/l

93.99

1093

4050

Neurological diseases, wide definition

1232

2143

2.99

215.54

4.0

3.3

132.76

131.37

g/l

1.08

1204

2096

Psychiatric diseases

4722

14224

1.71

213.62

3.7

3.5

130.02

129.34

g/l

1.13

4594

13912

Convulsions, not elsewhere classified

1106

4021

2.88

213.50

4.5

3.2

129.61

131.99

g/l

2.64

1079

3926

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

837

2664

3.40

211.76

3.4

132.92

131.70

g/l

0.84

810

2609

Oral corticosteroids

4575

16808

1.69

209.07

4.2

3.1

127.25

130.16

g/l

13.23

4454

16440

Dizziness and giddiness

3268

14945

1.84

208.13

3.7

3.3

128.67

128.73

g/l

0.05

3191

14608

ILD medications: immunosuppressive drugs

2645

13503

1.95

207.66

6.9

3.0

121.06

131.39

g/l

91.20

2583

13196

Injuries to the head

4628

18459

1.68

207.61

3.5

3.6

129.50

129.46

g/l

0.04

4526

18026

2756

13291

1.93

207.27

3.6

3.5

129.38

130.69

g/l

2.02

2672

12990

Asthma, hospital admission 2, infections

2575

13415

1.97

206.74

4.3

3.6

128.60

128.76

g/l

0.13

2510

13103

Asthma-related infections

2575

13415

1.97

206.74

4.3

3.6

128.60

128.76

g/l

0.13

2510

13103

2655

13005

1.95

206.59

3.7

3.5

129.24

130.69

g/l

2.34

2575

12715

Mental and behavioural disorders due to alcohol

2362

11849

2.03

205.94

3.6

3.5

130.02

130.69

g/l

0.67

2291

11583

Diseases of pulp and periapical tissues

1683

7687

2.31

204.67

5.8

3.0

124.42

131.24

g/l

25.91

1645

7519

Asthma (mode)

3241

9778

1.88

204.64

3.7

2.9

130.31

131.50

g/l

2.04

3170

9580

Disorders of gallbladder, biliary tract and pancreas

4241

16439

1.71

204.16

4.2

3.3

127.64

129.28

g/l

4.49

4143

16069

Hypokalaemia

698

2049

3.82

203.93

5.5

2.8

124.35

129.02

g/l

5.66

680

1995

Pacemaker

1803

8286

2.27

203.47

5.4

3.2

122.17

127.29

g/l

17.64

1721

8096

Major coronary heart disease event excluding revascularizations

3100

11884

1.88

202.99

4.4

3.1

125.01

129.69

g/l

22.87

3011

11642

Other anaemias

2084

10007

2.13

202.68

5.9

3.2

110.67

129.45

g/l

241.99

2033

9756

Other and unspecified anaemias

2064

9937

2.13

200.87

5.9

3.2

110.56

129.45

g/l

242.09

2013

9689

Other neurological diseases

3261

14936

1.83

200.74

3.9

3.3

128.61

128.32

g/l

0.29

3188

14583

Dorsalgia

4280

13880

1.72

200.69

3.4

3.3

130.36

129.51

g/l

1.51

4165

13581

Inflammatory bowel disease treatment related agents

4864

17157

1.65

200.51

4.5

3.2

127.38

130.27

g/l

13.64

4740

16782

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2684

14545

1.92

199.26

5.1

3.2

122.21

129.58

g/l

48.85

2597

14229

Alcohol use disorder, Swedish definition

2523

12494

1.96

196.87

3.7

3.5

128.93

130.74

g/l

3.19

2441

12218

Diseases of the digestive system

2195

11228

2.05

196.36

5.0

3.4

119.90

129.20

g/l

58.28

2138

10953

Unspecified kidney failure

674

2009

3.85

194.38

7.7

2.7

114.62

129.38

g/l

52.44

659

1959

GI-bleeding

1672

7809

2.28

194.12

4.9

3.4

118.28

128.97

g/l

55.52

1632

7611

Asthma (only as main-diagnosis)

2935

9670

1.89

193.07

3.8

2.9

129.90

131.46

g/l

2.95

2872

9473

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1225

4992

2.58

192.55

3.2

3.4

131.11

131.29

g/l

0.10

1186

4882

Other diseases of the digestive system

1659

7754

2.28

192.33

4.9

3.4

118.00

129.04

g/l

58.47

1618

7559

Examination and observation for other reasons

2683

8683

1.94

192.10

3.9

2.9

126.02

131.17

g/l

22.66

2650

8483

Oedema, not elsewhere classified

1396

6035

2.43

190.84

4.8

2.9

124.71

129.41

g/l

10.88

1357

5900

Any mental disorder

4751

14769

1.65

190.30

3.7

3.5

130.08

129.22

g/l

1.62

4631

14436

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2080

10619

2.05

187.29

3.7

3.5

129.56

130.93

g/l

1.75

2014

10381

Other disorders of teeth and supporting structures

1120

4466

2.70

187.08

5.4

3.1

124.84

130.03

g/l

10.56

1094

4365

Concussion

1987

8535

2.08

186.75

3.6

3.4

131.09

129.16

g/l

3.38

1948

8348

Low back pain

3064

13453

1.81

184.79

3.4

3.3

129.65

129.39

g/l

0.25

2984

13166

Cerebrovascular diseases

3344

14015

1.78

184.03

4.0

3.3

126.98

128.58

g/l

3.42

3272

13686

Polyarthropathies

2992

11217

1.84

183.91

4.6

3.3

124.18

130.23

g/l

35.14

2914

10983

Opioids

4110

13063

1.69

183.28

4.1

3.0

128.35

131.55

g/l

13.86

4001

12797

Suicide or other Intentional self-harm

1112

4453

2.65

182.33

3.3

3.4

131.07

131.37

g/l

0.17

1078

4354

Myocardial infarction

2356

8974

1.98

179.46

4.6

2.9

123.40

129.97

g/l

33.36

2283

8785

Lower back pain or/and sciatica

4249

18390

1.65

179.24

3.4

129.66

129.34

g/l

0.40

4139

17979

Gastrointestinal diseases

2360

6053

2.01

178.36

4.1

2.6

129.34

133.33

g/l

12.02

2303

5905

Codeine

3883

12879

1.70

177.16

3.7

3.0

128.97

131.49

g/l

8.49

3763

12616

Asthma-related pneumonia

1710

8344

2.16

175.31

4.7

3.6

125.89

127.65

g/l

2.44

1668

8142

Asthma, hospital admissions 3, pneumonia

1712

8361

2.16

175.07

4.7

3.6

125.89

127.65

g/l

2.43

1670

8158

Asthma-related pneumonia or sepsis

1712

8361

2.16

175.07

4.7

3.6

125.89

127.65

g/l

2.43

1670

8158

Alcohol use disorder, ICD-based

1911

9755

2.05

172.84

3.7

3.5

129.74

130.95

g/l

1.37

1850

9528

Alcohol abuse, main dg, excluding more controls

766

2619

3.17

171.80

3.5

3.4

133.26

131.29

g/l

1.44

748

2566

Mood disorders, excluding more controls

3795

14087

1.68

170.22

3.7

3.3

130.49

129.49

g/l

1.85

3694

13772

Disorders resulting from impaired renal tubular function

332

654

6.56

169.52

13.8

3.8

108.41

128.82

g/l

49.97

327

645

Heart failure and coronary heart disease

1744

6391

2.17

168.71

5.4

3.1

120.06

128.18

g/l

39.88

1690

6251

Symptoms and signs involving the urinary system

3331

15449

1.72

168.44

4.5

3.2

127.12

129.17

g/l

5.69

3247

15096

Pain, not elsewhere classified

1118

4660

2.52

167.38

4.8

3.0

129.05

130.97

g/l

1.95

1087

4551

Pain (limb, back, neck, head abdominally)

3175

9164

1.78

167.33

3.8

3.4

130.21

129.50

g/l

0.87

3103

8958

Fall on same level

4707

16939

1.59

165.61

3.9

3.4

127.90

130.51

g/l

11.13

4603

16536

Volume depletion

568

1690

3.77

162.81

5.7

3.0

122.59

127.61

g/l

5.14

555

1652

Other functional intestinal disorders

1934

9594

2.00

162.66

4.5

3.4

126.43

128.78

g/l

4.86

1881

9357

Coronary revascularization (ANGIO or CABG)

2180

8131

1.96

161.65

4.3

3.0

121.50

129.70

g/l

46.58

2106

7957

Other disorders of urethra and urinary system

2836

12320

1.78

160.78

4.3

3.2

125.31

128.75

g/l

13.39

2774

12007

Used for control exclusion in common control thyroid runs

4405

14204

1.61

160.00

4.4

3.2

128.60

130.81

g/l

7.56

4295

13889

Nutritional anaemias

2145

11351

1.92

159.24

4.8

3.3

114.49

129.07

g/l

146.31

2090

11081

Benign neoplasm of colon, rectum, anus and anal canal

2413

9563

1.88

158.96

4.2

3.2

124.95

131.50

g/l

33.75

2360

9348

All influenza

1178

5168

2.42

158.33

5.2

3.1

126.28

130.88

g/l

9.82

1138

5055

Unspecified mental disorder

1691

8510

2.07

158.11

3.3

3.5

130.81

130.69

g/l

0.08

1653

8324

Episodal and paroxysmal disorders

4541

14961

1.59

157.88

3.9

3.4

131.54

128.57

g/l

13.97

4428

14604

Neurological diseases

3524

10716

1.69

156.70

3.8

3.5

131.48

128.93

g/l

8.25

3436

10482

Schizophrenia or delusion, excluding more controls

1226

5438

2.34

155.63

3.0

3.3

130.72

130.87

g/l

0.09

1197

5325

Paralytic ileus and intestinal obstruction

1244

5630

2.35

155.57

4.3

3.2

125.22

128.40

g/l

4.79

1202

5495

Benign neoplasm: Colon

2170

9045

1.92

154.84

4.3

3.2

124.81

131.18

g/l

29.07

2121

8833

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2419

13761

1.83

154.75

5.1

3.2

122.37

129.27

g/l

38.88

2338

13455

Other antidepressants

4368

14613

1.60

154.69

3.7

3.3

130.09

129.30

g/l

1.37

4265

14297

Constipation

3636

16263

1.65

154.41

3.9

3.5

126.83

128.96

g/l

6.86

3534

15906

Gout

1436

6281

2.22

153.47

5.6

3.3

121.06

129.09

g/l

28.87

1391

6132

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1072

4587

2.49

152.87

4.3

3.4

132.09

130.59

g/l

1.24

1056

4465

Other pulmonary diagnosis

3266

9765

1.72

151.72

4.1

2.9

129.06

131.47

g/l

6.62

3184

9565

Disorders of thyroid, IBD co-morbidities

660

1530

3.28

151.14

3.5

2.5

133.22

129.91

g/l

2.85

643

1498

Infections of the skin and subcutaneous tissue

2339

13202

1.83

150.93

5.2

3.5

126.30

130.79

g/l

16.49

2280

12906

Unstable angina pectoris

1891

8290

2.00

150.69

4.5

3.1

125.82

128.91

g/l

7.03

1826

8112

Other medical care

1711

8592

2.03

150.63

4.6

2.8

117.49

129.96

g/l

89.19

1660

8375

Obesity, other/unspecified

1322

6187

2.24

150.48

4.2

3.4

130.06

129.89

g/l

0.09

1292

6051

Excluding asthma or asthma-COPD overlap

3257

9765

1.71

149.77

4.1

2.9

129.03

131.47

g/l

6.78

3175

9565

Autoimmune diseases

4579

15245

1.57

149.74

4.5

3.2

127.74

130.91

g/l

15.38

4468

14901

Asthma (diagnoses ohter than nonallergic)

3478

18635

1.64

149.62

3.9

3.4

129.56

129.10

g/l

0.56

3396

18203

Nerve, nerve root and plexus disorders

4314

17637

1.57

149.21

3.8

3.3

128.74

129.32

g/l

0.89

4184

17262

1809

9446

1.97

148.19

4.3

3.8

129.96

129.27

g/l

0.62

1761

9237

Peripheral artery disease

2118

9382

1.91

148.00

5.6

3.0

119.04

128.67

g/l

67.11

2058

9157

Iron deficiency anaemia

1822

9553

1.98

147.83

4.8

3.3

113.87

128.99

g/l

136.14

1778

9325

Stroke, including SAH

2789

12234

1.75

147.45

4.1

3.3

127.16

128.12

g/l

1.30

2727

11942

Personality disorders

1077

4674

2.42

147.18

3.3

3.5

131.71

131.75

g/l

0.02

1055

4567

Myocardial infarction, strict

2137

8580

1.90

145.92

4.5

2.9

123.51

129.97

g/l

29.59

2066

8401

COPD differential diagnosis

3242

9780

1.70

145.69

4.1

2.9

129.06

131.50

g/l

6.72

3159

9582

Substance use, excluding alcohol

865

3424

2.68

145.55

3.8

3.3

132.71

131.88

g/l

0.46

841

3348

Amiodarone users

653

2283

3.26

144.84

4.6

3.3

134.98

128.05

g/l

10.56

641

2219

ILD differential diagnosis

3237

9778

1.70

144.72

4.1

2.9

129.06

131.50

g/l

6.70

3154

9580

Insulin, fast-acting (human)

701

2511

2.99

143.94

6.4

3.1

122.05

132.51

g/l

23.93

683

2449

Conduction disorders

1251

4793

2.28

143.47

4.6

2.9

125.47

129.02

g/l

6.36

1204

4687

Other retinal disorders

2751

13231

1.73

141.96

4.9

3.2

124.65

128.73

g/l

16.79

2675

12919

Calcific aortic valvular stenosis, operated

1520

7547

2.10

141.91

4.9

3.3

118.20

127.40

g/l

44.37

1474

7363

Calcific aortic valvular stenosis

1520

7547

2.10

141.91

4.9

3.3

118.20

127.40

g/l

44.37

1474

7363

Operations 2 for CAVS

1517

7536

2.10

141.41

4.9

3.2

118.22

127.41

g/l

44.18

1471

7352

Calcific aortic valvular stenosis, diagnosis (helper)

1517

7536

2.10

141.41

4.9

3.2

118.22

127.41

g/l

44.18

1471

7352

Oxycodone

1638

8213

2.03

141.33

4.7

3.1

119.17

129.78

g/l

61.78

1587

8049

Anxiety disorders, excluding more controls

3105

12570

1.68

141.13

4.1

3.3

131.23

129.66

g/l

3.35

3031

12297

Other dorsopathies, not elsewhere classified

4091

13928

1.58

140.96

3.5

3.3

130.49

129.54

g/l

1.73

3984

13627

Calcific aortic valvular stenosis, including rheumatic fever

1518

7566

2.09

139.79

4.9

3.2

118.25

127.43

g/l

44.02

1472

7382

Disorders of adult personality and behaviour

1104

4953

2.33

139.34

3.3

3.5

131.53

131.81

g/l

0.15

1076

4843

Glomerulonephritis

590

1982

3.31

138.65

10.3

3.4

116.06

129.75

g/l

36.98

582

1926

Hyperkalaemia

383

980

4.57

138.62

8.9

2.6

115.41

128.25

g/l

21.74

374

957

Combinations of oral blood glucose lowering drugs

1282

6155

2.21

138.49

3.4

3.3

128.86

129.83

g/l

0.75

1265

5999

Other disorders of skin and subcutaneous tissue

2813

15691

1.70

138.35

4.8

3.2

122.81

129.15

g/l

41.56

2747

15326

Genitourinary diseases

2565

7380

1.79

137.21

5.1

2.8

128.72

134.27

g/l

22.90

2503

7216

Adjustment and management of implanted device

940

4005

2.53

136.74

4.7

2.9

127.62

129.10

g/l

1.20

924

3894

Haemorrhage from respiratory passages

1499

7045

2.06

136.69

4.8

3.1

125.56

127.90

g/l

3.40

1449

6878

Problems related to lifestyle

534

1695

3.43

136.36

3.9

3.2

134.32

132.23

g/l

1.17

520

1651

Chronic lower respiratory diseases

4810

17543

1.51

136.19

3.8

3.5

129.89

129.52

g/l

0.49

4696

17139

Codeine or tramadol medication

4605

17067

1.53

136.16

3.7

3.2

128.75

129.80

g/l

2.22

4469

16702

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4496

17122

1.53

134.96

4.4

3.3

128.12

129.79

g/l

4.87

4414

16715

Other disorders of kidney and ureter

711

2685

2.92

134.57

9.4

3.3

116.68

128.73

g/l

35.61

699

2613

Chronic periodontitis

790

3132

2.74

134.56

7.9

3.1

117.42

130.50

g/l

42.89

776

3054

4545

16029

1.53

134.10

4.2

3.2

128.86

129.27

g/l

0.56

4430

15663

Myocardial infarction, without ST-elevation

1911

9776

1.90

133.72

4.8

3.2

121.56

128.23

g/l

31.22

1844

9544

Obesity related asthma

1406

7060

2.09

133.50

4.6

3.5

131.02

129.18

g/l

2.20

1374

6895

Falls/tendency to fall

4415

14650

1.54

133.31

3.7

3.5

128.80

130.43

g/l

4.42

4322

14295

Stroke, excluding SAH

2628

11713

1.73

133.15

4.1

3.3

127.03

127.99

g/l

1.25

2570

11421

Other reaction to severe stress, and adjustment disorders

1301

6327

2.13

133.06

4.1

3.3

129.82

130.98

g/l

1.05

1265

6188

AV-block

845

3118

2.63

132.71

4.4

2.9

123.94

128.44

g/l

6.73

811

3049

Coronary artery bypass grafting

1400

5280

2.14

132.68

4.7

2.9

118.31

129.33

g/l

54.08

1342

5165

Disorders of choroid and retina

3352

15577

1.61

130.85

4.6

3.2

125.46

129.16

g/l

16.38

3263

15238

Depression

3647

16277

1.58

130.27

3.8

3.3

130.86

129.78

g/l

2.10

3552

15907

Alcohol abuse, main dg

766

3032

2.72

130.09

3.5

133.26

131.44

g/l

1.31

748

2960

Sciatica+with lumbago

2013

10810

1.83

129.87

3.5

3.3

129.95

129.06

g/l

0.99

1963

10580

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2668

15122

1.69

129.52

4.2

3.4

125.75

128.62

g/l

8.61

2618

14760

Specific personality disorders

917

3924

2.45

129.52

3.3

3.5

131.34

131.47

g/l

0.06

895

3838

Gout, FINNGEN

1436

7385

2.06

129.10

5.6

3.2

121.06

129.22

g/l

30.64

1391

7206

Chronic periapical parodontitis

976

4325

2.40

128.67

6.4

3.1

119.87

130.61

g/l

34.58

951

4221

Mood disorders

3987

17334

1.54

128.37

3.7

3.3

130.60

129.60

g/l

1.96

3882

16943

Transient ischemic attack

2294

11173

1.77

128.02

3.8

3.2

128.31

127.60

g/l

0.76

2249

10889

Bronchitis

4181

18344

1.53

127.90

4.4

3.2

128.88

129.45

g/l

0.85

4089

17912

Anxiety (asthma-related co-morbidities)

2046

9102

1.82

127.77

4.1

3.4

132.35

130.96

g/l

2.00

2002

8897

Diabetic nephropathy, excluding more controls

893

3180

2.59

127.43

9.4

3.1

113.12

131.32

g/l

97.71

874

3107

Mood [affective] disorders

3973

17314

1.54

127.39

3.7

3.3

130.62

129.60

g/l

2.04

3869

16922

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

485

1057

3.61

126.09

4.9

2.9

125.52

128.58

g/l

1.78

466

1035

Alcohol dependence

1247

6137

2.14

125.66

3.9

3.5

129.83

130.48

g/l

0.42

1217

5995

Kela-code for severe mental illness

1481

7740

1.99

124.35

3.2

3.5

130.49

130.75

g/l

0.17

1444

7563

Cholelithiasis, broad definition with cholecystitis

3428

15191

1.59

124.31

3.7

3.2

128.49

128.79

g/l

0.31

3350

14845

Benign neoplasm of colon, rectum, anus and anal canal

2607

14461

1.69

124.09

4.2

3.3

124.82

128.58

g/l

13.36

2548

14131

Intracranial injury

2325

13417

1.73

123.80

3.5

3.6

129.55

129.10

g/l

0.44

2279

13101

Intestinal stricture

1394

7191

2.04

123.40

4.3

3.5

124.64

128.01

g/l

5.89

1351

7016

Abnormal findings on examination of blood, without diagnosis

2050

11104

1.80

123.34

5.3

3.5

124.44

129.59

g/l

18.51

1996

10843

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

761

2972

2.65

122.96

7.6

4.6

121.18

130.71

g/l

21.61

744

2895

Atherosclerosis, excluding cerebral and coronary sclerosis

1944

8821

1.85

122.48

5.5

3.1

119.05

128.54

g/l

60.17

1890

8607

Cardiomyopathy

785

3233

2.59

121.98

5.3

2.9

128.45

130.03

g/l

0.98

761

3159

Ulcer of lower limb, not elsewhere classified

760

3111

2.67

121.91

6.4

3.2

114.89

128.56

g/l

48.08

750

3037

Other acute lower respiratory infections

2185

12340

1.75

120.33

4.7

3.6

128.02

129.03

g/l

1.28

2133

12048

Persons encountering health services in other circumstances, wide

4829

17303

1.48

120.32

4.4

3.3

128.78

129.74

g/l

1.95

4723

16893

Vocal cord dysfunction

445

1239

3.49

120.04

3.7

2.8

126.89

131.04

g/l

2.80

426

1211

Other and unspecified iron deficiency

1382

7190

2.01

118.51

4.7

3.3

113.93

129.00

g/l

106.43

1353

7021

Medical observation and evaluation for suspected diseases and conditions

2799

8802

1.67

117.83

4.1

2.9

129.75

131.06

g/l

2.03

2739

8597

Acute alcohol intoxication, ICD10

910

4074

2.37

117.08

3.5

3.6

133.36

131.32

g/l

1.85

887

3978

Hernia of abdominal wall, postoperative

788

3313

2.52

116.75

5.2

2.6

124.71

133.84

g/l

20.91

775

3234

Other or unspecified ileus, impaction or obstruction

882

3907

2.41

116.56

4.3

3.3

125.01

128.38

g/l

3.83

853

3822

Viral hepatitis, IBD co-morbidity

235

462

5.48

114.54

4.0

2.4

130.91

133.75

g/l

0.84

229

454

Other special examinations and investigations of persons without complaint or reported diagnosis

2810

8805

1.65

114.08

4.3

2.9

128.56

131.06

g/l

6.29

2746

8600

Spondylopathies

3198

12541

1.59

114.05

3.3

128.58

128.98

g/l

0.43

3110

12279

Osteopathies and chondropathies

2191

12492

1.72

113.97

5.0

3.3

124.36

128.99

g/l

18.34

2139

12203

Benign neoplasm: Colon

2218

13155

1.72

113.68

4.3

3.3

124.74

128.25

g/l

10.19

2168

12837

Acute alcohol intoxication

1143

5659

2.12

113.15

3.5

131.79

130.20

g/l

1.48

1112

5525

Disorders of other endocrine glands

1727

9598

1.83

113.01

6.1

3.6

124.96

128.73

g/l

9.68

1688

9381

Gastroduodenal ulcer

1231

6260

2.07

112.59

4.6

3.2

119.43

128.28

g/l

29.23

1207

6113

Disorders of lens

2774

11012

1.64

111.91

4.9

3.2

124.83

130.16

g/l

25.81

2700

10798

Cholelithiasis

3256

14958

1.56

111.87

3.6

3.2

128.55

128.74

g/l

0.18

3184

14616

Emotionally unstable personality disorder

480

1613

3.16

110.07

3.2

3.1

132.42

132.77

g/l

0.13

468

1577

Type 1 diabetes, definitions combined

427

1337

3.40

109.99

4.3

4.6

131.33

134.94

g/l

2.54

415

1307

Type 1 diabetes, strict (exclude DM2)

424

1327

3.40

109.33

4.3

4.9

131.28

134.69

g/l

2.31

412

1298

Emergency coronary revascularization (for ACS)

2483

11108

1.67

108.71

4.2

3.2

121.85

128.84

g/l

40.66

2397

10872

Cystic kidney disease

254

577

5.33

108.38

8.8

3.8

111.24

128.93

g/l

25.31

249

569

Ischaemic Stroke, excluding all haemorrhages

2410

11305

1.67

107.44

4.1

3.2

126.95

127.85

g/l

1.08

2356

11016

Neurotic, stress-related and somatoform disorders

3213

15047

1.55

107.27

4.1

3.4

131.32

129.93

g/l

2.87

3137

14698

All anxiety disorders

2064

9923

1.71

105.80

4.1

3.4

132.33

130.96

g/l

2.01

2020

9694

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1770

8999

1.80

105.48

3.5

3.3

118.25

130.63

g/l

93.80

1739

8772

External causes of morbidity and mortality

2601

8060

1.65

105.47

3.6

3.3

129.02

130.90

g/l

3.59

2534

7892

COPD (mode)

1371

5796

1.96

105.36

4.5

2.7

127.14

129.92

g/l

3.98

1333

5675

Misadventures to patients during surgical and medical care

664

2720

2.63

105.22

5.0

2.9

123.16

129.21

g/l

8.99

647

2652

Acute peritonitis

397

1248

3.60

105.15

10.8

3.3

113.65

127.76

g/l

25.14

392

1216

Schizophrenia or delusion

1226

6364

2.00

105.13

3.0

3.5

130.72

131.20

g/l

0.32

1197

6221

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

356

1037

3.79

104.93

3.6

3.3

131.76

130.32

g/l

0.58

347

1014

Congenital malformations of the urinary system

347

1000

3.91

104.91

8.5

4.6

114.92

129.92

g/l

24.40

339

975

Soft tissue disorders

4053

14427

1.49

104.89

4.2

3.4

129.75

129.71

g/l

0.04

3949

14103

Anxiety disorders

3242

15250

1.54

104.48

4.1

3.3

131.38

129.87

g/l

3.32

3164

14896

Schizophrenia, schizotypal and delusional disorders

1230

6415

1.99

104.00

3.0

3.5

130.69

131.19

g/l

0.33

1200

6272

Deposits [accretions] on teeth

396

1197

3.54

103.66

12.8

3.4

115.81

130.99

g/l

26.91

389

1165

Other anxiety disorders

1484

7237

1.87

103.20

3.7

3.3

132.11

131.26

g/l

0.78

1453

7077

Factors influencing health status and contact with health services

1339

3429

2.01

102.67

3.6

2.3

129.40

134.79

g/l

11.46

1307

3365

Gout, idiopatic and unspecified

1166

6062

2.04

101.97

5.7

3.4

121.51

128.82

g/l

20.14

1131

5907

Epilepsy

1269

6720

1.96

101.74

4.2

3.7

129.35

128.19

g/l

1.05

1242

6561

Viral pneumonia

590

2320

2.73

101.64

6.2

3.3

124.97

130.65

g/l

6.89

565

2262

Exposure to unspecified factor

3657

19475

1.49

101.58

3.8

3.5

129.08

129.55

g/l

0.59

3589

19003

Asthma/COPD (KELA code 203)

3629

17478

1.49

101.30

3.7

3.4

130.14

129.52

g/l

0.87

3544

17075

Unspecified haematuria

1804

9084

1.77

101.27

4.8

3.3

125.98

129.30

g/l

7.78

1773

8856

Venous thromboembolism

2207

13328

1.66

100.96

4.2

3.2

125.78

128.27

g/l

5.66

2159

13004

Asthma, including avohilmo

4509

18535

1.44

100.93

3.6

3.5

130.29

129.30

g/l

2.11

4409

18103

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

335

958

3.81

100.92

3.5

3.3

136.12

135.26

g/l

0.27

325

944

Sequelae of external causes of morbidity and mortality

1083

5504

2.07

100.11

4.5

3.4

122.47

128.99

g/l

16.37

1056

5374

Autoimmune diseases related-to ILD

3194

18912

1.52

99.77

4.4

3.3

128.11

129.76

g/l

3.81

3113

18490

Other diseases of urinary system

3922

15241

1.48

99.42

4.2

3.3

126.67

129.68

g/l

13.30

3839

14879

Dorsopathies

3982

14020

1.48

99.18

3.7

3.4

130.65

129.54

g/l

2.22

3876

13716

Cutaneous abscess, furuncle and carbuncle

1013

5037

2.10

98.77

5.7

3.4

125.51

131.17

g/l

11.11

986

4931

Continuous positive airway pressure

596

2022

2.64

97.34

5.0

3.6

128.29

130.46

g/l

1.24

585

1996

Asthma, hospital admissions , main diagnosis only

3083

18560

1.52

97.18

3.8

3.5

129.64

129.23

g/l

0.45

3016

18121

Other intervertebral disc disorders

3191

13054

1.53

97.11

3.5

3.3

129.85

129.17

g/l

0.87

3088

12778

Other bacterial intestinal infections

807

3724

2.30

96.60

7.0

3.1

120.14

128.50

g/l

19.62

784

3635

Cholecystectomy

2678

15490

1.57

96.44

3.6

3.3

129.40

128.05

g/l

2.44

2618

15123

Direct fill therapy

617

2546

2.60

96.01

10.1

3.6

118.20

130.82

g/l

30.52

603

2484

Other external causes of accidental injury

3251

10874

1.53

94.75

3.8

3.5

129.12

130.03

g/l

1.36

3175

10619

General examination and investigation of persons without complaint and reported diagnosis

2587

8774

1.60

94.58

4.3

2.9

128.35

131.10

g/l

6.86

2517

8569

Finngen Rheumatological endpoints

3646

14302

1.48

94.32

4.0

3.2

129.00

130.68

g/l

4.11

3547

13986

Diseases of liver

1368

7649

1.86

93.68

4.5

3.4

123.39

129.71

g/l

17.39

1330

7458

Other CVD

923

4553

2.16

93.65

4.7

3.3

123.53

127.18

g/l

5.62

888

4445

Dermatitis

2298

14686

1.61

93.60

4.2

3.3

126.51

129.25

g/l

7.08

2246

14349

Fungal Sepsis

249

621

4.70

93.52

9.2

2.6

116.24

128.90

g/l

12.34

242

606

Non-allergic asthma (mode), excluding more controls

770

3481

2.29

93.40

3.6

3.1

128.59

130.50

g/l

1.46

755

3413

Sulfonylureas

1543

7073

1.81

92.97

4.5

3.1

121.84

127.80

g/l

20.29

1510

6885

Benzodiazepine use

3773

18820

1.45

92.42

3.6

3.4

129.35

129.34

g/l

0.01

3676

18399

Retention of urine

1494

7239

1.82

91.85

4.4

3.3

125.06

128.97

g/l

8.91

1453

7045

Sleep disorders (combined)

3699

16925

1.46

91.42

3.9

3.3

132.90

128.81

g/l

22.48

3613

16523

Pulmonary heart disease, diseases of pulmonary circulation

1354

7620

1.86

91.01

4.5

3.3

125.84

127.49

g/l

1.73

1316

7441

Early onset COPD, excluding more controls

855

4118

2.18

90.94

4.7

2.8

129.72

131.40

g/l

1.21

832

4032

Diseases of the skin and subcutaneous tissue

3991

14066

1.45

89.80

4.2

3.2

128.14

130.61

g/l

8.84

3892

13735

Benign neoplasms

2808

10471

1.55

89.39

4.0

3.3

129.82

133.06

g/l

10.23

2737

10233

Disorders of calcium metabolism

329

1015

3.60

89.16

7.7

2.8

118.41

129.12

g/l

13.94

323

988

Congenital malformations, deformations and chromosomal abnormalities

2002

11965

1.64

89.13

5.2

3.5

127.42

131.08

g/l

9.97

1950

11692

Unspecified acute lower respiratory infection

676

3001

2.39

88.99

5.6

3.3

127.21

130.61

g/l

3.31

661

2934

Disorders of mineral metabolism

397

1366

3.18

88.95

7.4

2.9

120.46

129.46

g/l

12.00

389

1329

DVT of lower extremities and pulmonary embolism

1716

10339

1.72

88.78

4.2

3.3

126.22

127.79

g/l

2.04

1680

10079

Streptococcal septicaemia

426

1527

3.05

88.73

5.4

3.0

117.46

130.93

g/l

23.40

416

1486

Senile cataract

2503

10079

1.58

88.21

4.6

3.2

124.90

129.63

g/l

19.07

2433

9880

Implicit fungal Sepsis

227

561

4.74

86.36

9.2

2.4

116.25

128.47

g/l

10.68

220

548

Disorder of lipoprotein metabolism, unspecified

628

2744

2.45

86.27

4.6

2.8

127.29

128.69

g/l

0.78

618

2676

Benign neoplasms

3745

14700

1.45

86.08

4.0

3.3

129.25

130.46

g/l

2.40

3653

14370

Accidents

3195

10874

1.50

85.62

3.8

3.5

128.98

130.03

g/l

1.67

3121

10619

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

221

533

4.66

85.55

8.3

3.0

120.20

135.34

g/l

14.11

215

524

Diabetic retinopathy, excluding more controls

1289

3997

1.93

85.08

6.1

3.0

121.86

131.02

g/l

32.70

1254

3902

Explicit bacterial Sepsis

482

1877

2.76

84.91

5.6

3.0

117.67

130.49

g/l

24.60

470

1829

Other disorders of glucose regulation and pancreatic internal secretion

429

1581

2.95

84.70

5.9

3.6

123.89

129.01

g/l

4.30

416

1539

Other headache syndromes

1454

8490

1.76

84.47

3.6

3.2

131.48

128.14

g/l

7.28

1421

8292

Hernia

3542

16907

1.45

84.40

4.1

3.4

127.19

129.85

g/l

9.11

3475

16510

Unspecified fall

1880

11671

1.65

84.01

3.9

3.6

128.39

128.77

g/l

0.31

1842

11400

Nonorganic sleeping disorders, excluding more controls

628

2756

2.38

83.73

3.9

3.4

132.70

130.25

g/l

2.00

616

2697

Enterocolitis due to Clostridium difficile

540

2243

2.60

83.60

7.4

3.0

117.22

127.38

g/l

19.72

521

2181

Type 1 diabetes, strict definition, subgroup 1

297

880

3.57

83.59

4.1

4.9

132.75

136.69

g/l

2.16

287

866

Other cataract

1733

8184

1.69

82.91

4.8

3.2

123.94

129.30

g/l

17.34

1690

8010

Hydronephrosis

516

2102

2.64

82.81

5.2

2.6

118.22

130.81

g/l

27.91

504

2044

Cardiomyopathies, Primary/intrinsic

536

2223

2.57

82.39

5.7

3.0

128.81

130.18

g/l

0.61

517

2171

Hyperparathyroidism

828

4059

2.14

82.25

6.8

3.0

119.19

126.38

g/l

17.73

810

3957

Abnormal findings on diagnostic imaging of lung

1915

11804

1.63

81.88

4.2

3.3

125.31

128.32

g/l

6.96

1880

11505

ILD medications: azathioprine

605

2649

2.41

81.72

8.9

3.0

121.70

132.50

g/l

24.34

593

2589

Bacterial intestinal infections, IBD co-morbidities

801

3934

2.15

81.68

7.0

3.3

120.30

128.30

g/l

18.09

777

3839

Disorders of parathyroid gland

911

4627

2.05

81.50

6.8

3.0

119.52

126.42

g/l

18.35

890

4510

Bipolar affective disorders

657

2977

2.30

81.12

2.8

3.2

131.95

131.38

g/l

0.28

642

2915

Functional dyspepsia

1004

5328

1.96

80.97

3.9

3.2

130.71

129.13

g/l

1.54

981

5214

Conductive and sensorineural hearing loss

3091

14843

1.48

80.57

3.7

3.4

127.39

128.79

g/l

2.76

3012

14515

Delirium, not induced by alcohol and other psychoactive substances

561

2409

2.51

80.52

4.5

3.2

125.57

126.86

g/l

0.68

550

2347

Elevated blood glucose level

418

1565

2.92

80.29

7.8

3.3

125.56

129.60

g/l

2.75

406

1522

Cardiomyopathy (excluding other)

550

2335

2.51

80.29

5.7

2.9

128.73

130.31

g/l

0.75

530

2281

Other and unspecified nonorganic psychotic disorders

698

3258

2.23

80.20

2.9

3.5

132.45

132.53

g/l

0.03

682

3184

Other diseases of pleura

1878

10516

1.64

80.00

5.2

3.4

123.80

128.12

g/l

12.48

1821

10253

Gout, strict definition

845

4284

2.11

79.95

6.0

3.4

121.61

128.26

g/l

12.57

821

4173

Non-allergic asthma (mode)

770

3710

2.14

79.47

3.6

3.1

128.59

129.58

g/l

0.57

755

3638

Superficial injury of head

907

4689

2.02

79.31

3.4

3.5

128.75

129.04

g/l

0.16

884

4579

Other and unspecified dermatitis

1867

11829

1.62

79.13

4.0

3.3

126.71

129.11

g/l

4.60

1826

11550

Other/unspecified dorsalgia

1389

8132

1.75

78.72

3.5

3.3

129.04

128.42

g/l

0.48

1353

7951

Peripheral artery operations in Hilmo

625

2838

2.36

78.43

7.2

3.0

113.63

128.73

g/l

50.41

613

2773

Behavioural syndromes associated with physiological disturbances and physical factors

1060

5771

1.89

78.11

4.1

3.6

131.18

130.55

g/l

0.42

1039

5634

Pulmonary embolism

1211

6904

1.83

77.96

4.5

3.3

125.50

127.73

g/l

2.63

1181

6740

Other gastritis (incl. Duodenitis)

959

5091

1.97

77.87

4.3

3.3

123.77

128.95

g/l

9.21

939

4973

Acute upper respiratory infections of multiple and unspecified sites

2639

13396

1.50

77.85

4.3

3.4

130.22

129.45

g/l

0.97

2591

13081

Diseases of the respiratory system

2465

8112

1.55

77.74

3.7

2.9

128.44

130.68

g/l

4.65

2398

7951

Type 1 diabetes, strict definition

308

979

3.32

77.36

4.3

5.3

132.78

136.12

g/l

1.69

298

959

Chronic pancreatitis

577

2553

2.43

77.29

4.9

3.4

123.74

130.20

g/l

8.78

562

2493

Amputation

516

2180

2.57

77.24

8.0

3.2

113.07

128.17

g/l

40.62

503

2123

Cough

1410

8019

1.73

77.14

4.3

3.4

129.24

128.58

g/l

0.51

1379

7834

Pulmonary heart disease

1211

6929

1.82

77.00

4.5

3.3

125.50

127.77

g/l

2.72

1181

6761

Hypotension

772

3844

2.14

76.51

4.7

3.1

124.05

127.02

g/l

3.40

752

3749

Gout, unspecified

923

4895

2.00

76.23

5.6

3.3

121.45

128.73

g/l

15.99

894

4773

Sensorineural hearing loss

2945

14335

1.47

75.86

3.6

3.4

127.27

128.61

g/l

2.48

2868

14024

COPD

1848

9694

1.63

75.64

4.5

3.3

127.47

127.90

g/l

0.32

1797

9462

Injury, poisoning and certain other consequences of external causes

2038

6461

1.61

75.57

3.6

3.3

128.98

130.70

g/l

2.51

1982

6314

Azathioprine

605

2739

2.32

75.54

8.9

3.3

121.70

131.70

g/l

21.17

593

2675

Missing teeth due to accident, extraction or parodontitis

535

2317

2.47

75.16

5.7

3.1

123.30

129.54

g/l

7.46

525

2258

Panic disorder

488

2009

2.53

75.08

3.9

2.9

132.98

131.68

g/l

0.61

476

1969

Acute bronchitis

1569

9463

1.67

74.88

4.3

3.6

128.17

128.29

g/l

0.07

1530

9243

Use of hypnotics and sedatives

3987

16846

1.39

74.04

3.9

3.4

128.26

129.86

g/l

4.22

3889

16465

Cardiac arrest

260

646

3.70

73.90

6.2

2.4

122.92

133.13

g/l

8.98

245

636

Osteoporosis

1057

5607

1.88

73.77

5.2

3.0

123.01

126.37

g/l

5.90

1030

5469

Open wound of head

1977

12700

1.57

73.61

3.5

3.6

128.57

129.41

g/l

0.89

1931

12398

Hypoglycaemia, other or unspecified

347

1233

3.08

73.57

6.1

3.8

123.34

128.81

g/l

3.92

337

1203

Viral and other specified intestinal infections

728

3480

2.11

73.20

6.9

3.4

127.64

132.40

g/l

6.55

702

3405

Presence of other functional implants

2173

10152

1.56

73.10

4.2

2.8

125.06

129.40

g/l

15.65

2113

9935

Sequelae with surgical and medical care as external cause

834

4328

2.03

72.94

4.6

3.3

121.10

128.50

g/l

16.24

813

4217

Neoplasms

2745

10043

1.49

72.94

4.9

3.3

128.35

133.34

g/l

22.02

2678

9821

Injuries to the thorax

1730

11004

1.62

72.47

4.0

3.4

128.05

129.15

g/l

1.19

1698

10742

Gastric ulcer

796

4074

2.06

72.38

4.8

3.1

118.73

128.28

g/l

23.16

779

3975

Diseases of peritoneum

490

2079

2.54

72.36

9.4

3.1

116.56

128.44

g/l

22.74

482

2028

Depression or dysthymia

2650

10101

1.50

72.20

3.9

3.4

130.52

129.14

g/l

2.29

2578

9882

Injuries to the abdomen, lower back, lumbar spine and pelvis

1495

9126

1.68

72.15

3.8

3.4

126.59

128.58

g/l

2.84

1465

8918

Non-selective monoamine reuptake inhibitors

1486

8840

1.68

71.95

3.6

3.2

127.61

127.99

g/l

0.28

1437

8643

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

3243

13633

1.43

71.06

4.6

3.4

124.50

131.85

g/l

56.81

3175

13315

Vascular disorders of the intestines

354

1298

3.00

71.05

5.5

3.0

115.46

128.37

g/l

20.09

342

1267

Malignant neoplasm, wide definition for exclusion

3243

13635

1.43

71.01

4.6

3.4

124.50

131.85

g/l

56.77

3175

13317

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

3242

13632

1.43

70.97

4.6

3.4

124.48

131.85

g/l

57.05

3174

13314

Peripheral arterial reconstruction

803

4169

2.05

70.80

6.0

3.3

116.01

127.52

g/l

39.46

778

4063

Cytomegalovirus infection, IBD co-morbidity

165

376

5.30

70.31

11.8

3.8

109.26

129.29

g/l

22.12

156

371

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

401

1575

2.74

69.63

4.9

3.0

125.82

129.77

g/l

2.98

387

1538

Coronary angioplasty

1520

7206

1.68

69.62

3.9

3.0

124.53

129.54

g/l

14.16

1474

7047

Diabetic nephropathy

899

4845

1.98

69.56

9.3

3.6

113.12

129.03

g/l

83.04

879

4728

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

760

3889

2.07

69.54

3.7

3.3

117.70

130.25

g/l

46.76

746

3788

Other symptoms and signs involving cognitive functions and awareness

1693

10142

1.61

69.12

3.5

3.3

127.88

g/l

0.00

1651

9898

Tobacco use

267

848

3.49

69.09

3.8

3.1

133.92

130.79

g/l

1.22

262

831

Persons encountering health services for examination and investigation

2581

8805

1.50

68.86

3.7

2.9

129.39

131.06

g/l

2.93

2522

8600

Cytomegaloviral disease

165

383

5.15

68.51

11.8

3.6

109.26

128.78

g/l

21.26

156

377

Acute sinusitis

1723

10288

1.60

68.49

4.3

3.3

131.13

130.14

g/l

1.03

1678

10052

Dentofacial anomalies [including malocclusion]

897

4792

1.91

67.82

6.1

3.0

130.25

131.26

g/l

0.72

877

4679

Dysphagia

902

4901

1.91

67.77

4.0

3.1

125.62

128.18

g/l

2.80

876

4785

Other disorders of ear

3393

16424

1.40

67.19

3.7

3.5

128.41

129.16

g/l

1.10

3312

16055

Cervicobrachial syndrome

802

4207

1.98

66.97

3.2

3.4

131.65

128.67

g/l

3.46

782

4109

Symptoms and signs concerning food and fluid intake

418

1701

2.61

66.71

6.0

3.2

124.44

130.16

g/l

5.61

401

1658

Mycoses

990

5567

1.85

66.65

5.8

3.4

125.42

129.47

g/l

6.30

969

5428

Certain disorders involving the immune mechanism

764

3964

2.02

66.59

8.4

3.4

122.99

130.06

g/l

13.09

745

3863

Diseases of the eye and adnexa

2949

10386

1.44

66.12

4.5

3.4

129.91

131.59

g/l

3.24

2874

10169

Recurrent or chronic depression

1297

5582

1.72

66.03

3.6

3.3

132.70

130.42

g/l

3.07

1265

5467

Dipeptidyl peptidase 4 (DPP-4) inhibitors

533

2442

2.34

65.78

4.2

3.1

125.57

129.14

g/l

2.79

523

2379

Other chronic obstructive pulmonary disease

1748

9430

1.59

65.70

4.6

3.3

127.47

127.81

g/l

0.24

1699

9207

Acute pancreatitis

806

4279

1.97

65.62

4.6

3.4

128.17

129.69

g/l

0.97

779

4174

Focal epilepsy

834

4479

1.94

65.22

4.0

3.8

129.30

129.44

g/l

0.06

818

4368

Other and unspecified drugs and medicaments

386

1540

2.71

65.16

4.9

3.3

125.54

128.43

g/l

1.73

373

1503

Transport accidents

1555

8717

1.62

64.86

3.2

3.3

131.41

130.75

g/l

0.54

1516

8519

Other viral diseases

980

5514

1.83

64.52

6.9

3.9

125.89

131.49

g/l

10.92

952

5387

Schizophrenia

626

3056

2.14

64.48

3.2

3.4

130.95

131.66

g/l

0.33

610

2987

Shoulder lesions

2902

12636

1.43

64.29

3.5

3.2

130.12

129.29

g/l

1.09

2811

12356

Amputation of toe

374

1495

2.75

63.67

8.7

3.1

112.14

127.62

g/l

32.48

365

1453

Temporomandibular joint disorders

508

2287

2.30

63.62

4.0

3.1

130.54

129.11

g/l

0.81

495

2232

Spinal stenosis

1964

10289

1.54

63.32

3.4

3.3

126.26

127.96

g/l

2.73

1920

10076

Intestinal adhesions without obstruction

391

1593

2.65

63.16

3.7

3.1

127.06

129.01

g/l

0.90

375

1556

Other specified and unspecified personality disorders

363

1420

2.71

63.03

3.2

3.1

130.42

132.13

g/l

0.72

354

1388

Other diseases of pericardium

226

687

3.65

62.83

6.7

2.9

117.26

129.46

g/l

11.82

219

668

Other blood glucose lowering drugs, excl. Insulins

689

3531

2.05

62.48

4.1

3.2

126.25

128.81

g/l

2.12

670

3433

KRA_PSY_EATING, excluding more controls

233

709

3.41

62.40

5.7

3.4

128.28

130.78

g/l

1.00

227

694

Cellulitis

828

4515

1.91

61.76

5.6

3.4

124.38

130.46

g/l

11.37

806

4408

Schizoaffective disorder

318

1179

2.88

61.63

2.8

3.1

130.74

131.95

g/l

0.46

309

1152

Sleep apnoea

3281

16373

1.38

60.35

4.0

3.3

133.12

128.86

g/l

21.25

3206

15991

Hernia of abdominal wall

1689

11142

1.56

60.27

4.4

3.3

127.14

129.42

g/l

3.66

1650

10880

Symptoms and signs involving the skin and subcutaneous tissue

2371

16599

1.45

60.24

4.1

3.4

129.51

128.91

g/l

0.68

2310

16213

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1721

8829

1.57

60.17

3.3

119.82

130.47

g/l

62.99

1684

8613

Injuries to the hip and thigh

1771

10779

1.54

59.95

4.0

3.4

124.61

128.36

g/l

9.86

1732

10522

Mental and behavioural disorders due to sedatives or hypnotics

297

1080

2.96

59.94

3.5

3.2

132.39

131.72

g/l

0.19

290

1053

Chronic periodontitis, complicated

437

1919

2.45

59.94

8.7

3.3

116.49

129.54

g/l

24.41

431

1866

Enlarged lymph nodes

554

2652

2.18

59.88

4.3

3.2

126.47

131.23

g/l

4.90

542

2593

Organic, including symptomatic, mental disorders

1953

9512

1.53

59.86

3.7

3.4

126.56

127.02

g/l

0.42

1910

9265

Other complications of surgical and medical care, not elsewhere classified

401

1690

2.52

59.71

4.7

2.8

125.97

129.93

g/l

2.77

386

1649

Assault

470

2118

2.32

59.26

3.5

3.6

134.62

134.05

g/l

0.21

460

2079

Ascites

333

1299

2.78

58.97

7.4

2.8

113.16

128.64

g/l

28.64

327

1262

Post-traumatic stress disorder

253

847

3.13

58.39

4.9

3.0

132.47

131.84

g/l

0.18

246

837

Spondylosis

1938

11292

1.51

58.29

3.1

3.3

129.77

128.63

g/l

1.38

1885

11056

Ventral hernia

933

5370

1.81

58.23

4.2

3.2

125.46

128.74

g/l

4.08

907

5235

Noninfective enteritis and colitis

1616

10612

1.56

58.10

4.8

3.7

127.64

129.77

g/l

3.27

1578

10365

Other chronic obstructive pulmonary disease, including avohilmo

2074

11902

1.49

57.88

4.4

3.3

128.06

128.19

g/l

0.09

2020

11626

Migraine

1385

7434

1.61

57.70

3.1

3.2

133.22

128.95

g/l

11.56

1344

7262

COPD related to multimorbidity

1579

8700

1.58

57.54

4.7

3.3

127.27

127.74

g/l

0.33

1535

8482

Gastro-oesophageal reflux disease

2358

14785

1.44

56.97

4.0

3.3

127.99

130.03

g/l

4.25

2288

14462

Viral infections characterized by skin and mucous membrane lesions

1453

9374

1.59

56.96

5.0

3.6

127.34

129.81

g/l

3.92

1411

9163

Allergic asthma (mode), excluding more controls

698

3608

1.95

56.73

3.6

2.9

131.78

132.70

g/l

0.48

683

3544

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1091

6588

1.71

56.63

4.3

3.5

129.33

130.08

g/l

0.52

1067

6439

Diseases of the musculoskeletal system and connective tissue

1966

6608

1.52

56.55

4.1

3.4

130.31

131.23

g/l

0.92

1916

6469

Other infectious diseases

373

1569

2.56

56.35

6.6

3.1

123.46

128.13

g/l

3.59

368

1528

Malignant neoplasm

3212

14081

1.38

56.04

4.5

3.4

124.16

131.39

g/l

55.63

3140

13760

Mental and behavioural disorders due to opioids

172

469

4.00

55.92

3.7

3.1

131.41

135.17

g/l

1.14

165

461

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

352

1451

2.62

55.56

5.0

3.0

122.74

128.01

g/l

4.03

346

1412

Diseases of oral cavity, salivary glands and jaws

3467

13256

1.36

55.50

4.8

3.1

127.96

129.96

g/l

5.37

3387

12959

Left ventricular outflow tract obstruction (LVOTO), broad definition

429

1926

2.37

55.45

6.9

4.3

123.22

131.74

g/l

9.74

419

1882

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

615

3168

2.06

55.42

5.0

3.6

116.42

129.84

g/l

32.47

601

3093

Other metabolic disorders

432

1933

2.34

55.41

5.1

2.8

128.54

130.00

g/l

0.67

416

1888

Iron deficiency anaemia secondary to blood loss (chronic)

660

3475

1.99

55.35

5.6

3.2

111.23

128.92

g/l

60.47

640

3399

All influenza (not pneumonia)

566

2823

2.09

54.98

5.4

3.0

127.76

132.35

g/l

5.01

544

2760

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

621

3218

2.04

54.85

3.6

3.4

119.67

130.88

g/l

28.09

608

3130

Acute pancreatitis (for exclusion)

806

4530

1.86

54.82

4.6

3.4

128.17

129.44

g/l

0.76

779

4422

Selective serotonin reuptake inhibitors

3696

14692

1.34

54.37

3.5

3.4

130.95

129.30

g/l

4.13

3598

14374

Fitting and adjustment of other devices

1260

7392

1.63

54.36

3.7

2.7

127.50

129.05

g/l

1.76

1240

7196

Focal epilepsy, strict definition

752

4163

1.88

53.55

4.0

3.7

129.43

129.21

g/l

0.09

740

4062

Acute upper respiratory infections

3711

17690

1.33

53.50

4.0

3.3

129.99

128.86

g/l

2.30

3621

17280

Visual disturbances

1628

10930

1.53

53.24

4.6

3.4

129.73

128.72

g/l

1.05

1579

10674

Sleep disorders

715

3900

1.90

52.99

3.8

3.5

132.22

130.44

g/l

1.37

702

3804

Lumbar disc prolapse

2179

12214

1.44

52.85

3.6

3.3

130.12

129.42

g/l

0.70

2107

11951

Cystitis

2889

12961

1.38

52.84

4.0

3.2

126.82

128.95

g/l

5.85

2827

12630

Focal epilepsy, mode (most common among epilepsy diagnosis)

712

3894

1.91

52.74

3.6

3.7

129.68

129.28

g/l

0.19

700

3797

Sleep apnoea, including avohilmo

3391

16601

1.35

52.45

3.9

3.3

133.07

128.86

g/l

21.50

3310

16214

Postprocedural endocrine and metabolic disorders, not elsewhere classified

398

1764

2.36

52.28

4.3

2.6

129.19

129.79

g/l

0.21

383

1720

Myocarditis

168

472

3.78

51.68

6.2

2.4

130.90

136.30

g/l

2.10

162

463

Endocarditis

182

550

3.67

51.21

7.5

3.1

113.29

130.09

g/l

13.08

176

534

Speech and linguistic disorders, excluding more controls

264

911

2.86

51.13

6.7

5.9

131.40

130.20

g/l

0.36

259

890

Decubitus ulcer and pressure area

293

1157

2.77

51.08

7.6

3.1

116.74

127.55

g/l

10.87

286

1130

Polyneuropathies and other disorders of the peripheral nervous system

864

5060

1.78

51.08

5.2

3.4

124.29

128.60

g/l

6.51

842

4932

Irritable bowel syndrome

873

5098

1.76

51.07

3.6

3.1

131.73

129.55

g/l

2.49

855

4986

Aortic aneurysm

929

5444

1.74

51.06

4.4

3.2

125.23

129.57

g/l

6.13

902

5312

Visual disturbances and blindness

1750

12023

1.49

50.93

4.7

3.4

129.20

128.61

g/l

0.52

1697

11749

Other and unspecified local infections of skin and subcutaneous tissue

393

1767

2.36

50.60

7.2

3.5

122.94

129.41

g/l

6.04

385

1717

Coxarthrosis [arthrosis of hip](FG)

2049

10414

1.45

50.42

3.4

3.2

127.28

129.15

g/l

3.25

2005

10190

Carpal tunnel syndrome

2059

13144

1.44

50.32

3.5

3.2

128.43

128.86

g/l

0.37

2006

12872

Traumatic subdural haemorrhage

534

2655

2.08

50.25

4.0

3.1

126.31

126.65

g/l

0.13

520

2593

Toxic effects of substances chiefly nonmedicinal as to source

439

2066

2.24

50.16

3.4

3.5

131.82

130.81

g/l

0.43

433

2014

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1110

6940

1.65

50.13

4.1

3.5

132.16

128.50

g/l

6.29

1066

6787

Injuries to the ankle and foot

2177

14159

1.42

50.07

4.3

3.5

129.81

130.72

g/l

1.10

2136

13809

Diseases of the ear and mastoid process

4156

16306

1.31

50.06

3.6

3.5

130.36

129.69

g/l

1.05

4057

15931

Parodontitis or operation codes

3180

17686

1.35

50.01

4.3

3.2

127.46

129.67

g/l

6.01

3105

17285

Fracture of rib(s), sternum and thoracic spine

1125

7088

1.64

49.65

3.9

3.4

128.26

129.00

g/l

0.50

1103

6911

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

796

4508

1.79

49.59

7.3

3.5

128.27

130.85

g/l

2.77

772

4401

Other respiratory disorders and diseases

819

4763

1.79

49.58

5.7

3.6

126.16

127.63

g/l

0.97

780

4654

Other diseases of the respiratory system

819

4763

1.79

49.58

5.7

3.6

126.16

127.63

g/l

0.97

780

4654

Nonorganic sleeping disorders

628

3359

1.94

49.58

3.9

3.4

132.70

130.62

g/l

1.60

616

3276

ILD, hospital admission 2, with pulmonary infections

406

1869

2.31

49.52

5.3

3.0

125.01

128.64

g/l

2.56

390

1820

Other local infections of skin and subcutaneous tissue

411

1900

2.29

49.40

7.0

3.4

123.28

129.65

g/l

6.13

403

1846

Other and unspecified effects of external causes

873

5149

1.74

49.35

3.8

131.39

130.41

g/l

0.65

855

5032

Parodontitis

3172

17687

1.34

49.29

4.3

3.2

127.48

129.67

g/l

5.89

3097

17286

COPD, hospital admissions

1749

10212

1.49

49.16

4.6

3.3

127.49

127.86

g/l

0.26

1699

9963

Phobic anxiety disorders

380

1689

2.33

49.14

5.0

3.2

133.40

133.10

g/l

0.09

370

1657

Somatoform disorder

545

2797

2.02

48.76

3.8

3.3

131.19

129.30

g/l

1.24

528

2735

Early onset COPD

855

5053

1.76

48.68

4.7

3.4

129.72

129.39

g/l

0.15

832

4922

Allergic asthma (mode)

698

3794

1.85

48.56

3.6

3.0

131.78

132.00

g/l

0.09

683

3722

Other diseases of pancreas

342

1482

2.49

48.51

5.3

3.1

124.02

129.07

g/l

3.52

336

1442

COPD, early/later onset

1758

10280

1.48

48.37

4.6

3.3

127.51

127.88

g/l

0.26

1708

10029

Other viral diseases, not elsewhere classified

641

3474

1.91

48.21

7.2

3.8

127.16

130.66

g/l

3.34

626

3386

Benign neoplasm: Colon, unspecified

922

5549

1.72

48.17

4.8

3.3

124.99

130.34

g/l

10.03

898

5400

Chronic periodontitis, including avohilmo

3153

17695

1.34

48.12

4.3

3.2

127.46

129.69

g/l

6.06

3079

17293

Disturbances of skin sensation

860

5092

1.74

47.97

3.2

3.4

132.89

130.19

g/l

3.34

831

4969

Pain in thoracic spine

521

2649

2.04

47.93

3.2

3.3

130.83

129.20

g/l

0.92

507

2582

Other noninfective gastroenteritis and colitis

865

5144

1.74

47.57

5.2

3.7

125.47

128.92

g/l

4.49

851

5021

Other and unspecified polyneuropathies, also in other diseases

762

4400

1.81

47.53

5.1

3.4

123.91

128.57

g/l

6.83

742

4291

Injuries to the knee and lower leg

4162

18664

1.29

47.45

3.6

3.4

129.44

g/l

0.00

4069

18225

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

409

1926

2.26

47.19

5.5

3.1

119.25

128.70

g/l

12.46

400

1876

Aortic valve malfunction, age under 60 years

386

1776

2.31

47.10

6.8

3.8

122.09

131.73

g/l

11.09

377

1735

Noninfectious colitis NAS

517

2646

2.05

47.04

5.0

3.5

125.81

128.92

g/l

2.37

510

2582

Systemic connective tissue disorders

1225

7961

1.58

46.93

4.9

3.3

124.19

127.60

g/l

6.70

1199

7770

Candidiasis

490

2467

2.08

46.71

7.2

3.0

121.70

129.12

g/l

10.07

481

2399

Vitreous haemorrhage

426

2048

2.21

46.59

6.2

3.1

119.59

128.46

g/l

10.51

414

1989

Other skin changes

653

3629

1.88

46.30

4.5

3.4

126.17

128.21

g/l

1.48

640

3534

Diaphragmatic hernia

1300

8599

1.56

46.06

3.6

3.2

123.68

128.23

g/l

10.26

1282

8380

Coxarthrosis

1894

9037

1.45

45.87

3.4

3.2

127.30

129.10

g/l

2.76

1852

8854

Other diseases of anus and rectum

1044

6572

1.63

45.74

4.3

3.1

125.66

128.69

g/l

3.88

1019

6412

Myalgia

725

4164

1.79

45.16

3.9

3.2

131.46

129.01

g/l

2.45

709

4075

Exclusions for E4_PCOS_BROAD

596

3238

1.91

44.99

6.7

4.0

130.39

129.73

g/l

0.28

579

3156

Injuries to the shoulder and upper arm

2917

18570

1.34

44.98

3.6

3.4

128.91

129.49

g/l

0.68

2841

18155

Migraine with aura

643

3561

1.85

44.96

2.8

3.1

133.72

129.19

g/l

6.37

626

3483

Gonarthrosis [arthrosis of knee](FG)

2763

12163

1.36

44.74

3.1

3.2

129.41

129.89

g/l

0.51

2693

11898

Disorders of eyelid, lacrimal system and orbit

2914

17347

1.34

44.68

3.7

3.4

128.49

128.65

g/l

0.15

2844

16955

Alcohol withdrawal state with delirium

327

1443

2.44

44.57

4.3

3.5

128.94

130.95

g/l

0.76

317

1412

Congenital malformations of heart and great arteries

470

2297

2.07

44.22

6.4

5.0

126.40

130.71

g/l

3.51

460

2240

Type1 diabetes, definitions combined, early onset

231

858

2.82

43.97

5.1

5.9

131.27

135.64

g/l

2.11

225

839

Sequelae of cerebrovascular disease

1341

7893

1.53

43.84

4.0

3.3

125.61

127.45

g/l

2.23

1310

7694

Other and unspecified mood [affective] disorders

227

847

2.81

43.14

2.6

2.9

131.15

132.29

g/l

0.34

222

832

Congenital malformations of the circulatory system

506

2568

1.99

42.69

6.4

4.8

127.24

130.70

g/l

2.58

494

2502

Other problems related to primary support group, including family circumstances

356

1594

2.26

42.63

12.2

3.5

126.70

131.52

g/l

4.12

349

1559

Viral pneumonia (unknown virus, not influenza)

272

1128

2.57

42.23

6.0

3.4

125.89

130.65

g/l

2.59

266

1102

COPD, hospital admission 2, with asthma infections

1227

6948

1.55

42.04

5.2

3.3

126.76

127.70

g/l

0.71

1191

6769

Duodenal ulcer

472

2444

2.03

41.89

4.1

3.2

119.17

128.90

g/l

12.86

463

2387

Insomnia

523

2794

1.94

41.62

4.1

3.3

132.90

130.67

g/l

1.51

514

2724

Other diseases of liver

621

3507

1.84

41.52

3.8

3.4

126.89

129.83

g/l

2.30

611

3421

Undetermined asthma, excluding more controls

417

2072

2.09

40.84

5.1

2.6

131.50

130.99

g/l

0.19

406

2024

Vascular diseases of the intestine

194

698

3.07

40.71

5.4

2.8

119.18

127.52

g/l

5.43

188

683

Later onset COPD, excluding more controls

838

3998

1.70

40.45

4.5

2.7

125.12

128.18

g/l

3.26

814

3902

Benign neoplasm: Colon, unspecified

922

5830

1.64

40.43

4.8

3.3

124.99

127.95

g/l

3.50

898

5688

Parodontitis and operation codes

2927

17529

1.32

40.30

4.3

3.3

127.58

129.67

g/l

5.12

2856

17132

Fibrosis and cirrhosis of liver

320

1460

2.35

40.24

5.6

3.1

115.04

128.68

g/l

18.87

312

1423

Colectomy operation

654

3793

1.80

40.22

4.1

3.4

120.36

128.31

g/l

13.69

639

3700

Left ventricular outflow tract obstruction, narrow definition

219

843

2.81

40.03

6.2

5.2

122.59

131.64

g/l

6.63

212

824

Disorders of the thyroid gland

3258

16585

1.30

39.98

3.7

3.4

129.10

128.88

g/l

0.22

3166

16222

Other viral hepatitis

233

920

2.68

39.94

4.8

3.3

131.07

133.93

g/l

0.99

227

903

Migraine without aura

500

2669

1.92

39.36

3.4

3.3

132.73

129.77

g/l

2.44

482

2607

ILD, hospital admissions 3, with pneumonia sepsis

353

1688

2.23

39.36

5.7

2.9

123.80

128.25

g/l

3.25

338

1644

Benign neoplasm of other and ill-defined parts of digestive system

633

3657

1.80

39.30

4.1

3.2

123.49

130.09

g/l

10.62

616

3548

Other arthritis (FG)

1025

6662

1.58

39.20

4.0

3.3

126.04

129.82

g/l

5.83

1003

6517

Arthropathies

3139

12352

1.31

38.76

3.8

3.4

130.16

130.74

g/l

0.70

3061

12086

Rotator cuff syndrome

2152

11843

1.37

38.74

3.5

3.2

129.85

129.03

g/l

0.89

2088

11586

Thoracic aortic aneurysm

548

3059

1.88

38.67

4.6

3.3

125.94

130.43

g/l

4.07

529

2985

Diabetic retinopathy, strict definition

860

4764

1.67

38.53

7.4

3.7

119.11

129.38

g/l

32.00

837

4650

Idiopathic gout

407

2073

2.10

38.46

6.0

3.3

122.72

128.81

g/l

5.19

398

2022

Arthrosis

2590

10767

1.34

38.42

3.3

3.2

130.53

130.19

g/l

0.30

2520

10542

Abnormal serum enzyme levels

1149

7610

1.54

38.36

4.2

3.5

125.94

129.87

g/l

6.62

1122

7421

Alcohol-induced chronic pancreatitis

287

1283

2.40

37.93

4.5

3.6

126.30

131.23

g/l

2.62

277

1254

Primary_lymphoid and hematopoietic malignant neoplasms

863

5456

1.63

37.66

6.2

3.4

116.29

130.44

g/l

55.60

843

5309

Pain in joint

1766

8400

1.41

37.35

3.6

3.2

129.60

129.69

g/l

0.05

1723

8207

Other respiratory diseases principally affecting the interstitium

694

4182

1.73

37.14

5.1

3.3

123.15

127.59

g/l

5.58

669

4077

Chronic gastritis

1004

6592

1.57

36.98

3.8

3.1

122.69

127.81

g/l

9.60

978

6437

Type of accident

936

6052

1.59

36.79

4.2

3.5

128.86

129.81

g/l

0.67

916

5918

Acute and transient psychotic disorders

401

2048

2.04

36.66

2.9

3.3

131.16

131.54

g/l

0.12

387

2003

Diabetic retinopathy

1578

7103

1.46

36.63

5.8

3.6

121.65

128.31

g/l

24.07

1536

6939

Dermatitis and eczema

3705

19428

1.26

36.53

4.0

3.5

127.95

129.75

g/l

5.05

3617

18975

Fracture of lower leg, including ankle

1824

13325

1.39

36.50

3.8

3.4

127.28

129.36

g/l

3.50

1780

13021

Gonarthrosis

2357

10184

1.35

36.35

3.1

3.2

129.65

129.76

g/l

0.08

2296

9973

Cervicalgia

679

4074

1.72

36.33

3.9

3.3

129.97

128.04

g/l

1.39

662

3984

Use of disulfiram, acamprosate or naltrexone

337

1627

2.18

36.33

3.6

132.47

133.45

g/l

0.31

327

1593

Fracture of lumbar spine and pelvis

798

4994

1.65

36.29

4.0

3.2

124.60

127.33

g/l

2.85

782

4873

Assault by bodily force

254

1092

2.44

36.07

3.3

3.5

135.61

134.42

g/l

0.38

246

1072

Zoster [herpes zoster]

641

3807

1.75

36.04

4.2

3.3

125.11

127.79

g/l

2.36

626

3706

Pneumonitis due to solids and liquids

346

1697

2.16

36.01

4.8

3.2

124.07

127.58

g/l

2.05

330

1659

Other specified/unspecified arthritis

890

5717

1.60

35.96

3.9

3.3

126.26

129.50

g/l

3.83

871

5593

Any event in cancer register

3122

14516

1.29

35.87

3.9

3.4

125.35

131.10

g/l

35.56

3051

14189

Soft tissue disorders related to use, overuse and pressure

888

5718

1.59

35.58

3.5

3.2

129.14

128.81

g/l

0.17

873

5590

Diseases of the myoneural junction and muscle

464

2528

1.92

35.33

6.0

3.4

127.73

128.51

g/l

0.30

456

2459

Other and unspecified myopathies

355

1775

2.12

35.12

6.4

3.1

126.76

128.21

g/l

0.54

348

1727

Undetermined asthma

417

2188

1.97

35.02

5.1

2.7

131.50

130.24

g/l

0.59

406

2135

Exclusions for E4_PCOS_CONSORTIUM

2146

10063

1.35

34.99

4.0

3.3

128.40

128.56

g/l

0.12

2085

9840

Diagnoses used for exclusion with ILD

912

5943

1.58

34.83

4.5

3.4

126.27

128.73

g/l

2.48

880

5801

Eating disorder

234

980

2.47

34.82

5.7

3.6

128.32

131.20

g/l

1.33

228

960

Impacted teeth

459

2304

1.90

34.65

4.4

3.4

134.36

133.97

g/l

0.15

453

2255

Congenital malformations of aortic and mitral valves

184

699

2.85

34.65

6.0

4.4

121.34

131.34

g/l

6.84

178

684

Other diseases of intestine

442

2385

1.93

34.52

5.8

3.3

120.82

129.38

g/l

10.02

429

2331

L04AX Other immunosuppressants

1738

12765

1.38

34.48

5.3

3.4

125.14

129.89

g/l

15.18

1690

12477

Chronic viral hepatitis

191

738

2.74

34.28

4.1

3.3

132.31

134.59

g/l

0.62

185

724

Total colectomy

185

710

2.82

34.12

5.4

3.1

124.36

129.67

g/l

1.98

179

697

Total colectomy operation

185

710

2.82

34.12

5.4

3.1

124.36

129.67

g/l

1.98

179

697

Unspecified misadventure during surgical and medical care

235

1013

2.50

33.94

5.5

3.1

123.16

128.72

g/l

2.98

226

984

Extreme obesity with alveolar hypoventilation

186

722

2.81

33.70

4.6

3.0

134.99

128.59

g/l

2.80

176

704

Disorders of psychological development

347

1596

2.08

33.69

4.9

5.8

132.26

132.01

g/l

0.07

339

1558

Second line medication for Crohn's disease

1772

13102

1.37

33.68

5.3

3.4

125.27

129.95

g/l

14.95

1724

12804

COPD, hospital admissions 3, with asthma pneumonia sepsis

1026

5854

1.54

33.57

5.5

3.3

125.64

127.25

g/l

1.36

995

5709

Benign neoplasm of other and ill-defined parts of digestive system

633

3823

1.72

33.50

4.1

3.3

123.49

127.95

g/l

5.26

616

3713

Hypothyroidism, strict autoimmune

2365

11972

1.32

33.49

3.8

3.0

127.66

129.66

g/l

4.15

2301

11716

Disorders of skin appendages

1418

10114

1.43

33.48

4.7

3.4

128.56

130.34

g/l

2.22

1391

9883

Coagulation defects, purpura and other haemorrhagic conditions

642

3891

1.70

33.27

6.0

3.5

120.97

129.19

g/l

14.67

628

3796

Disorders of vitreous body and globe

1664

11922

1.39

33.23

4.1

3.3

127.86

127.82

g/l

0.02

1625

11638

Diabetic neuropathy

570

3371

1.80

33.15

6.4

4.0

120.62

127.90

g/l

12.22

553

3298

Abnormal findings on diagnostic imaging of other body structures

452

2491

1.89

33.07

4.6

3.1

124.51

128.43

g/l

3.15

443

2425

Obsessive-compulsive disorder

184

708

2.71

32.95

5.2

3.0

131.39

132.48

g/l

0.28

179

697

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

817

5270

1.60

32.92

3.3

117.38

130.52

g/l

48.87

807

5130

Disorders of vitreous body

1615

11593

1.39

32.65

4.0

3.4

128.08

127.88

g/l

0.12

1577

11313

Haemorrhage, not elsewhere classified

165

613

2.92

32.47

5.0

2.9

119.60

128.83

g/l

5.23

160

601

Other diseases of biliary tract

340

1723

2.08

32.33

4.9

3.3

119.95

127.35

g/l

7.52

331

1681

Open wound of ankle and foot

366

1897

2.02

32.32

5.2

3.4

122.49

130.46

g/l

7.92

361

1841

Viral hepatitis

253

1144

2.32

32.09

4.7

3.3

130.93

132.99

g/l

0.67

247

1121

Eating disorders

291

1384

2.17

32.01

4.8

3.3

128.95

130.36

g/l

0.54

283

1355

Urolithiasis

1146

7960

1.48

32.00

4.1

3.5

131.13

129.02

g/l

2.38

1124

7758

Injuries to the wrist and hand

3223

18707

1.26

31.98

3.6

3.5

131.66

129.43

g/l

6.50

3148

18271

Primary_lymphoid and hematopoietic malignant neoplasms

863

5671

1.57

31.93

6.2

3.4

116.29

128.84

g/l

44.91

843

5521

Acute gastritis

308

1512

2.15

31.91

4.2

2.9

127.15

128.84

g/l

0.65

294

1472

Other systemic involvement of connective tissue (FG)

844

5483

1.57

31.54

4.0

3.1

125.50

128.17

g/l

3.41

824

5365

Other arthrosis

1814

9666

1.37

31.52

3.3

3.2

128.53

129.76

g/l

1.44

1764

9472

Unspecified dementia

450

2257

1.87

31.43

3.7

3.2

125.08

123.97

g/l

0.58

445

2199

Cholecystitis

515

2994

1.79

31.36

4.3

3.2

125.52

127.93

g/l

1.43

504

2919

severe traumatic brain injury, does not include concussion

806

5239

1.59

31.34

3.7

3.5

126.72

128.30

g/l

1.21

788

5114

410

2223

1.91

31.26

7.0

3.1

124.66

130.17

g/l

5.08

402

2160

Intentional self-harm by sharp object

106

310

3.70

31.23

3.5

2.8

132.22

133.54

g/l

0.28

101

303

Other ulcerative colitis

219

946

2.45

31.12

5.2

3.1

129.60

131.25

g/l

0.50

209

922

Artificial opening status

229

1016

2.42

30.97

5.9

3.5

120.22

129.81

g/l

6.94

224

987

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

466

2381

1.82

30.82

4.4

4.8

133.54

133.89

g/l

0.13

455

2333

Fracture of skull and facial bones

681

4269

1.64

30.69

3.8

3.6

131.15

130.60

g/l

0.25

657

4169

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3283

17217

1.26

30.60

4.0

3.3

127.80

129.42

g/l

3.65

3202

16833

Fracture of femur

966

5969

1.52

30.54

4.3

3.3

121.10

126.82

g/l

12.88

947

5820

Infective dermatitis

418

2306

1.89

30.49

4.7

3.2

125.18

129.69

g/l

3.75

410

2241

Purpura and other haemorrhagic conditions

475

2726

1.81

30.34

6.0

3.4

119.62

129.17

g/l

14.43

467

2649

Hypothyroidism, other/unspecified

2928

15382

1.27

30.33

3.8

3.4

128.39

128.65

g/l

0.26

2837

15047

COPD, hospital admissions 1, only main diagnosis

1274

7733

1.44

30.27

4.9

3.3

128.33

127.57

g/l

0.55

1239

7536

Superficial injury of lower leg

755

4867

1.59

30.11

3.5

3.4

128.94

129.43

g/l

0.25

746

4760

Other degenerative diseases of the nervous system

886

4449

1.54

29.94

3.3

3.0

128.55

127.05

g/l

1.18

865

4350

Generalized anxiety disorder

384

2062

1.91

29.92

2.7

3.1

133.34

131.64

g/l

0.80

379

2022

Paralytic ileus

173

687

2.72

29.88

5.7

3.0

124.51

129.33

g/l

1.86

164

668

Migraine with aura and triptan purchases

380

2038

1.91

29.76

2.7

3.4

133.85

130.13

g/l

3.06

371

1991

Hyperkinetic disorders, excluding more controls

210

875

2.39

29.55

5.0

4.5

132.84

133.92

g/l

0.29

205

859

Other embolism and thrombosis

481

2800

1.79

29.28

4.6

3.2

124.58

128.44

g/l

3.09

471

2731

Aneurysms, operations, SAH

568

3454

1.70

29.24

3.3

126.68

128.08

g/l

0.74

556

3370

Speech and linguistic disorders

268

1229

2.17

29.18

6.8

5.8

131.42

131.25

g/l

0.04

263

1198

Undefined dementia

457

2403

1.82

29.17

3.7

3.0

125.08

124.56

g/l

0.22

452

2349

Hypothyreosis and Thyroxine purchase for inclusion criteria

3014

15969

1.26

28.97

3.7

3.3

128.38

128.71

g/l

0.34

2919

15626

Cholangitis (primary sclerosing, PSC)

242

1127

2.28

28.90

6.1

3.3

119.71

128.37

g/l

7.30

235

1104

Calculus of kidney and ureter

1050

7320

1.47

28.83

4.1

3.5

131.01

129.16

g/l

1.76

1031

7131

Psychotic depression

210

918

2.39

28.83

3.6

3.0

132.59

129.19

g/l

1.42

203

896

Mental and behavioural disorders due to tobacco

302

1527

2.08

28.82

4.5

3.1

130.02

130.22

g/l

0.05

294

1486

Injuries to the neck

686

4377

1.61

28.66

3.0

3.5

131.10

130.65

g/l

0.20

672

4273

Other and unspecified nerve root and plexus disorders, also in other diseases

590

3635

1.67

28.66

3.7

3.4

131.59

130.23

g/l

0.75

563

3555

Other congenital malformations of the digestive system

179

730

2.60

28.63

10.9

6.3

123.18

128.90

g/l

2.49

174

716

Smoking dependency

302

1534

2.07

28.45

4.5

3.1

130.02

130.33

g/l

0.08

294

1492

Benign neoplasm: Sigmoid colon

634

3995

1.64

28.40

3.7

3.4

124.32

130.46

g/l

8.49

623

3889

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

483

2838

1.77

28.34

4.4

3.3

124.70

130.22

g/l

5.50

472

2759

COPD-related respiratory insufficiency

460

2679

1.80

28.18

6.4

3.2

126.52

127.42

g/l

0.34

436

2609

Viral warts

327

1711

1.99

28.05

6.9

3.3

126.46

130.56

g/l

2.28

314

1671

Other necrotizing vasculopathies

289

1458

2.10

28.04

6.8

3.0

120.63

127.85

g/l

6.00

284

1419

Dental caries 2 and operation codes, only avohilmo

1361

11504

0.72

27.77

3.2

3.9

131.02

129.44

g/l

1.71

1335

11195

Gonarthrosis,primary

3113

15852

1.25

27.72

3.0

3.4

128.94

128.53

g/l

0.44

3036

15492

Respiratory insufficiency

309

1595

2.03

27.64

5.5

3.0

131.66

128.07

g/l

1.79

290

1552

Leisure time condition

582

3617

1.66

27.40

4.1

3.4

129.77

129.73

g/l

0.01

573

3523

Alcoholic liver disease

375

2075

1.89

27.36

4.2

3.4

118.41

130.13

g/l

14.86

364

2028

Open wound of lower leg

497

2971

1.73

27.33

4.6

3.4

126.06

129.22

g/l

2.11

485

2902

Superficial injury of hip and thigh

510

3070

1.72

27.28

4.0

3.2

126.09

128.42

g/l

1.54

501

2992

Bicuspidal aortic valve syndrome

156

618

2.73

27.13

5.3

4.2

120.43

131.20

g/l

6.56

150

604

Benign neoplasm: Skin of other and unspecified parts of face

389

2180

1.86

27.06

3.9

3.1

128.04

129.95

g/l

1.01

381

2114

Abnormal involuntary movements

455

2667

1.77

26.99

4.4

3.3

128.99

129.02

g/l

0.01

446

2598

ILD, hospital admissions

546

3375

1.68

26.65

4.7

3.3

125.87

127.63

g/l

1.06

527

3289

Persistent mood disorders

580

3620

1.64

26.63

4.0

3.2

128.78

129.37

g/l

0.27

562

3542

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

980

6811

1.46

26.63

3.9

3.6

132.71

131.85

g/l

0.59

962

6646

Other pleural conditions

395

2239

1.85

26.61

6.0

3.2

118.25

127.17

g/l

11.95

384

2175

Polycystic ovarian syndrome, consortium definition

1907

8804

1.32

26.49

3.6

2.9

127.52

g/l

0.00

1864

8607

Inflammatory bowel disease

965

6717

1.46

26.48

4.5

3.6

129.59

130.65

g/l

0.73

933

6568

Parkinson's disease, excluding more controls

462

2660

1.75

26.44

3.3

3.1

126.87

126.39

g/l

0.19

448

2595

Status epilepticus

160

650

2.65

26.37

5.9

3.5

125.54

127.81

g/l

0.56

155

634

Superficial injury of abdomen, lower back and pelvis

481

2875

1.72

26.35

4.2

3.4

129.45

130.04

g/l

0.24

472

2804

Symptoms and signs involving the nervous and musculoskeletal systems

1834

14141

1.32

26.16

4.2

3.5

129.24

128.79

g/l

0.38

1780

13822

Benign neoplasm: Ascending colon

463

2757

1.75

26.15

4.8

3.1

124.33

130.50

g/l

6.87

455

2678

Immunodeficiencies

185

804

2.45

26.13

10.9

4.0

125.09

128.32

g/l

1.08

180

782

Psoriasis

904

6244

1.48

26.01

3.8

3.5

129.18

130.02

g/l

0.52

889

6087

Other diseases of lip and oral mucosa

525

3223

1.68

26.00

4.1

3.0

128.02

129.16

g/l

0.55

512

3146

Deforming dorsopathies

834

5666

1.50

25.98

3.9

3.4

128.30

128.56

g/l

0.13

814

5539

Papulosquamous disorders

1248

9119

1.39

25.96

3.8

3.5

128.90

129.26

g/l

0.22

1225

8909

Disorders of synovium and tendon

1611

10996

1.34

25.68

3.7

3.1

129.82

129.42

g/l

0.29

1563

10763

Dental operations

2441

9911

1.28

25.63

4.0

3.2

127.98

129.33

g/l

2.03

2374

9715

Other interstitial pulmonary diseases

550

3440

1.66

25.60

4.7

3.3

125.82

127.64

g/l

1.12

531

3351

Colorectal cancer, excluding all cancers (controls excluding all cancers)

960

6510

1.46

25.55

3.1

3.3

121.11

129.94

g/l

24.77

937

6334

Interstitial lung disease

550

3444

1.66

25.48

4.7

3.3

125.82

127.63

g/l

1.12

531

3355

Interstitial lung disease endpoints

550

3444

1.66

25.48

4.7

3.3

125.82

127.63

g/l

1.12

531

3355

Other diseases of arteries and capillaries

327

1773

1.93

25.39

5.2

3.1

119.72

128.94

g/l

10.28

317

1725

Pleural effusion

569

3595

1.64

25.34

5.5

3.2

117.57

127.60

g/l

21.48

560

3500

Irregular menses

1104

6390

1.42

25.32

4.1

2.9

128.82

128.69

g/l

0.07

1079

6234

Thyroiditis, ILD-related definition

349

1927

1.87

25.27

3.6

3.2

130.73

128.76

g/l

1.01

343

1879

Coxarthrosis, primary

2048

13956

1.29

25.23

3.3

3.4

127.22

127.64

g/l

0.37

2007

13619

Tubulo-interstitial nephritis, not specified as acute or chronic

245

1212

2.11

24.82

5.2

2.6

121.77

129.86

g/l

6.57

239

1186

Nontraumatic intracranial haemmorrhage

704

4678

1.55

24.78

3.7

3.3

126.67

127.39

g/l

0.38

691

4563

Disorders of vestibular function (Vertigo)

1499

11267

1.34

24.75

3.3

130.49

127.56

g/l

6.30

1464

10992

ILD, hospital admissions 1, main diag only

490

3010

1.69

24.62

4.6

3.3

126.21

127.53

g/l

0.65

474

2933

Cervical disc disorders

1153

8389

1.40

24.59

3.5

3.3

129.61

128.91

g/l

0.49

1119

8205

Parodontitis or/and operation codes

2025

9391

1.30

24.59

4.4

3.4

127.85

129.83

g/l

3.31

1978

9141

Polyuria

749

5050

1.52

24.59

4.2

3.2

129.27

129.13

g/l

0.06

736

4911

Complications of internal orthopaedic prosthetic devices, implants and grafts

758

5125

1.52

24.58

3.9

3.0

122.36

128.02

g/l

9.47

736

5006

Nonischemic cardiomyopathy

215

1020

2.23

24.57

6.1

3.0

131.56

132.04

g/l

0.09

206

998

Somnolence, stupor and coma

175

763

2.44

24.56

5.7

3.2

123.76

127.84

g/l

1.50

168

744

Suppurative and necrotic conditions of lower respiratory tract

222

1069

2.21

24.55

5.7

3.2

121.20

128.77

g/l

4.55

214

1041

Ovarian cyst

1026

4164

1.45

24.54

3.3

3.0

128.59

126.71

g/l

2.10

996

4082

Superficial injury of thorax

496

3052

1.68

24.42

4.2

3.4

128.59

129.74

g/l

0.55

486

2980

Lung diseases due to external agents

502

3103

1.67

24.40

4.3

3.2

125.54

127.67

g/l

1.27

484

3022

Vitamin deficiency

184

822

2.37

24.38

5.4

3.0

127.99

127.43

g/l

0.12

176

796

Vitamin deficiency, wide

184

822

2.37

24.38

5.4

3.0

127.99

127.43

g/l

0.12

176

796

Other symptoms and signs involving the digestive system and abdomen

464

2801

1.70

24.38

5.3

3.1

124.60

127.71

g/l

2.28

448

2733

Unspecified privation

368

2093

1.83

24.35

4.6

3.3

126.05

129.60

g/l

1.99

361

2032

Other necrotizing vasculopathies (FG)

246

1234

2.11

24.32

6.3

3.0

121.90

128.82

g/l

4.81

241

1208

Other epidermal thickening

175

769

2.43

24.22

5.1

3.1

123.93

128.23

g/l

1.71

170

750

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

320

1758

1.92

24.10

5.3

3.1

113.76

129.64

g/l

28.55

308

1703

Radiculopathy

552

3498

1.62

24.03

3.9

3.3

129.28

127.52

g/l

0.99

536

3418

Secondary right heart disease

185

839

2.37

23.96

5.7

3.2

128.10

125.57

g/l

0.68

176

816

DVT of lower extremities

668

4426

1.55

23.93

3.7

3.3

127.07

128.39

g/l

0.83

660

4329

Cerebral cysts

194

893

2.28

23.78

5.0

3.3

131.27

129.62

g/l

0.41

187

870

Benign neoplasm: Sigmoid colon

634

4166

1.57

23.74

3.7

3.4

124.32

128.42

g/l

4.16

623

4063

Other diseases of blood and blood-forming organs, wide

696

4655

1.53

23.73

6.2

3.4

121.96

129.20

g/l

10.66

676

4533

Nonalcoholic fatty liver disease

299

1611

1.93

23.63

3.4

3.3

131.60

130.53

g/l

0.31

294

1569

Superficial injury of wrist and hand

550

3489

1.61

23.62

3.5

132.01

130.45

g/l

0.89

543

3403

Other pulmonary heart/vessel disease

200

941

2.28

23.61

5.6

3.3

129.18

125.57

g/l

1.23

191

916

Parkinson's disease, strict definition, excluding more controls

427

2501

1.73

23.57

3.3

3.1

127.40

126.22

g/l

0.57

414

2442

Hypopituitarism

245

1238

2.07

23.49

5.7

4.5

133.81

132.40

g/l

0.40

236

1209

Benign neoplasm: Skin of other and unspecified parts of face

389

2276

1.78

23.41

3.9

3.1

128.04

127.75

g/l

0.10

381

2216

Adverse effects, not elsewhere classified

549

3496

1.61

23.24

4.2

3.6

129.93

129.61

g/l

0.12

538

3411

Fracture of foot, except ankle

681

4549

1.53

23.15

4.8

3.5

127.92

130.67

g/l

2.48

666

4436

Degeneration of macula and posterior pole

1600

10145

1.32

23.14

3.7

3.2

125.63

127.20

g/l

2.05

1562

9886

Fall on and from stairs and steps

796

5493

1.48

23.13

3.5

128.00

129.08

g/l

0.68

778

5364

Diseases of inner ear

1742

13289

1.30

23.10

3.4

3.3

130.46

127.98

g/l

5.16

1697

12975

Myocardial infarction, with ST-elevation

658

4383

1.55

23.10

4.3

3.4

124.71

128.14

g/l

3.35

640

4275

Psoriatic and enteropathic arthropathies

380

2213

1.77

23.05

4.0

3.3

129.84

130.91

g/l

0.41

372

2167

Cerebral palsy and other paralytic syndromes

379

2209

1.78

22.98

4.8

3.6

129.66

128.94

g/l

0.25

370

2152

Emphysema

267

1404

2.00

22.93

4.0

3.3

129.87

127.29

g/l

0.93

258

1365

Operations for atrial fibrillation

312

3.43

22.82

5.1

3.4

123.85

128.29

g/l

0.98

307

Injuries to unspecified part of trunk, limb or body region

338

1914

1.84

22.78

4.5

3.5

124.67

128.81

g/l

2.47

330

1863

Erosion of teeth

212

3.84

22.76

16.7

3.3

113.55

130.76

g/l

7.09

205

Fentanyl

372

2166

1.78

22.68

4.2

3.0

118.28

128.25

g/l

15.31

361

2120

Phlebitis and thrombophlebitis (not including DVT)

730

4978

1.50

22.63

4.4

3.3

127.35

128.78

g/l

1.02

717

4872

Other specific joint derangements/joint disorders

2198

11755

1.27

22.50

3.4

3.3

130.47

130.84

g/l

0.31

2139

11505

Other systemic involvement of connective tissue

859

6051

1.45

22.32

4.3

3.2

125.61

127.45

g/l

1.88

839

5904

Heartburn

308

1703

1.87

22.27

4.2

2.9

129.95

130.04

g/l

0.02

297

1660

Benign paroxysmal vertigo

912

6501

1.43

22.25

3.3

130.80

127.25

g/l

5.54

891

6350

Fall on same level involving ice and snow

1736

13586

1.30

22.22

3.4

128.43

129.07

g/l

0.57

1699

13271

Benign neoplasm: Ascending colon

463

2879

1.67

22.21

4.8

3.2

124.33

128.06

g/l

2.89

455

2807

Benign neoplasm: Adrenal gland

260

1371

1.99

22.20

3.9

3.0

126.58

130.94

g/l

2.16

249

1329

Other aneurysm

218

1083

2.13

22.19

5.6

3.0

122.60

128.88

g/l

3.00

210

1053

Subjective visual disturbances

726

4970

1.49

21.99

4.0

3.2

129.78

129.19

g/l

0.29

700

4853

Arterial embolism and thrombosis

232

1182

2.07

21.89

6.5

2.9

120.00

128.53

g/l

6.21

224

1152

Other disorders of skin and subcutaneous tissue, not elsewhere classified

480

3016

1.64

21.83

5.1

3.1

119.05

129.43

g/l

19.56

471

2936

Injuries to the elbow and forearm

2118

15350

1.26

21.70

3.7

3.5

128.71

129.27

g/l

0.55

2082

14990

Other other unspecified disorders of the circulatory system

158

700

2.43

21.65

4.9

3.4

120.79

127.92

g/l

3.65

143

685

Melanocytic naevi

798

5574

1.46

21.59

4.2

3.3

128.15

131.72

g/l

4.47

778

5432

Dermatophytosis

441

2726

1.67

21.53

4.1

3.3

129.34

129.41

g/l

0.02

432

2650

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1027

6531

1.39

21.43

3.9

3.0

126.97

128.79

g/l

1.92

1005

6378

Cerebral aneurysm, nonruptured

295

1638

1.88

21.31

3.4

3.1

127.21

128.95

g/l

0.62

289

1590

Appendectomy

1894

14483

1.27

21.30

3.3

3.4

130.46

130.20

g/l

0.20

1853

14141

Familial hypercholesterolemia

519

3340

1.60

21.29

3.6

3.0

125.36

128.19

g/l

1.97

508

3254

Other diseases of hard tissues of teeth

1966

11647

1.27

21.25

5.7

3.0

127.10

130.83

g/l

10.11

1918

11380

Cyst of kidney

265

1432

1.95

21.15

4.8

3.0

122.80

127.84

g/l

2.98

258

1393

Disorders of sclera, cornea, iris and ciliary body

1643

12858

1.29

21.06

4.6

3.3

127.73

129.71

g/l

2.94

1599

12561

Embedded and impacted teeth

593

3317

1.54

20.97

4.7

3.4

132.85

133.73

g/l

0.45

580

3240

Asthma and allergy, excluding more controls

298

1639

1.83

20.72

4.2

3.3

134.58

133.64

g/l

0.29

293

1607

Excessive, frequent and irregular menstruation

1073

4344

1.39

20.72

3.9

3.0

128.24

126.88

g/l

1.30

1049

4253

Other symptoms and signs involving the circulatory and respiratory systems

203

1002

2.11

20.70

4.7

3.2

129.35

128.35

g/l

0.23

191

968

Other and unspecified tonsillitis

877

5297

1.42

20.67

4.4

3.5

134.40

133.12

g/l

0.89

853

5186

Benign neoplasm of other and unspecified endocrine glands

400

2437

1.70

20.64

3.7

3.1

127.59

131.16

g/l

2.30

380

2367

Umbilical hernia

858

6138

1.43

20.51

4.6

3.3

128.72

130.79

g/l

1.76

843

5988

Pruritus

337

1964

1.77

20.47

5.5

3.0

124.13

128.51

g/l

3.28

332

1911

Crohn disease

389

2354

1.70

20.45

5.1

3.4

129.19

130.76

g/l

0.67

378

2292

Other joint disorders

2804

12306

1.22

20.40

3.6

3.4

131.34

130.76

g/l

0.66

2724

12041

Fracture of shoulder and upper arm

1116

8327

1.36

20.33

3.7

3.5

125.62

128.76

g/l

4.74

1084

8144

Parodontitis, operation under 40 years and operation codes

190

918

2.12

20.21

4.7

3.5

131.38

136.40

g/l

2.06

185

895

Gingivitis and periodontal diseases

3048

13082

1.21

20.21

4.0

3.0

128.46

130.02

g/l

3.11

2961

12791

Other arterial embolism and thrombosis

121

491

2.65

20.12

6.1

3.0

118.46

126.69

g/l

3.33

116

481

Diplopia

425

2648

1.66

20.08

4.8

3.1

130.04

128.94

g/l

0.47

411

2577

Pulmonary oedema

322

3.12

19.98

7.2

3.1

112.16

124.21

g/l

5.32

314

Parodontitis, under 40 years, or operation codes

200

990

2.07

19.93

4.7

3.5

131.82

136.66

g/l

2.03

195

967

Benign neoplasm: Stomach

325

1898

1.78

19.80

4.3

3.1

122.03

129.87

g/l

8.04

317

1842

Contact with and exposure to communicable diseases

318

5343

0.58

19.79

7.1

3.8

129.62

132.14

g/l

1.17

301

5222

Exposure to other specified factors

2225

17011

1.24

19.69

3.7

3.5

129.53

130.21

g/l

0.71

2175

16615

Diseases of salivary glands

567

3779

1.53

19.64

3.3

3.0

129.50

129.65

g/l

0.05

558

3688

Parodontitis, under 40 years and operation codes

188

916

2.10

19.57

4.7

3.5

131.64

136.47

g/l

1.93

183

893

Dental caries 1 and operation codes, only avohilmo

638

4673

0.67

19.54

3.6

4.5

128.79

127.94

g/l

0.42

621

4562

Malignant neoplasm of bladder

281

1584

1.86

19.50

4.6

3.2

124.54

126.98

g/l

0.92

276

1551

Ulcerative colitis

722

5053

1.46

19.44

4.3

3.5

128.86

130.65

g/l

1.25

693

4939

Anosmia

148

3.97

19.40

2.9

1.7

130.63

138.11

g/l

1.83

148

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

288

1638

1.84

19.33

5.2

2.9

115.01

127.45

g/l

17.23

281

1598

Viral pneumonia (known virus, not influenza)

108

425

2.77

19.33

10.0

5.3

124.80

125.66

g/l

0.13

102

418

Parodontitis, under 40 years

198

989

2.05

19.26

4.6

3.5

132.07

136.69

g/l

1.88

193

966

Panniculitis affecting regions of neck and back

137

599

2.41

19.13

4.0

2.9

128.94

128.23

g/l

0.14

132

580

Extrapyramidal and movement disorders

1177

8954

1.34

18.98

3.6

3.4

128.54

127.65

g/l

0.74

1150

8731

Pregnancy hypertension

891

5826

1.40

18.98

4.1

3.0

127.17

129.04

g/l

1.76

872

5681

Osteoporosis with pathological fracture (FG)

259

1441

1.89

18.87

5.5

2.8

121.36

126.88

g/l

4.24

253

1409

1015

6695

1.37

18.83

3.4

3.1

124.74

126.30

g/l

1.54

988

6522

Psoriasis vulgaris

578

3908

1.52

18.80

4.0

3.4

129.14

130.03

g/l

0.41

567

3806

Hypothyroidism, strict autoimmune, 3 medication purchases required

2598

14679

1.22

18.78

3.6

3.3

127.49

128.51

g/l

1.52

2527

14356

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

543

3563

1.54

18.76

3.0

3.1

121.49

127.55

g/l

9.21

536

3477

Postprocedural disorders of digestive system, not elsewhere classified

132

576

2.46

18.75

5.6

3.9

121.17

127.67

g/l

2.03

127

565

Neuromuscular dysfunction of bladder

306

1784

1.78

18.74

6.0

3.0

127.27

129.56

g/l

0.98

292

1737

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

423

2685

1.63

18.67

4.7

3.2

118.89

130.40

g/l

18.59

417

2613

Pyothorax

169

818

2.20

18.61

5.9

3.3

121.14

128.84

g/l

3.54

162

801

Asthma and allergy

298

1694

1.77

18.58

4.2

3.4

134.58

132.92

g/l

0.61

293

1659

Other diseases of stomach and duodenum

225

1202

1.96

18.50

4.3

2.9

121.56

128.82

g/l

4.64

219

1170

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

641

4446

1.48

18.42

3.2

3.3

120.06

129.55

g/l

18.34

626

4331

Malignant neoplasm of digestive organs

1284

9777

1.32

18.32

3.4

120.15

127.80

g/l

27.54

1255

9528

Benign neoplasm: Adrenal gland

260

1461

1.86

18.28

3.9

3.0

126.58

128.25

g/l

0.52

249

1421

Abnormalities of gait and mobility

411

2606

1.63

18.24

5.4

3.6

126.85

127.81

g/l

0.39

401

2539

Retinal vascular occlusion

426

2727

1.62

18.16

4.3

3.1

123.26

127.35

g/l

3.25

418

2651

Seborrhoeic keratosis

716

5082

1.44

18.10

3.8

3.1

127.18

128.22

g/l

0.63

701

4960

Hepatic failure, not elsewhere classified

146

676

2.31

18.04

8.5

3.0

114.13

128.08

g/l

9.15

136

662

Other disorders of eyelid

1423

10792

1.29

17.98

3.8

3.3

127.79

127.08

g/l

0.60

1396

10524

Migraine without aura and triptan purchases

350

2132

1.67

17.78

3.6

3.5

133.21

130.44

g/l

1.72

339

2087

Benign neoplasm: Rectum

569

3889

1.50

17.71

3.8

3.3

124.93

130.73

g/l

7.08

553

3793

Dementia, including avohilmo

1522

8290

1.29

17.64

3.2

3.3

127.00

126.13

g/l

0.88

1487

8073

Disorders of ocular muscles, binocular movement, accommodation and refraction

1285

9889

1.30

17.62

4.9

3.8

129.74

130.05

g/l

0.20

1255

9668

Thyrotoxicosis

699

4956

1.44

17.59

3.7

3.3

131.46

127.81

g/l

4.56

678

4836

Cardiac murmurs and other cardiac sounds

251

1387

1.84

17.49

6.3

4.6

124.74

128.78

g/l

1.80

239

1352

Other disorders of nervous system

228

1247

1.91

17.47

4.5

3.1

125.98

128.90

g/l

1.02

218

1214

Corns and callosities

239

1326

1.88

17.47

5.3

2.9

121.33

129.14

g/l

5.90

231

1290

Arthropod-borne viral fevers and viral haemorrhagic fevers

323

1952

1.71

17.37

3.6

3.3

130.59

129.83

g/l

0.23

313

1899

Ulcer of oesophagus

263

1506

1.83

17.35

4.2

3.1

122.52

129.24

g/l

4.40

258

1464

Other benign neoplasms of skin

1107

8289

1.33

17.33

4.0

3.2

127.83

130.35

g/l

3.35

1086

8075

Psoriatic arthropathies

319

1919

1.71

17.33

3.9

3.4

129.49

130.47

g/l

0.33

314

1878

Diseases of male genital organs

1887

7682

1.26

17.32

4.4

3.8

131.78

132.03

g/l

0.16

1835

7520

Retinal vascular disorders

429

2781

1.60

17.31

4.3

3.1

123.15

127.39

g/l

3.46

421

2702

Diseases of pulp and periapical tissues, including avohilmo

3649

16238

1.18

17.21

3.9

3.3

129.09

129.35

g/l

0.28

3563

15874

Dislocation, sprain and strain of joints and ligaments at neck level

395

2504

1.61

17.20

2.8

3.3

134.57

131.47

g/l

2.07

388

2439

Intracerebral haemorrhage

430

2790

1.59

17.18

4.0

3.1

126.62

127.00

g/l

0.13

423

2719

Benign neoplasm of other and unspecified endocrine glands

400

2556

1.61

17.08

3.7

3.2

127.59

129.03

g/l

0.59

380

2485

Any dementia, excluding more controls

1194

6373

1.32

17.06

3.4

3.2

126.51

125.81

g/l

0.54

1177

6207

Dental pulpitis 4

3653

16268

1.18

17.05

3.9

3.3

129.12

129.34

g/l

0.23

3566

15903

Other diseases of jaws

219

1190

1.91

16.98

4.0

2.9

127.13

130.16

g/l

1.17

212

1157

Secondary parkinsonism, excluding more controls

378

2.71

16.97

4.7

3.0

126.59

126.50

g/l

0.01

368

Artrosis, including avohilmo

2838

13101

1.20

16.84

3.1

3.5

131.15

129.34

g/l

3.88

2762

12811

Dental pulpitis 1

3648

16271

1.17

16.75

3.9

3.3

129.13

129.34

g/l

0.22

3561

15907

Melanocytic naevi

798

5838

1.39

16.65

4.2

3.4

128.15

129.83

g/l

1.29

778

5697

Disorders of muscles

310

1871

1.71

16.64

4.8

3.2

128.90

129.87

g/l

0.32

300

1825

Abdominal aortic aneurysm (AAA)

365

2282

1.64

16.53

4.6

3.2

121.56

128.03

g/l

5.53

358

2226

Other disorders of bone

556

3825

1.48

16.52

3.6

3.3

131.64

131.02

g/l

0.27

540

3739

Trochanteric bursitis

395

2536

1.60

16.43

3.1

2.9

128.22

127.23

g/l

0.42

387

2478

Pedal cyclist injured in other and unspecified transport accidents

334

2068

1.66

16.23

3.8

3.4

126.68

130.53

g/l

2.57

326

2015

Viral haemorrhagic fevers, not elsewhere classified/unspecified

262

1526

1.78

16.21

3.6

3.2

130.82

129.97

g/l

0.24

257

1487

Follow-up examination after treatment for conditions other than malignant neoplasms

1313

6717

1.29

16.16

3.3

2.9

128.19

130.18

g/l

2.62

1283

6567

Endovascular or surgical operations to intracerebral aneurysms

221

1228

1.88

16.13

3.6

3.1

127.05

128.51

g/l

0.41

221

1196

Agranulocytosis

343

2151

1.65

15.91

6.5

3.3

114.52

129.14

g/l

25.23

333

2092

Dental caries 3 and operation codes, only avohilmo

750

5153

0.72

15.82

3.5

4.4

128.93

128.03

g/l

0.51

728

5041

Other and unspecified visual disturbances

298

1808

1.70

15.81

5.5

3.2

132.01

129.02

g/l

1.78

293

1763

Melanocytic naevi of trunk

331

2060

1.65

15.74

3.8

3.1

126.29

132.15

g/l

4.81

322

1995

Other bursopathies

403

2628

1.57

15.70

3.8

3.3

126.47

128.98

g/l

1.43

398

2562

Use of biperiden

183

967

1.98

15.64

3.1

126.90

130.08

g/l

1.16

178

945

Other noninflammatory disorders of uterus, except cervix

677

3297

1.43

15.64

2.9

3.0

126.38

125.38

g/l

0.61

663

3235

Benign neoplasm: Rectum, anus and anal canal

625

4452

1.44

15.58

3.8

3.3

124.96

130.46

g/l

7.25

607

4344

!Aliquae complicationes praecoces traumatis

150

742

2.13

15.54

4.0

3.1

126.76

130.39

g/l

0.99

145

723

Early complications of trauma

150

742

2.13

15.54

4.0

3.1

126.76

130.39

g/l

0.99

145

723

Open wound of wrist and hand

1253

9765

1.29

15.47

3.5

133.10

131.16

g/l

2.31

1228

9528

Benign neoplasm: Stomach

325

2032

1.66

15.39

4.3

3.1

122.03

127.60

g/l

4.45

317

1980

Pyogenic arthritis

234

1340

1.81

15.39

5.7

3.3

121.25

129.39

g/l

5.70

227

1311

Lesion of ulnar nerve

421

2789

1.55

15.26

3.7

3.3

129.44

130.00

g/l

0.19

412

2724

Anorexia (incl.atypical)

160

810

2.04

15.23

5.2

2.9

129.20

129.86

g/l

0.15

155

793

Stomatitis and related lesions

245

1423

1.77

15.20

8.6

3.1

126.46

131.15

g/l

2.54

238

1389

Haemorrhoids and perianal venous thrombosis

879

6623

1.35

15.14

3.5

3.1

126.88

128.38

g/l

1.27

852

6465

722

5009

1.40

15.11

3.5

3.1

124.20

126.03

g/l

1.56

700

4881

Paracetamol of NSAID medication

622

2189

1.45

15.02

4.0

3.8

129.56

130.68

g/l

0.53

612

2141

Other sleep disorders

333

2102

1.63

14.98

3.8

3.2

130.31

128.74

g/l

0.68

320

2051

Multiple myeloma and malignant plasma cell neoplasms

173

914

2.00

14.97

5.8

2.8

108.79

129.70

g/l

24.71

167

887

Familial hypercholesterolemia, with ischemic heart disease

322

2023

1.65

14.96

4.0

2.8

124.36

128.85

g/l

3.01

315

1976

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

435

2919

1.53

14.95

4.5

3.2

119.52

130.34

g/l

17.90

427

2835

Acute posthaemorrhagic anaemia

135

655

2.18

14.81

5.1

2.8

109.49

128.10

g/l

12.97

130

640

Thyrotoxicosis, other and/or unspecified

533

3717

1.46

14.80

3.5

3.2

132.02

127.97

g/l

4.19

514

3633

Injury of unspecified body region

245

1439

1.77

14.75

4.4

3.5

124.73

128.56

g/l

1.75

240

1400

Cervicocranial syndrome

305

1891

1.66

14.74

4.4

3.2

130.83

128.06

g/l

1.62

300

1844

Disorders of lacrimal system

1194

9417

1.28

14.63

4.1

3.3

127.86

127.94

g/l

0.04

1161

9196

Childhood asthma (age<16), excluding more controls

246

1130

1.75

14.52

3.4

4.2

133.60

137.02

g/l

1.52

240

1115

Multiple myeloma, excluding all cancers (controls excluding all cancers)

173

926

1.97

14.40

5.8

2.8

108.88

129.85

g/l

24.68

167

898

Thrombocytopenia, unspecified

237

1391

1.77

14.38

6.1

3.4

116.58

128.46

g/l

10.71

232

1352

Herpesviral [herpes simplex] infections

331

2107

1.61

14.38

5.3

3.2

127.03

129.33

g/l

1.09

323

2045

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

846

6394

1.34

14.36

3.6

131.82

130.84

g/l

0.60

830

6244

Other enthesopathies

818

6148

1.35

14.36

3.4

3.2

130.93

129.05

g/l

1.64

796

6020

Need for immunization against other single viral diseases

351

2.65

14.34

7.9

3.2

110.77

131.67

g/l

12.34

345

Hyperplasia of prostate

1327

6009

1.28

14.33

4.1

3.4

130.38

130.13

g/l

0.13

1284

5887

Dental pulpitis 3

262

1113

1.72

14.29

5.0

132.84

134.27

g/l

0.49

256

1092

Unspecified event, undetermined intent

374

2.55

14.27

3.9

3.7

131.04

130.90

g/l

0.02

367

Discitis, unspecified

300

2.81

14.22

6.9

3.0

118.12

126.79

g/l

2.67

292

Disorders of optic nerve and visual pathways

274

1674

1.69

14.13

5.6

3.6

129.59

129.72

g/l

0.03

269

1628

Problems related to social environment

100

439

2.40

13.98

4.0

2.8

122.09

127.63

g/l

1.78

430

Malnutrition

345

2.63

13.84

8.6

5.5

121.16

126.70

g/l

1.41

337

Appendicitis, broad definition

2181

16801

1.20

13.80

3.3

3.4

131.76

130.03

g/l

3.11

2135

16405

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

178

976

1.92

13.78

4.9

2.9

117.88

130.65

g/l

12.27

171

944

TMD related operations

431

2928

1.50

13.77

5.1

3.5

131.86

130.48

g/l

0.68

421

2859

Spondylolisthesis/Spondylolysis

513

3604

1.45

13.77

3.8

3.3

128.56

128.27

g/l

0.10

500

3519

Acute appendicitis

2037

16111

1.20

13.71

3.2

3.5

131.97

130.12

g/l

3.30

1993

15732

Rheumatoid arthritis

967

6798

1.31

13.71

3.6

3.2

123.87

128.41

g/l

8.72

942

6654

Oligomenorrhoea

422

2.39

13.70

5.7

3.0

130.62

128.23

g/l

0.54

411

Conjunctivitis (acute, non atopic)

746

5554

1.36

13.69

4.1

4.0

130.77

129.67

g/l

0.67

730

5426

Right hemicolectomy

215

1248

1.80

13.69

4.2

3.0

118.15

126.96

g/l

6.47

210

1214

Nontoxic multinodular goitre

596

4308

1.41

13.65

3.1

129.05

126.08

g/l

2.92

578

4205

Benign neoplasm: Rectum

569

4090

1.43

13.60

3.8

3.4

124.93

128.50

g/l

3.04

553

3994

Orchitis and epididymitis

311

1983

1.62

13.55

5.5

3.7

130.46

130.98

g/l

0.13

304

1937

Dementia

1404

7831

1.26

13.50

3.2

3.3

126.99

126.20

g/l

0.73

1375

7627

Pedal cyclist injured in transport accident

608

4414

1.40

13.46

3.3

3.5

129.32

130.64

g/l

0.79

592

4315

Diseases of appendix

2194

16896

1.19

13.41

3.3

3.4

131.70

129.99

g/l

3.05

2148

16498

Dental caries 2, only avohilmo

1468

14182

0.81

13.41

3.2

3.6

130.99

130.53

g/l

0.32

1442

13839

Childhood asthma (age<16)

246

1157

1.71

13.41

3.4

4.2

133.60

136.57

g/l

1.23

240

1143

Use of pramipexole

665

4910

1.38

13.39

5.0

3.3

126.15

127.63

g/l

0.96

647

4792

Superficial injury of ankle and foot

298

1887

1.61

13.19

3.9

3.4

130.55

131.42

g/l

0.27

290

1837

Iridocyclitis

652

4807

1.38

13.16

5.0

3.2

126.32

129.85

g/l

3.60

637

4690

Car occupant injured in other and unspecified transport accidents

497

3500

1.44

13.13

3.1

3.3

132.99

130.80

g/l

1.31

486

3412

Reimbursement for rheumatic diseases

1690

13972

1.22

13.09

4.2

3.4

125.59

129.00

g/l

8.19

1643

13650

Urticaria and erythema

946

7363

1.30

12.89

4.5

3.6

129.71

129.31

g/l

0.22

919

7200

Polyarthrosis

608

4264

1.39

12.89

3.6

3.2

126.11

126.90

g/l

0.39

588

4183

Acute suppurative otitis media

609

4151

1.39

12.79

5.3

3.9

130.51

133.34

g/l

2.28

598

4053

Symptoms and signs involving speech and voice

935

7288

1.30

12.72

4.1

3.4

128.01

128.23

g/l

0.11

913

7108

Other specified disorders of kidney and ureter

123

612

2.12

12.71

8.7

3.3

123.54

127.58

g/l

1.10

123

603

In situ neoplasms

995

7449

1.29

12.70

3.7

3.2

124.94

129.56

g/l

9.18

966

7260

Gestational [pregnancy-induced] hypertension

491

3458

1.43

12.67

4.2

3.0

127.70

129.66

g/l

1.20

479

3368

Other diseases of oesophagus

307

1986

1.59

12.58

3.8

3.0

124.54

128.57

g/l

2.14

298

1937

Other renal tubulo-interstitial diseases

334

2.53

12.56

6.7

2.5

117.75

127.28

g/l

2.99

328

Oxicams

933

4099

1.31

12.54

3.5

4.0

131.18

126.77

g/l

7.07

912

4014

Injuries involving multiple body regions

124

620

2.09

12.53

5.0

3.3

127.36

129.74

g/l

0.52

119

606

Fracture at wrist and hand level

940

7338

1.30

12.51

4.1

3.6

129.96

130.65

g/l

0.42

921

7159

Glaucoma

1788

13126

1.21

12.50

3.6

3.3

125.41

127.61

g/l

3.82

1741

12801

Correction of physiology of bite - demanding therapy visit

181

1022

1.82

12.47

6.8

3.1

128.69

130.01

g/l

0.39

174

999

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1577

8913

1.23

12.43

3.7

3.3

126.26

130.12

g/l

9.99

1538

8697

Pre-eclampsia

412

2828

1.48

12.42

4.1

3.1

126.38

129.61

g/l

2.31

401

2755

Invasive ventilation

236

1441

1.70

12.40

4.7

3.6

121.49

128.44

g/l

4.29

228

1399

Anterior Iridocyclitis

581

4250

1.39

12.38

5.2

3.3

126.12

129.75

g/l

3.40

567

4143

Subarachnoid haemorrhage

329

2171

1.56

12.34

3.2

3.0

126.40

128.08

g/l

0.68

322

2114

Nontoxic goitre/thyroid nodule

853

6602

1.31

12.31

3.1

129.22

126.65

g/l

2.98

833

6439

Melanocytic naevi of trunk

331

2189

1.55

12.21

3.8

3.1

126.29

129.52

g/l

1.78

322

2128

Benign neoplasm: Rectum, anus and anal canal

625

4643

1.37

12.19

3.8

3.4

124.96

128.34

g/l

3.10

607

4532

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

713

5388

1.34

12.13

3.3

3.5

133.33

130.82

g/l

2.34

692

5261

Pre-eclampsia or eclampsia

444

3106

1.45

12.12

4.2

3.1

126.19

129.40

g/l

2.42

432

3031

Open wound of forearm

272

1727

1.62

12.08

4.4

3.2

128.69

129.84

g/l

0.39

266

1682

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

1715

9760

1.21

12.05

3.6

3.3

126.36

130.48

g/l

11.87

1671

9524

Alzheimer disease, excluding more controls

553

2668

1.41

12.01

2.7

3.0

127.88

125.66

g/l

1.53

541

2608

Alzheimer’s disease (Atypical or mixed), excluding more controls

260

1412

1.64

11.90

2.8

3.0

128.67

124.85

g/l

1.94

252

1374

Other benign neoplasms of skin

1107

8885

1.26

11.84

4.0

3.3

127.83

128.04

g/l

0.11

1086

8664

1320

10159

1.24

11.81

3.6

3.2

126.25

126.70

g/l

0.32

1289

9907

Primary gonarthrosis, bilateral

1599

11647

1.22

11.78

3.0

3.4

128.02

127.60

g/l

0.32

1562

11377

Sarcoidosis

392

2704

1.48

11.78

4.5

3.2

127.48

129.82

g/l

1.12

379

2636

Strabismus

704

5328

1.34

11.77

5.0

4.0

129.85

129.94

g/l

0.03

689

5197

5-aminosalicylic acid

558

4089

1.38

11.69

4.2

3.3

130.23

131.88

g/l

0.91

537

4002

Other fall from one level to another

632

4724

1.36

11.68

4.0

3.9

129.56

130.72

g/l

0.65

618

4614

Acute appendicitis, no complications

1522

12591

1.22

11.68

3.3

3.5

132.70

130.56

g/l

3.30

1490

12298

Burns and corrosions

381

2617

1.49

11.65

3.5

3.8

130.24

131.28

g/l

0.38

371

2550

Multiple myeloma and malignant plasma cell neoplasms

173

992

1.83

11.64

5.8

3.0

108.79

127.03

g/l

20.01

167

966

Retinal detachments and breaks

1074

8614

1.26

11.62

4.2

3.2

125.96

128.45

g/l

3.06

1053

8406

ILD-related respiratory insufficiency

128

670

2.03

11.61

6.7

3.2

121.53

125.91

g/l

1.23

116

653

Fracture of neck

200

1193

1.75

11.59

3.5

3.2

123.51

128.20

g/l

2.10

195

1165

Spondyloarthritis

513

3718

1.40

11.55

4.3

3.3

126.44

129.78

g/l

2.67

496

3630

Seborrhoeic dermatitis

294

1922

1.57

11.54

3.9

3.4

128.77

129.94

g/l

0.38

283

1870

Fibroblastic disorders

710

5411

1.33

11.53

3.3

128.20

128.41

g/l

0.09

696

5271

Trigger finger

385

2655

1.48

11.52

3.9

3.2

128.14

128.93

g/l

0.28

373

2586

Any dementia

1261

7229

1.25

11.51

3.3

3.2

126.59

125.74

g/l

0.75

1242

7038

Other disorders of conjunctiva

432

3053

1.45

11.45

5.0

3.3

129.98

127.69

g/l

1.30

417

2979

Carbimazole or st.post thyroidectomy, condition for graves disease

526

3837

1.39

11.40

3.0

3.2

132.00

128.67

g/l

2.89

504

3737

Recurring oral aphthae, including avohilmo

379

2614

1.48

11.39

6.1

3.3

126.67

129.08

g/l

1.36

370

2544

Infarction of spleen

109

3.97

11.38

4.9

3.5

119.78

125.99

g/l

0.75

109

IBD patients in KELA-register

604

4502

1.36

11.36

4.1

3.5

130.63

131.55

g/l

0.43

582

4397

Other disorders of eye and adnexa

373

2566

1.48

11.33

3.8

3.5

130.18

129.08

g/l

0.45

363

2501

Pre-eclampsia or poor fetal growth

578

4264

1.37

11.31

4.3

3.1

126.63

129.75

g/l

2.88

562

4162

Wet age-related macular degeneration

580

4239

1.37

11.24

3.3

3.1

125.08

125.94

g/l

0.43

567

4135

Generalized epilepsy

127

666

1.98

11.17

4.5

4.7

128.75

129.93

g/l

0.22

119

651

Acute and subacute iridocyclitis

545

4016

1.38

11.15

5.2

3.2

126.58

129.89

g/l

2.72

531

3912

Adhesive capsulitis of shoulder

477

3441

1.41

11.13

3.8

3.2

128.46

128.97

g/l

0.19

461

3362

Alkalosis

8.01

11.12

11.4

1.6

118.82

125.77

g/l

0.41

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

409

2887

1.45

10.98

4.1

3.1

123.71

128.86

g/l

5.19

401

2802

Coxarthrosis, primary, with hip surgery

1488

11762

1.21

10.97

3.3

126.69

127.22

g/l

0.41

1455

11469

Need for other prophylactic measures

176

1029

1.78

10.95

9.3

3.5

123.58

129.74

g/l

3.10

176

1001

Gonarthrosis, primary, with knee surgery

1788

12360

1.19

10.92

3.2

3.4

126.20

127.44

g/l

1.51

1748

12076

Other disorders of lacrimal gland

921

7311

1.28

10.87

4.5

3.3

127.20

128.05

g/l

0.58

893

7138

Colorectal cancer

739

5718

1.32

10.86

3.1

3.4

121.74

127.69

g/l

9.98

720

5577

Neuralgia and neuritis, unspecified

155

878

1.83

10.72

4.0

2.7

129.44

130.10

g/l

0.14

146

852

Diabetes mellitus in pregnancy

541

2563

1.38

10.72

3.6

3.2

130.15

130.51

g/l

0.15

527

2498

Other disorders of the musculoskeletal system and connective tissue

424

3022

1.43

10.71

3.0

3.3

128.35

128.64

g/l

0.09

411

2940

Redundant prepuce, phimosis and paraphimosis

605

4539

1.35

10.65

4.6

3.7

132.66

133.45

g/l

0.35

592

4447

Crohn's disease NAS

183

1089

1.73

10.58

5.7

3.6

127.55

131.47

g/l

1.37

175

1062

Recurring oral aphthae

145

810

1.86

10.57

11.2

3.2

125.39

127.60

g/l

0.56

140

789

Vitamin B12 deficiency anaemia

346

2386

1.49

10.52

4.3

3.1

118.06

128.25

g/l

12.40

335

2332

Suppurative and unspecified otitis media

880

6167

1.28

10.47

4.7

3.8

130.29

131.98

g/l

1.37

862

6024

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

460

2.15

10.44

9.6

7.0

129.65

130.95

g/l

0.19

452

Sequelae of injuries, of poisoning and of other consequences of external causes

642

4900

1.33

10.35

3.3

3.6

128.91

130.89

g/l

1.30

626

4788

Disorders of continuity of bone

249

1608

1.59

10.32

4.9

3.2

124.74

130.01

g/l

3.13

243

1568

Squamous cell neoplasms and carcinomas of the skin

409

2923

1.44

10.30

4.1

3.2

123.71

126.49

g/l

1.83

401

2849

Disturbance of activity and attention

196

1178

1.67

10.20

5.1

4.8

132.81

134.70

g/l

0.61

191

1152

Hypersensitivity angiitis

4.02

10.17

8.3

3.9

114.66

125.95

g/l

2.20

Chronic sinusitis

1189

9767

1.23

10.16

3.7

3.4

130.22

129.30

g/l

0.75

1154

9538

Malignant neoplasm of colon

470

3449

1.39

10.06

3.2

3.3

120.63

127.45

g/l

8.06

458

3359

Nondiabetic hypoglycaemic coma

5.23

9.91

4.0

3.9

127.36

132.85

g/l

0.41

Sleep disorders, other/unspecified

450

2.12

9.90

3.3

132.17

130.86

g/l

0.24

442

Inflammatory bowel disease, strict (require KELA)

604

4600

1.33

9.88

4.1

3.6

130.63

131.49

g/l

0.39

582

4495

Fracture of forearm

1535

12124

1.20

9.87

3.7

3.4

127.85

128.60

g/l

0.68

1511

11851

Coeliac disease

326

2250

1.48

9.82

5.2

3.3

125.80

130.17

g/l

3.24

317

2190

Fluid overload

6.13

9.81

8.3

3.2

126.63

128.68

g/l

0.11

Hypoplasia of dental enamel, prenatal

6.65

9.80

44.1

19.7

117.63

123.16

g/l

0.44

Other condition

374

2649

1.44

9.79

4.3

3.4

127.51

130.59

g/l

1.85

363

2578

Blepharochalasis

858

6852

1.27

9.77

3.6

3.3

128.66

126.86

g/l

1.64

839

6683

Filling of root of tooth

496

2.07

9.70

7.3

3.2

122.10

129.24

g/l

2.09

488

Abnormal results of function studies

241

1570

1.58

9.68

5.2

3.5

126.25

129.52

g/l

1.44

236

1525

Inguinal hernia

1938

11217

1.17

9.67

3.9

3.4

129.46

130.93

g/l

1.94

1898

10950

Abscess of anal and rectal regions

228

1466

1.59

9.66

3.8

3.4

127.77

132.69

g/l

2.32

219

1433

Intentional self-harm by smoke, fire and flames

7.50

9.64

4.8

5.0

128.12

130.07

g/l

0.10

conjunctival haemorrhage

234

1520

1.59

9.63

4.7

3.1

127.93

127.87

g/l

0.01

226

1478

Other maltreatment syndromes

435

2.13

9.61

2.9

3.1

136.55

133.84

g/l

0.52

427

Bell's palsy

332

2311

1.47

9.60

3.7

3.2

127.99

129.03

g/l

0.35

322

2254

Enthesopathies of lower limb, excluding foot

559

4229

1.34

9.60

4.4

3.4

130.78

129.33

g/l

0.80

543

4135

Temporomandibular joint disorders, including avohilmo

946

7626

1.25

9.57

3.5

3.3

130.87

129.91

g/l

0.75

917

7450

malignant neoplasm of female genital organs

415

3011

1.41

9.51

2.8

2.9

121.22

125.90

g/l

4.54

408

2940

Osteonecrosis

177

1082

1.69

9.40

5.1

3.0

121.67

129.38

g/l

3.83

171

1055

Other/unspecified synovitis and tenosynovitis

312

2155

1.48

9.37

3.4

3.2

129.14

129.04

g/l

0.03

305

2096

Idiopathic pulmonary fibrosis

254

1693

1.55

9.34

4.1

3.1

126.98

126.83

g/l

0.03

245

1651

Malignant neoplasm of urinary organs

318

2214

1.48

9.33

4.9

3.2

118.06

128.16

g/l

10.99

313

2149

Hyperkinetic disorders

210

1316

1.60

9.27

5.0

4.8

132.84

134.69

g/l

0.61

205

1288

Other and unspecified disorders of vitreous body

1158

9548

1.22

9.23

3.3

130.49

127.49

g/l

4.91

1134

9325

Atypical facial pain

149

874

1.76

9.21

2.8

131.06

127.13

g/l

1.54

141

857

Henoch-Schönlein purpura nephritis (HSPN)

4.78

9.16

10.0

4.1

118.83

128.71

g/l

0.93

Keratitis

953

7749

1.24

9.14

4.3

3.3

127.98

129.80

g/l

1.62

928

7574

Skin changes due to chronic exposure to nonionizing radiation

1229

9704

1.21

9.12

3.6

3.2

125.96

126.63

g/l

0.51

1199

9465

Lyme disease

402

5474

0.72

9.05

2.2

3.5

131.89

128.79

g/l

2.39

396

5336

Mandibular retrognathia

161

964

1.71

9.01

3.1

4.2

135.75

131.38

g/l

2.01

156

940

Impingement syndrome of shoulder

681

5340

1.29

9.01

3.6

3.3

131.67

129.38

g/l

1.85

652

5217

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

221

1436

1.58

9.00

5.2

3.0

125.79

130.86

g/l

2.57

213

1392

Follicular cysts of skin and subcutaneous tissue

501

3777

1.35

8.93

4.1

3.3

128.14

130.01

g/l

1.03

487

3685

Inflammatory diseases of female pelvic organs

1423

9046

1.19

8.89

3.5

3.0

128.76

127.44

g/l

1.61

1392

8841

Fissure and fistula of anal and rectal regions

644

5022

1.30

8.88

3.4

3.2

130.04

130.15

g/l

0.04

629

4900

Actinic keratosis

1198

9503

1.21

8.82

3.7

3.2

125.91

126.58

g/l

0.51

1170

9268

Pneumothorax

216

1407

1.58

8.78

4.5

3.2

127.96

128.78

g/l

0.18

209

1371

Persistent delusional disorders

218

1422

1.57

8.77

2.4

3.1

131.56

129.12

g/l

0.90

212

1387

Sulfasalazine

767

6120

1.27

8.74

3.6

3.2

126.82

130.22

g/l

3.98

743

5985

Rheumatism, unspecified

349

2495

1.42

8.69

3.2

3.0

128.31

127.18

g/l

0.45

333

2442

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1757

11951

1.17

8.68

3.5

3.3

125.39

127.32

g/l

3.25

1713

11666

Preparation and fitting of bite rail to mouth

331

2347

1.43

8.64

5.5

3.4

132.77

130.84

g/l

0.91

324

2290

Injury of eye and orbit

365

2632

1.41

8.64

4.2

3.6

132.30

131.41

g/l

0.31

360

2568

Burns and corrosions of external body surface, specified by site

291

2018

1.47

8.63

3.6

3.8

129.99

131.02

g/l

0.32

286

1967

Other extrapyramidal and movement disorders in other diseases

635

4971

1.30

8.61

3.6

3.4

128.76

128.31

g/l

0.20

624

4851

Postprocedural musculoskeletal disorders, not elsewhere classified

212

1384

1.58

8.59

3.0

3.1

126.51

127.94

g/l

0.40

203

1348

Other and unspecified vascular occlusions

300

2100

1.47

8.59

4.5

3.0

123.42

127.58

g/l

2.56

294

2042

Outcome of delivery

121

1305

0.57

8.55

2.0

2.9

135.49

130.69

g/l

2.32

121

1277

Other spirochaetal diseases

412

5538

0.73

8.54

2.3

3.6

131.70

128.79

g/l

2.18

405

5400

Anomalies of dental arch relationship, including avohilmo

448

2997

1.36

8.48

5.3

3.6

131.00

131.22

g/l

0.07

440

2924

Pain associated with micturition

313

2209

1.45

8.46

5.4

3.2

127.86

128.34

g/l

0.15

306

2148

Glaucoma suspect

1056

8772

1.22

8.31

3.4

126.01

127.51

g/l

1.35

1024

8560

Malignant neoplasm of skin

1979

12991

1.16

8.26

3.4

3.3

125.52

127.64

g/l

4.09

1928

12680

Hyperaldosteronism

528

1.95

8.22

3.9

3.4

132.52

127.91

g/l

1.11

519

Dislocation, sprain and strain of joints and ligaments of head

106

582

1.88

8.19

6.3

4.0

131.42

130.35

g/l

0.22

106

568

Menorrhagia

896

4014

1.25

8.19

4.1

3.0

127.66

126.35

g/l

1.07

877

3932

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

104

572

1.90

8.14

16.6

3.3

113.74

130.94

g/l

10.31

104

561

Weight loss

280

1955

1.47

8.11

4.3

3.6

126.21

127.77

g/l

0.57

267

1902

Ulcerative colitis, NAS

363

2646

1.39

8.10

4.9

3.5

127.48

130.82

g/l

1.91

347

2576

Hypoplasia of dental enamel, prenatal , including avohilmo

4.10

8.09

41.1

15.0

119.71

125.48

g/l

0.56

Maternal care for other conditions predominantly related to pregnancy

343

2436

1.40

8.09

3.3

129.87

130.23

g/l

0.12

333

2375

Polyp of the female genital tract

815

3813

1.26

8.07

3.0

3.1

128.65

126.17

g/l

2.81

797

3738

Anxious personality disorder

226

2.45

8.05

4.9

2.9

129.87

134.03

g/l

0.59

221

Primary coxarthrosis, bilateral

881

7221

1.24

8.02

3.4

3.3

126.78

126.87

g/l

0.04

857

7048

Noninflammatory disorders of female genital tract

1071

4447

1.22

8.00

2.9

3.1

129.06

126.99

g/l

2.62

1046

4352

Budesonide

337

2432

1.41

7.98

3.6

3.1

129.81

131.03

g/l

0.45

320

2371

Superficial injury of shoulder and upper arm

302

2144

1.44

7.92

3.9

3.3

129.79

130.08

g/l

0.08

297

2084

Acute nasopharyngitis (common cold)

322

2297

1.42

7.89

3.7

3.5

132.59

133.36

g/l

0.23

310

2244

Benign lipomatous neoplasm

788

6392

1.25

7.85

4.0

3.3

130.53

131.08

g/l

0.29

760

6228

Presence of other devices

397

5291

0.74

7.85

3.9

2.9

123.57

128.14

g/l

3.61

377

5176

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

586

4600

1.29

7.84

2.7

3.3

122.07

129.87

g/l

12.82

567

4475

Visual field defects

250

1722

1.49

7.81

4.0

3.2

127.90

127.99

g/l

0.02

240

1676

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

1469

8674

1.18

7.80

3.4

3.3

126.09

129.98

g/l

9.41

1429

8460

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

175

1118

1.61

7.79

2.9

118.19

128.38

g/l

7.70

170

1085

Faecal incontinence

227

1536

1.51

7.70

3.5

2.8

126.12

126.55

g/l

0.12

220

1500

Other intracranial haemorrhages

112

643

1.82

7.67

5.3

3.4

126.33

126.56

g/l

0.03

107

629

Other enthesopathy of foot (+metatarsalgia)

248

1708

1.48

7.66

3.4

3.2

130.48

128.90

g/l

0.55

242

1663

Right bundle-branch block

103

577

1.85

7.55

6.8

2.4

129.43

128.91

g/l

0.09

559

Urticaria

707

5690

1.25

7.53

4.8

3.7

130.77

129.76

g/l

0.60

690

5559

Benign neoplasm of mouth and pharynx

294

2099

1.43

7.52

3.4

3.1

129.23

131.29

g/l

0.80

287

2035

Secondary parkinsonism+Parkinsonism in other disease

544

1.89

7.51

4.7

3.1

126.74

125.77

g/l

0.18

536

Secondary parkinsonism

533

1.89

7.37

4.7

3.2

126.59

125.79

g/l

0.14

525

Other inflammatory liver diseases

183

1200

1.57

7.28

3.4

3.1

124.95

129.22

g/l

1.54

177

1170

Parkinson's disease, including avohilmo

484

3752

1.31

7.25

3.3

3.2

126.95

127.34

g/l

0.16

470

3660

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

195

1298

1.54

7.22

3.0

2.9

126.78

130.77

g/l

1.57

189

1259

Renal agenesis and other reduction defects of kidney

3.55

7.19

6.9

12.0

119.54

127.44

g/l

0.85

Collagenous colitis

240

1670

1.47

7.13

4.8

3.3

123.82

128.39

g/l

2.70

235

1624

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

1479

8782

1.17

7.11

3.4

3.3

126.31

130.02

g/l

8.60

1439

8568

Effects of foreign body entering through natural orifice

662

5335

1.26

7.07

3.6

3.8

131.41

131.27

g/l

0.06

646

5209

Personal history of other diseases and conditions

226

1545

1.48

7.06

8.1

3.4

123.98

132.01

g/l

6.17

220

1509

Hydrocephalus

235

1634

1.48

7.06

3.1

3.3

129.64

127.24

g/l

0.99

228

1592

Other specified/unspecified necrotizing vasculopathies

269

2.27

7.03

7.4

3.2

115.98

127.39

g/l

3.09

264

Bronchiectasis

240

1679

1.47

6.99

3.3

3.2

124.63

127.21

g/l

1.06

235

1636

Rare circulating lymphoid malignancy

104

603

1.80

6.90

16.6

4.0

113.74

127.03

g/l

6.77

104

589

Accidental poisoning by and exposure to other gases and vapours

3.44

6.90

2.4

4.2

131.38

128.71

g/l

0.23

Disorders of refraction and accommodation

615

4907

1.26

6.89

5.4

4.0

129.76

130.50

g/l

0.35

599

4790

Other strabismus

523

4100

1.29

6.88

5.2

3.9

130.98

130.39

g/l

0.25

512

3998

In situ neoplasms

995

8373

1.20

6.87

3.7

3.2

124.94

127.11

g/l

2.46

966

8169

Acute pharyngitis

330

2416

1.37

6.87

5.2

3.9

133.04

132.67

g/l

0.10

319

2367

Excessive attrition of teeth

1023

4647

1.20

6.82

4.6

3.0

130.37

131.09

g/l

0.44

995

4519

Sequelae of injuries of head

145

918

1.62

6.77

3.7

3.4

129.31

131.50

g/l

0.55

140

894

Parkinson's disease

462

3595

1.31

6.76

3.3

3.2

126.87

127.51

g/l

0.27

448

3509

Scleritis and episcleritis

152

974

1.60

6.72

5.5

3.3

128.56

130.14

g/l

0.41

146

951

Central retinal artery occlusion

448

1.93

6.70

3.5

3.2

124.77

125.80

g/l

0.14

436

Suggestive for eosinophilic asthma

255

1818

1.43

6.65

3.8

3.0

133.24

128.88

g/l

2.43

250

1766

Other keratitis

277

2001

1.41

6.64

4.7

3.3

127.82

130.48

g/l

1.09

271

1954

Abnormal weight loss

250

1779

1.44

6.63

3.9

3.6

126.79

127.91

g/l

0.34

238

1731

Otitis externa, unspecified

272

1960

1.41

6.62

3.4

3.6

131.92

129.74

g/l

0.81

263

1904

Dislocation, sprain and strain of joints and ligaments of knee

1566

12706

1.15

6.55

3.1

3.4

134.09

130.99

g/l

6.13

1532

12423

Chondropathies

390

2976

1.33

6.52

3.2

3.3

132.88

130.75

g/l

1.10

378

2898

Other obstetric conditions, not elsewhere classified

485

2448

1.30

6.51

4.2

2.9

130.24

131.75

g/l

0.86

468

2395

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

367

2784

1.34

6.48

2.8

3.3

123.45

130.37

g/l

6.98

357

2706

Accidental poisoning by and exposure to alcohol

256

2.20

6.48

6.9

3.5

132.93

131.00

g/l

0.27

249

Sexual assault by bodily force

5.32

6.45

3.9

2.7

128.86

131.67

g/l

0.17

Other general symptoms and signs

115

687

1.69

6.44

3.3

4.1

125.48

129.57

g/l

1.05

107

671

Injury of muscle and tendon at wrist and hand level

358

2712

1.34

6.34

2.8

3.4

132.85

130.29

g/l

1.34

348

2640

Sequelae of injuries of lower limb

242

1724

1.43

6.33

3.5

3.2

127.67

130.57

g/l

1.10

236

1683

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

351

2659

1.35

6.29

2.8

3.1

121.00

129.80

g/l

9.33

339

2587

Otitis externa

554

4440

1.26

6.27

3.7

3.6

130.58

129.83

g/l

0.32

538

4339

L04AC Interleukin inhibitors

119

732

1.67

6.26

3.7

3.0

132.42

131.64

g/l

0.13

119

717

Vascular dementia (mixed)

296

2.11

6.22

2.0

3.0

124.22

122.91

g/l

0.16

288

Striking against or struck by other objects

828

6913

1.21

6.21

3.8

3.9

131.68

131.50

g/l

0.08

806

6749

Paralytic strabismus

205

1426

1.47

6.20

4.3

3.2

127.78

128.43

g/l

0.15

200

1383

Leiomyoma of uterus

1079

5160

1.19

6.18

3.0

3.1

127.95

129.04

g/l

0.91

1049

5037

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

319

2382

1.35

6.16

3.2

3.1

128.61

128.57

g/l

0.01

310

2331

Dental caries 2

1611

14380

0.88

6.14

4.7

3.5

129.33

130.68

g/l

1.51

1584

14028

Exposure to other and unspecified inanimate mechanical forces

176

1189

1.51

6.14

3.4

3.8

129.20

131.07

g/l

0.51

171

1160

Seropositive rheumatoid arthritis

684

5607

1.23

6.13

3.5

3.2

122.91

128.25

g/l

8.88

668

5485

Artificial joint operation, meniscal resection

2873

17340

1.11

6.12

3.2

3.4

128.96

129.01

g/l

0.03

2811

16942

Crohn's disease of large intestine

129

814

1.62

6.12

3.8

3.2

127.69

131.69

g/l

1.12

124

795

Polymyalgia rheumatica

397

3072

1.32

6.12

3.8

3.1

123.04

126.76

g/l

3.38

390

2995

Basal cell carcinoma

1747

12310

1.14

6.09

3.3

125.41

127.27

g/l

3.01

1700

12017

Complications predominantly related to the puerperium

472

3724

1.28

6.05

3.0

3.2

130.94

128.83

g/l

1.52

462

3641

Early lumbar disc prolapse, operated

193

1329

1.47

6.02

3.9

3.2

134.58

135.10

g/l

0.11

182

1300

Parkinson's disease, strict definition

427

3350

1.30

5.93

3.3

3.2

127.40

127.24

g/l

0.06

414

3268

Otitis media, unspecified

256

1712

1.40

5.88

6.0

4.7

130.22

131.19

g/l

0.29

244

1671

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1457

12513

1.15

5.86

4.2

3.5

130.36

129.83

g/l

0.38

1409

12215

Biological medication for rheuma

348

2655

1.33

5.85

3.8

3.6

129.77

131.74

g/l

0.85

337

2596

Erosion of teeth, including avohilmo

452

3446

1.28

5.81

5.8

2.9

127.73

131.97

g/l

3.39

440

3349

Thyrotoxicosis with diffuse goitre

311

2340

1.35

5.78

3.6

3.3

131.56

128.20

g/l

1.99

303

2288

Meniscus derangement

1683

10180

1.14

5.76

3.3

3.2

131.34

130.20

g/l

1.22

1643

9974

UC patients in KELA-register (code 208), prior to 1994

132

854

1.59

5.73

4.4

3.2

127.80

129.73

g/l

0.38

123

835

Vulvovaginal ulceration/inflammation in other diseases

113

702

1.64

5.70

3.9

2.7

129.87

129.68

g/l

0.03

108

685

Superficial injury of neck

263

2.09

5.67

2.2

3.9

136.43

132.45

g/l

0.77

258

Schizoid personality disorder

292

2.04

5.64

2.3

3.1

129.04

132.07

g/l

0.46

287

Congenital malformation of biliary tract

4.11

5.63

22.8

16.0

118.94

126.63

g/l

0.55

Later onset COPD

912

6092

1.19

5.57

4.5

3.2

125.27

126.65

g/l

1.02

885

5925

Benign neoplasm of mouth and pharynx

294

2211

1.35

5.57

3.4

3.1

129.23

128.72

g/l

0.14

287

2145

Cryoglobulinemia

5.60

5.56

6.8

4.1

112.83

128.46

g/l

1.86

Lateral epicondylitis

310

2348

1.34

5.53

3.3

132.01

130.36

g/l

0.68

301

2291

Other diseases of upper respiratory tract

3614

17331

1.09

5.52

3.6

3.5

130.07

128.79

g/l

2.67

3529

16940

Malignant neoplasm of respiratory system and intrathoracic organs

428

4953

0.79

5.52

3.4

123.03

127.20

g/l

3.33

417

4825

Basal cell carcinoma, including avohilmo

1777

12472

1.13

5.49

3.3

125.63

127.30

g/l

2.58

1730

12173

Dental caries 2 and operation codes

1577

14137

0.88

5.47

4.5

3.5

129.53

130.65

g/l

1.13

1550

13795

Malignant neoplasm of bronchus and lung

359

4303

0.77

5.43

3.5

3.3

123.31

126.96

g/l

2.35

353

4196

Other maternal disorders predominantly related to pregnancy

1134

6153

1.16

5.41

3.2

3.1

130.66

128.43

g/l

3.07

1105

6019

Other symptoms and signs involving the nervous and musculoskeletal systems

1088

9412

1.16

5.40

4.5

3.6

130.76

128.89

g/l

2.10

1049

9193

Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]

13.82

5.36

5.8

3.6

116.44

129.10

g/l

—

Mixed connective tissue disease

164

1126

1.49

5.35

3.5

3.0

123.03

127.56

g/l

2.02

159

1101

Haemorrhage in early pregnancy

503

3962

1.25

5.32

2.8

3.2

130.65

128.72

g/l

1.32

493

3868

Colorectal adenocarcinoma

586

4823

1.23

5.32

2.7

3.4

122.07

127.67

g/l

7.08

567

4702

Intentional self-harm by jumping from a high place

3.44

5.32

3.9

3.6

136.74

135.59

g/l

0.07

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

460

2372

1.27

5.27

4.4

2.9

130.16

131.79

g/l

0.92

443

2319

Diseases of middle ear and mastoid

1456

10523

1.14

5.27

4.3

3.7

130.57

130.65

g/l

0.04

1425

10268

Acute laryngitis and tracheitis

242

1750

1.38

5.25

4.0

4.2

132.23

132.85

g/l

0.16

235

1715

Adalimumab

199

1419

1.43

5.24

3.7

3.6

130.98

132.21

g/l

0.30

190

1384

Occlusion and stenosis of arteries, not leading to stroke

245

2.10

5.23

2.6

3.1

121.00

125.84

g/l

0.76

239

Food allergy

4.89

5.18

3.7

3.4

135.83

133.63

g/l

0.15

Impacted maxillary molar

595

1.66

5.17

6.4

3.7

132.98

134.87

g/l

0.46

582

Rheumatoid lung disease

3.27

5.14

4.5

3.9

133.38

127.11

g/l

0.63

Burn and corrosion of hip and lower limb, except ankle and foot

382

1.85

5.10

4.8

3.7

130.62

129.53

g/l

0.14

375

Nontoxic single thyroid nodule

184

1305

1.44

5.06

3.1

3.0

130.90

127.47

g/l

1.44

184

1279

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

438

3513

1.26

5.02

4.3

3.5

130.64

131.35

g/l

0.25

418

3434

Calcinosis cutis

5.40

5.01

24.5

4.0

105.09

129.96

g/l

2.35

Perforation of tympanic membrane

261

1962

1.35

5.00

4.9

3.3

128.63

129.42

g/l

0.21

254

1912

Other and unspecified disorders of binocular movement

3.04

5.00

4.2

7.6

130.68

129.69

g/l

0.07

Failure of sterile precautions during surgical operation

4.05

4.99

2.8

4.1

123.93

126.55

g/l

0.20

Nummular dermatitis

224

1648

1.39

4.98

4.6

3.1

125.53

129.41

g/l

1.69

219

1600

Preterm labour and delivery

477

3863

1.24

4.96

3.2

3.3

128.49

128.29

g/l

0.07

467

3781

Colon adenocarcinoma

351

2754

1.30

4.96

2.8

3.2

121.00

127.33

g/l

5.22

339

2680

Examination and encounter for administrative purposes

121

796

1.56

4.91

3.5

3.0

131.83

130.25

g/l

0.31

115

774

Degenerative macular diseases

356

2802

1.29

4.90

3.6

3.0

128.75

127.31

g/l

0.60

347

2734

Hallux valgus (acquired)

909

5645

1.17

4.89

2.8

3.2

127.84

127.88

g/l

0.02

883

5533

Retinal haemorrhage

471

1.75

4.88

4.9

2.9

124.27

127.49

g/l

0.69

460

Benign lipomatous neoplasm

788

6717

1.18

4.84

4.0

3.5

130.53

128.79

g/l

1.43

760

6555

Use of levodopa decarboxylase inhibitor

392

3130

1.27

4.80

3.1

3.2

126.77

126.93

g/l

0.05

381

3052

Calcific tendinitis of shoulder

144

986

1.49

4.79

3.8

3.0

133.40

130.00

g/l

1.02

138

961

Palmar fascial fibromatosis [Dupuytren]

463

3763

1.25

4.79

3.4

128.12

128.35

g/l

0.07

456

3660

Spondylopathies (FG)

330

2575

1.30

4.79

3.8

3.3

130.31

131.65

g/l

0.49

323

2523

Ulcerative colitis (strict definition, require KELA)

402

3214

1.26

4.77

4.3

3.5

130.30

131.34

g/l

0.38

383

3141

Other congenital musculoskeletal deformities

4.48

4.75

4.3

14.2

125.42

131.93

g/l

0.54

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

387

3083

1.27

4.74

4.3

3.5

130.40

131.35

g/l

0.33

371

3010

Persons encountering health services in circumstances related to reproduction

1136

8789

0.87

4.73

4.8

3.9

130.73

132.04

g/l

1.10

1098

8600

Demyelinating diseases of the central nervous system

184

1321

1.41

4.70

4.7

3.0

133.06

130.59

g/l

0.92

179

1289

Tumor necrosis factor alpha inhibitors

306

2371

1.31

4.69

3.7

3.6

129.71

131.84

g/l

0.87

295

2320

Vascular dementia (subcortical)

585

1.65

4.67

3.4

2.9

127.14

124.05

g/l

0.76

570

Specific developmental disorder of motor function

223

2.06

4.66

5.4

15.1

132.42

128.63

g/l

0.51

217

Motor disorders

227

2.05

4.64

5.4

14.1

132.42

128.93

g/l

0.46

222

Other specified and unspecified retinal disorders

101

649

1.61

4.62

5.3

3.0

128.39

127.70

g/l

0.12

635

Spontaneous rupture of synovium and tendon

212

1569

1.38

4.55

3.8

3.2

129.87

128.80

g/l

0.27

203

1523

Defect, injury or illness of neck

3.03

4.55

3.2

3.8

134.10

127.90

g/l

0.73

Mixed conductive and sensorineural hearing loss

334

2634

1.29

4.54

3.9

3.3

126.76

127.99

g/l

0.47

329

2565

Oter anti-inflammatory and antirheumatic agents, non-steroids

820

3889

1.18

4.52

3.1

3.9

128.78

126.45

g/l

2.03

801

3810

Malignant neoplasm of endocrine gland

178

1283

1.41

4.51

4.9

3.2

124.97

128.07

g/l

1.02

172

1249

Assault by other specified means

112

2.53

4.51

3.1

3.7

130.67

131.85

g/l

0.08

112

Maternal care for known or suspected fetal abnormality and damage

124

1618

0.68

4.47

2.3

3.4

131.91

130.12

g/l

0.42

119

1577

Injury of muscle and tendon at shoulder and upper arm level

1017

8902

1.15

4.43

3.2

3.4

130.93

129.72

g/l

0.93

988

8688

Contact with sharp object, undetermined intent

325

1.84

4.42

4.3

3.2

129.07

132.02

g/l

0.42

320

Episcleritis

123

832

1.51

4.39

5.3

3.3

128.59

129.58

g/l

0.20

117

814

Hereditary hypogammaglobulinemia

3.44

4.38

2.5

3.6

121.75

130.55

g/l

0.50

Spinal osteochondrosis

166

2.21

4.33

2.3

2.6

130.91

131.30

g/l

0.03

161

Acute appendicitis, with complications

515

4276

1.22

4.32

3.0

3.6

129.83

129.71

g/l

0.04

503

4179

Benign neoplasm of urinary organs

124

845

1.50

4.31

4.6

2.7

124.10

129.89

g/l

2.00

119

821

Nonsuppurative otitis media

498

3554

1.22

4.28

5.5

3.9

130.48

131.57

g/l

0.50

489

3466

Cerebral palsy

228

2.00

4.26

6.9

7.6

130.70

130.12

g/l

0.06

223

Other peripheral vascular diseases

192

1415

1.38

4.26

3.8

2.8

124.56

129.18

g/l

2.20

184

1382

Voice disturbances

656

5574

1.19

4.25

3.8

3.4

128.10

128.35

g/l

0.10

636

5439

Other/unspecified enthesopathies of lower limb, excluding foot

157

1119

1.42

4.24

5.8

3.1

129.93

128.69

g/l

0.28

152

1086

Rheumatoid arthritis, including avohilmo

1029

9046

1.15

4.20

3.5

3.3

124.38

127.99

g/l

6.12

1002

8838

Other disorders of the genitourinary system

319

2527

1.28

4.20

4.1

3.0

126.93

126.57

g/l

0.11

312

2461

Colonic or urogenital fistula

705

6033

1.18

4.19

3.5

3.6

129.36

129.58

g/l

0.09

688

5884

Postmenopausal bleeding

726

3399

1.18

4.18

3.2

3.1

127.14

125.34

g/l

1.39

706

3337

Other and unspecified injuries of wrist and hand

593

1.59

4.14

3.8

125.86

128.77

g/l

0.48

582

Other peripheral vertigo

244

1873

1.33

4.14

3.4

2.9

133.31

127.49

g/l

4.53

238

1825

Immunodeficiency associated with other major defects

3.53

4.14

20.1

14.2

127.00

128.58

g/l

0.10

Autoimmune thyroiditis

252

1.93

4.13

3.4

3.5

131.57

127.79

g/l

0.66

247

Open wound of shoulder and upper arm

311

1.83

4.11

4.3

3.1

126.96

130.83

g/l

0.57

305

Contact with heat and hot substances

130

903

1.47

4.09

3.0

4.1

128.91

129.73

g/l

0.15

125

885

Viral infections of the central nervous system

177

1297

1.39

4.09

4.4

3.2

125.47

129.96

g/l

1.87

172

1269

Idiopathic progressive neuropathy

4.89

4.08

3.5

3.1

133.10

122.75

g/l

—

Atopic dermatitis, strict definition with reimbursement

623

5121

1.19

4.08

3.3

4.0

132.30

131.63

g/l

0.32

610

4995

Rash and other nonspecific skin eruption

244

1876

1.32

4.07

4.0

3.5

129.28

128.24

g/l

0.35

239

1829

Lung cancer and mesothelioma

517

3690

1.21

4.06

3.6

2.8

122.54

128.97

g/l

8.80

509

3604

Dental pulpitis 2

2394

11243

1.10

4.05

3.9

3.3

128.22

129.15

g/l

1.14

2336

11004

Carcinoma in situ of skin

226

1726

1.34

4.03

3.5

3.1

125.34

129.07

g/l

1.75

219

1673

Other coagulation defects

169

1233

1.39

4.02

5.7

3.2

125.67

128.86

g/l

1.03

164

1201

Orthopaedic devices associated with adverse incidents

354

0.32

4.01

3.2

2.9

119.67

125.57

g/l

0.28

348

Hydrocele

344

2767

1.26

4.00

4.3

3.8

125.85

129.65

g/l

2.09

335

2710

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

286

1.87

3.99

3.5

2.8

116.55

130.91

g/l

3.30

281

Impacted cerumen

154

2114

0.72

3.99

3.4

3.5

129.06

127.89

g/l

0.26

148

2055

Dental operations, only avohilmo

2392

11248

1.09

3.99

3.5

3.6

129.10

128.60

g/l

0.48

2321

11025

APECED

14.96

3.97

8.2

12.8

126.50

132.60

g/l

—

Injury of heart

4.03

3.96

3.0

3.2

137.00

129.65

g/l

0.43

Other noninflammatory disorders of vulva and perineum

189

1406

1.36

3.94

2.8

3.1

128.92

126.26

g/l

1.04

189

1380

Peritonsillar abscess

485

4040

1.21

3.94

3.0

3.5

133.06

131.11

g/l

1.16

477

3948

Left hemicolectomy

478

1.65

3.90

4.5

3.2

116.66

125.97

g/l

2.58

468

Childhood allergy (age < 16)

244

1548

1.31

3.85

3.7

6.3

133.26

134.00

g/l

0.22

239

1517

Other hammer toe(s) (acquired)

476

3727

1.21

3.80

3.5

3.1

126.00

126.74

g/l

0.32

462

3654

Selective deficiency of immunoglobulin M [IgM]

13.76

3.78

10.5

130.83

113.67

g/l

—

Inflammatory diseases of prostate (prostatitis)

372

3040

1.24

3.77

3.3

3.5

133.82

130.80

g/l

1.69

365

2966

Malignant neoplasm of thyroid gland

163

1199

1.38

3.73

2.9

3.0

126.06

128.06

g/l

0.52

158

1166

Hypertrophy of breast in women and men

392

3218

1.23

3.73

3.3

3.1

129.98

128.71

g/l

0.54

383

3127

Premature rupture of membranes

215

2060

0.76

3.71

2.7

3.2

131.47

129.76

g/l

0.64

207

2011

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

3.38

3.70

11.1

2.4

119.79

127.67

g/l

0.59

Plantar fascial fibromatosis

218

1674

1.32

3.69

2.8

3.0

130.58

128.85

g/l

0.64

212

1630

Enteropathogenic Escherichia coli infection

3.36

3.69

4.6

6.5

124.07

128.02

g/l

0.25

Other abnormal uterine and vaginal bleeding

564

3407

1.19

3.69

3.1

3.0

127.41

125.62

g/l

1.30

550

3342

Carcinoma in situ of skin of upper limb, including shoulder

455

1.65

3.67

4.0

2.7

124.37

127.64

g/l

0.67

442

Myopia

252

1973

1.29

3.66

5.4

3.6

130.45

131.08

g/l

0.17

245

1921

Murder, homicide, or other assault by rifle, shotgun and larger firearm discharge

11.96

3.66

1.7

11.0

126.67

123.50

g/l

—

Benign neoplasm of meninges

245

1917

1.30

3.64

3.7

3.0

127.11

129.39

g/l

1.01

240

1862

Corneal ulcer

434

3612

1.21

3.62

4.6

3.2

128.42

130.69

g/l

1.23

424

3524

Deep bite

242

1649

1.30

3.62

7.3

4.1

129.80

130.76

g/l

0.31

237

1603

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

104

713

1.50

3.60

4.3

2.9

103.45

128.76

g/l

20.24

696

Benign neoplasm: Heart

3.03

3.59

7.8

3.1

127.19

127.67

g/l

0.03

Maternal care related to the fetus and amniotic cavity and possible delivery problems

620

4260

0.85

3.56

2.9

3.2

130.84

129.29

g/l

1.11

608

4159

Trigeminal neuralgia

147

1074

1.39

3.53

3.2

2.9

131.15

127.88

g/l

1.14

142

1052

Methotrexate

350

2860

1.24

3.53

3.5

3.0

124.51

129.47

g/l

4.15

340

2787

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

253

1.86

3.52

3.3

2.4

123.02

126.92

g/l

0.55

244

Other menopausal disorders

454

3127

0.83

3.50

3.0

3.1

130.96

126.09

g/l

5.59

445

3065

Autoimmune polyglandular failure

6.53

3.49

7.4

17.4

119.75

125.93

g/l

—

Brachial plexus disorders

188

1427

1.33

3.48

3.1

3.0

131.22

130.65

g/l

0.12

179

1394

Alzheimer’s disease (Atypical or mixed)

265

2103

1.28

3.48

2.8

3.1

128.53

123.90

g/l

2.83

257

2059

Ethmoidectomy

194

2522

0.76

3.46

2.9

3.3

131.90

130.19

g/l

0.49

181

2456

Tooth eruption problems

240

1862

1.29

3.45

8.1

3.8

127.65

132.89

g/l

3.40

228

1821

Alzheimer’s disease, wide definition

541

5292

0.85

3.44

2.4

3.2

126.57

124.96

g/l

1.05

528

5164

Spondylopathies in diseases classified elsewhere

204

1.95

3.44

7.5

2.9

117.95

125.76

g/l

1.37

197

Benign neoplasm: Heart

2.93

3.39

7.8

2.7

127.19

129.13

g/l

0.12

Localized swelling, mass and lump of skin and subcutaneous tissue

788

6921

1.15

3.36

5.1

3.5

128.14

128.96

g/l

0.47

769

6754

Hereditary angioödema type 1

7.58

3.36

60.4

2.8

129.43

123.18

g/l

—

Other inflammation of eyelid

314

2554

1.24

3.36

3.8

3.3

130.83

128.41

g/l

1.18

308

2480

Abscess of mediastinum

4.07

3.35

2.4

3.1

130.20

127.36

g/l

—

FESS (DNB20)

184

2395

0.76

3.33

2.5

3.4

131.76

130.22

g/l

0.42

172

2333

Dental pulpitis 4, only avohilmo

3473

17012

1.07

3.31

3.5

3.4

130.31

129.08

g/l

2.48

3386

16633

Carcinoma in situ of skin of scalp and neck

485

1.58

3.26

3.9

2.8

118.30

128.72

g/l

3.50

471

Benign lipomatous neoplasm of other sites/unspecified

228

1796

1.29

3.26

3.2

3.0

129.12

130.23

g/l

0.32

219

1744

Meningitis

123

886

1.41

3.25

2.9

3.1

125.87

130.39

g/l

1.57

123

866

Secondary malignant neoplasm of respiratory and digestive organs

253

1.82

3.23

3.2

117.25

125.54

g/l

1.99

248

Alzheimer’s disease (Late onset)

492

4939

0.85

3.23

2.4

3.2

126.59

124.63

g/l

1.31

480

4821

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

298

1.74

3.21

4.2

3.1

111.70

127.91

g/l

6.22

289

Benign neoplasm of urinary organs

124

898

1.41

3.20

4.6

3.1

124.10

127.08

g/l

0.75

119

874

Complications associated with artificial fertilization

151

2.03

3.19

1.9

3.6

127.93

129.56

g/l

0.14

146

Rapidly progressive nephritic syndrome

3.59

3.19

9.9

4.8

112.18

124.26

g/l

1.21

Achilles tendinitis

242

1924

1.27

3.19

4.0

3.5

132.01

129.23

g/l

1.05

232

1871

Other symptoms and signs involving the urinary system

262

2104

1.26

3.18

4.1

3.2

126.18

129.02

g/l

1.30

256

2043

Carcinoma in situ of skin of upper limb, including shoulder

472

1.58

3.18

4.0

3.0

124.37

124.97

g/l

0.09

460

Benign neoplasm: Hypopharynx

2.62

3.18

3.4

3.0

124.39

128.28

g/l

0.22

Salpingitis and oophoritis

364

3022

1.21

3.17

4.3

3.1

127.68

127.37

g/l

0.10

355

2954

Disorders of copper metabolism

6.77

3.17

3.9

8.8

126.00

132.92

g/l

—

Glycosuria

5.54

3.16

3.0

13.3

132.13

123.31

g/l

—

Marfan's syndrome

2.58

3.15

3.8

3.4

134.61

130.84

g/l

0.20

Disorders of optic nerve, not elsewhere classified

401

1.63

3.14

4.8

3.2

122.84

126.48

g/l

0.49

394

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

273

2207

1.25

3.14

2.8

3.1

123.69

130.61

g/l

5.85

266

2140

Opening and dilatation of root channel of tooth

135

993

1.38

3.14

6.9

3.0

125.17

131.34

g/l

2.44

127

973

3.12

3.13

4.6

3.5

115.38

133.91

g/l

1.30

Cysts of oral region, not elsewhere classified

109

775

1.43

3.12

4.0

2.7

127.86

131.81

g/l

1.05

103

751

Carcinoma in situ of skin

226

1792

1.28

3.12

3.5

3.1

125.34

126.95

g/l

0.51

219

1746

Diseases of external ear

867

7706

1.13

3.10

3.8

3.7

129.70

129.14

g/l

0.30

842

7518

Special screening examination for neoplasms

117

844

1.41

3.09

3.0

128.86

129.75

g/l

0.13

112

817

Separation of retinal layers (serosa)

105

744

1.44

3.09

5.4

3.1

131.66

131.28

g/l

0.05

100

731

L02BB Anti-androgens

263

2125

1.26

3.08

3.3

3.5

118.00

127.92

g/l

11.18

256

2064

Victim of lightning

11.26

3.07

2.2

1.2

128.80

112.20

g/l

—

Testicular dysfunction

629

1.48

3.06

4.3

3.7

137.52

135.02

g/l

0.40

616

Early lumbar disc prolapse operation

198

1546

1.29

3.01

3.8

3.3

135.07

135.85

g/l

0.18

187

1515

Other and specified injuries of hip and thigh

405

1.60

3.01

4.5

3.0

125.14

126.91

g/l

0.28

397

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

357

1.64

3.00

4.7

2.8

123.35

128.20

g/l

0.95

344

Female genital prolapse

727

3679

1.15

3.00

2.8

3.1

127.18

125.79

g/l

1.08

708

3609

Fibrosis and sclerosis of liver

7.80

3.00

2.7

2.9

114.33

138.33

g/l

—

Melanoma in situ of lip

11.32

2.96

3.4

1.3

109.20

141.83

g/l

—

Ganglion

449

3823

1.18

2.96

3.6

3.2

131.81

129.56

g/l

1.30

435

3739

Benign neoplasm: Skin, unspecified

659

1.46

2.94

4.9

2.8

127.72

130.36

g/l

0.51

640

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

302

2485

1.23

2.93

4.0

3.3

131.15

131.87

g/l

0.23

291

2411

Other and unspecified diseases of spleen

2.64

2.90

9.1

2.4

118.06

131.18

g/l

1.16

Drug-induced dystonia

3.29

2.90

3.7

2.4

124.18

124.03

g/l

0.01

Crowding of teeth, including avohilmo

162

1019

1.32

2.89

8.9

5.1

132.06

132.26

g/l

0.04

156

995

Other and unspecified mononeuropathies, also in other diseases

563

1.49

2.89

4.0

2.9

126.69

128.06

g/l

0.22

552

Abnormal findings on diagnostic imaging of breast

224

1.81

2.88

3.8

2.5

123.64

128.19

g/l

0.78

218

Benign mammary dysplasia

330

2746

1.21

2.87

3.3

3.0

126.19

126.25

g/l

0.02

320

2681

Sicca syndrome [Sjögren]

199

1569

1.29

2.86

5.6

3.0

125.37

127.62

g/l

0.80

192

1531

Ankyloglossia

194

1.84

2.83

8.2

10.1

133.26

129.89

g/l

0.35

189

Benign neoplasm: Liver/bile ducts (ICD-9)

7.04

2.83

2.0

2.5

117.00

128.30

g/l

—

Peptic ulcer

174

1.92

2.83

5.6

2.9

120.06

126.60

g/l

0.80

169

Other/unspecified enthesopathies, not elsewhere classified

215

1715

1.27

2.81

3.3

3.1

130.47

128.84

g/l

0.47

209

1667

Dental pulpitis 1, only avohilmo

3464

17070

1.06

2.80

3.4

3.5

130.37

129.04

g/l

2.80

3378

16688

Malignant otitis externa

4.21

2.80

5.0

2.5

117.56

132.96

g/l

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

992

5823

1.12

2.80

2.5

3.1

124.54

128.95

g/l

9.13

970

5685

Nephropathy induced by other drugs, medicaments and biological substances

3.56

2.79

14.5

3.6

111.10

129.97

g/l

—

Pemphigoid

544

1.49

2.78

3.1

3.0

121.96

125.21

g/l

0.73

531

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

326

1.64

2.77

3.6

2.7

125.44

136.94

g/l

2.22

318

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

992

5826

1.12

2.77

2.5

3.1

124.54

128.95

g/l

9.14

970

5688

D07AA Corticosteroids, weak (group I)

331

2760

1.21

2.77

4.3

129.31

129.95

g/l

0.20

323

2694

Hyperchylomicronaemia

3.47

2.77

6.0

2.2

110.80

132.94

g/l

—

Bullous pemphigoid

439

1.55

2.76

3.0

3.2

119.15

124.00

g/l

1.19

426

Persons with potential health hazards related to communicable diseases

619

6989

0.87

2.76

7.9

3.8

125.22

131.71

g/l

9.95

599

6827

Dislocation, sprain and strain of joints and ligaments of thorax

560

1.48

2.76

4.0

3.1

133.00

129.46

g/l

0.91

550

Distal bite

498

1.50

2.75

6.1

132.77

131.37

g/l

0.25

481

Osteogenesis imperfecta

3.41

2.74

5.0

9.9

129.50

130.50

g/l

—

Polyglandular dysfunction

3.40

2.74

6.1

9.3

118.10

130.41

g/l

—

Single spontaneous delivery

807

4826

0.89

2.74

2.5

3.2

128.59

126.05

g/l

2.93

780

4721

Carcinoma in situ of skin of other and unspecified parts of face

223

1797

1.26

2.73

3.8

3.0

122.39

128.10

g/l

3.65

213

1747

Hidradenitis suppurativa

470

1.51

2.73

3.7

3.0

128.76

132.02

g/l

0.56

462

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

344

1.62

2.72

17.4

3.1

119.91

130.16

g/l

3.65

338

Other disorders of bladder

314

2618

1.21

2.72

4.9

3.2

127.52

129.06

g/l

0.58

302

2544

Failure in dosage during surgical and medical care

4.64

2.72

4.4

3.4

119.00

134.90

g/l

—

Radial styloid tenosynovitis [de Quervain]

111

812

1.39

2.71

2.3

2.7

132.25

130.13

g/l

0.47

105

794

Injury of muscle and tendon at hip and thigh level

223

1797

1.26

2.69

3.1

3.5

128.73

130.71

g/l

0.63

216

1753

Bronchitis, not specified as acute or chronic

214

1716

1.26

2.69

5.1

3.2

128.16

129.48

g/l

0.36

209

1675

Carcinoma in situ of skin of scalp and neck

508

1.51

2.69

3.9

3.2

118.30

125.41

g/l

1.92

496

Lichen planus

311

2594

1.21

2.68

3.9

3.1

127.30

127.95

g/l

0.21

303

2520

Nonspecific lymphadenitis

132

995

1.34

2.67

7.8

3.2

129.11

130.12

g/l

0.21

127

973

Uterine polyps

204

1629

1.27

2.65

2.7

3.1

129.56

125.57

g/l

2.15

198

1596

Glucosamine medication

1470

10798

1.09

2.65

2.9

3.3

127.61

126.65

g/l

0.92

1436

10539

Syndactyly

4.33

2.65

7.6

2.8

126.50

137.10

g/l

—

Exposure to high and low air pressure and changes in air pressure

6.17

2.64

1.0

2.4

128.83

137.73

g/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

260

2136

1.23

2.64

2.9

3.1

123.75

130.62

g/l

5.45

253

2073

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

2.80

2.63

29.3

3.2

117.85

132.36

g/l

1.18

Nanophthalmos, microphthalmos and macrophthalmos

6.73

2.63

3.5

19.1

135.33

126.92

g/l

—

Other and unspecified glaucoma

189

1501

1.28

2.62

3.3

2.9

125.21

126.82

g/l

0.45

184

1466

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

171

1341

1.29

2.62

3.9

3.2

120.54

130.38

g/l

7.38

164

1296

Multiple sites

6.61

2.62

5.8

6.6

121.67

133.00

g/l

—

Flat foot [pes planus] (acquired)

212

1705

1.26

2.60

3.1

3.2

126.30

128.76

g/l

0.92

207

1672

Q fever

8.91

2.60

3.6

8.5

135.40

140.13

g/l

—

Alzheimer’s disease (Early onset)

941

0.67

2.60

2.4

3.0

126.69

124.63

g/l

0.42

917

Benign neoplasm of meninges

245

2006

1.24

2.57

3.7

3.0

127.11

127.49

g/l

0.11

240

1956

Vasomotor and allergic rhinitis

869

7701

1.12

2.57

3.7

3.8

133.35

130.22

g/l

4.19

852

7532

Melanoma in situ of lip

8.43

2.57

3.4

1.9

109.20

132.00

g/l

—

Supervision of normal pregnancy

250

1747

0.81

2.55

2.0

3.0

134.06

130.14

g/l

2.51

243

1711

Drug phototoxic response

5.98

2.54

1.2

5.8

142.83

124.50

g/l

—

Carcinoma in situ of skin of other and unspecified parts of face

223

1815

1.25

2.52

3.8

3.0

122.39

125.61

g/l

1.44

213

1773

Murder, homicide, or other assault by handgun discharge

7.75

2.51

1.0

5.8

117.60

123.63

g/l

—

Bladder disorders in in diseases classified elsewhere

5.78

2.51

2.5

3.5

137.33

120.92

g/l

—

Periodontosis

3.69

2.50

2.8

3.2

125.33

134.44

g/l

—

Etanercept

129

981

1.33

2.49

3.9

3.5

125.93

130.79

g/l

1.46

124

957

Ulcerative colitis (strict definition, all Crohn cases excluded)

322

2715

1.20

2.47

4.0

3.5

131.41

131.32

g/l

0.02

310

2649

Pedestrian injured in transport accident

160

1255

1.29

2.46

3.3

3.1

128.45

129.44

g/l

0.21

152

1227

Other specified/unspecified hearing loss

205

1657

1.25

2.45

4.8

3.3

125.78

127.98

g/l

0.66

205

1610

Other and unspecified urticaria

414

3567

1.17

2.43

5.0

3.6

130.06

129.73

g/l

0.11

404

3479

Malignant neoplasm of ovary

110

822

1.36

2.43

3.1

2.7

118.66

126.62

g/l

3.42

105

801

Other and unspecified rosacea

190

1524

1.26

2.43

6.3

3.0

131.02

128.85

g/l

0.68

184

1490

Dental caries 1 and operation codes

2848

13779

1.06

2.42

4.0

3.3

128.54

129.43

g/l

1.22

2777

13491

Isolated patent ductus arteriosus

3.86

2.42

2.5

3.2

123.87

134.45

g/l

—

Interstitial emphysema and related conditions originating in the perinatal period

3.62

2.42

15.3

23.6

118.44

123.39

g/l

—

Malignant neoplasm of testis

283

1.64

2.42

3.2

3.3

127.84

134.03

g/l

0.82

276

Other abnormal products of conception

496

2874

1.15

2.40

2.3

3.3

131.18

130.03

g/l

0.61

486

2794

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

668

5953

1.13

2.40

3.4

3.3

123.03

127.63

g/l

6.68

652

5809

Familial erythrocytosis

2.30

2.40

3.6

2.9

150.88

129.23

g/l

2.03

Posteruptive colour changes of dental hard tissues

7.31

2.39

23.6

2.3

106.80

137.33

g/l

—

Mental and behavioural disorders due to use of volatile solvents

3.05

2.37

5.2

2.3

129.20

138.23

g/l

—

Fall on and from ladder

207

1684

1.25

2.36

3.3

3.4

132.48

129.89

g/l

1.00

202

1639

Endometriosis

769

4095

1.12

2.36

2.8

3.0

128.83

126.69

g/l

2.22

760

4014

Endocrine disorders, other/unspecified

316

0.46

2.36

22.5

3.5

128.67

128.60

g/l

0.00

311

Abuse of non-dependence-producing substances

4.36

2.35

5.9

3.2

132.43

122.50

g/l

—

Disorders of breast

1051

8891

1.10

2.34

3.4

3.1

128.23

127.16

g/l

0.95

1029

8695

Rat-bite fevers

6.72

2.34

6.8

2.7

128.20

126.78

g/l

—

Pyoderma

318

1.58

2.31

7.5

3.7

124.94

128.92

g/l

0.63

311

Bacterial agents resistant to antibiotics

4.38

2.29

4.6

2.7

129.29

136.16

g/l

—

Bitten or struck by other mammals

215

1761

1.23

2.27

3.7

3.4

131.19

130.35

g/l

0.22

206

1719

Thalassaemia

2.77

2.25

6.3

5.7

127.55

124.02

g/l

0.24

Drug-induced Cushing's syndrome

4.82

2.24

1.2

2.7

121.67

131.36

g/l

—

Toxic colitis

2.54

2.22

5.8

3.7

118.77

129.75

g/l

0.86

Hereditary nephropathy, not elsewhere classified

2.66

2.20

25.8

2.6

122.17

131.94

g/l

1.11

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1061

11370

0.91

2.20

3.2

3.4

130.88

129.35

g/l

1.52

1035

11115

Hypertrophy of breast

302

2561

1.19

2.20

2.8

3.0

130.56

128.08

g/l

1.25

296

2491

Other primary thrombocytopenia

2.51

2.19

8.8

4.0

118.08

130.20

g/l

1.40

Benign neoplasm: Pituitary gland, craniopharyngeal duct

111

844

1.33

2.19

4.5

2.8

132.17

131.65

g/l

0.09

105

819

Benign neoplasm of middle ear and respiratory system

191

1554

1.24

2.19

3.3

3.0

126.33

131.65

g/l

2.63

186

1505

Other nonautoimmune haemolytic anaemias

3.25

2.18

4.9

2.8

106.00

123.84

g/l

—

Other disorders of white blood cells

133

1038

1.30

2.18

4.8

3.1

123.48

128.56

g/l

1.51

128

1011

Other/unspecified seropositive rheumatoid arthritis

677

6078

1.12

2.17

3.5

3.3

122.87

127.62

g/l

7.18

661

5934

Coxibs

911

4403

1.11

2.15

2.8

4.0

131.67

127.17

g/l

7.35

881

4312

Need for immunization against other single infectious diseases

4.68

2.15

4.0

8.8

128.33

127.80

g/l

—

Dental caries, including avohilmo

2586

12486

1.06

2.15

4.0

3.3

128.33

129.27

g/l

1.22

2522

12218

Atopic dermatitis, strict definition

577

5029

1.13

2.15

3.4

4.4

132.51

131.58

g/l

0.47

566

4909

Benign neoplasm: Skin, unspecified

701

1.36

2.14

4.9

3.0

127.72

128.38

g/l

0.10

686

Visual impairment including blindness (binocular or monocular)

168

1353

1.26

2.13

5.7

3.4

123.06

127.16

g/l

1.63

162

1321

Seropositive rheumatoid arthritis, wide

684

6156

1.12

2.11

3.5

3.3

122.91

127.67

g/l

7.31

668

6010

Delivery

830

4844

0.90

2.11

2.6

3.2

128.70

126.05

g/l

3.22

802

4737

Rickettsioses

3.37

2.09

2.8

4.4

139.38

130.92

g/l

—

Tooth agenesis EXCLUDE clefts and syndromes

431

1.46

2.09

4.6

4.9

131.30

131.64

g/l

0.05

417

Rosacea

244

2044

1.20

2.08

6.9

3.1

130.21

128.87

g/l

0.45

237

1989

Unspecific neurodegenerative disorder

1212

7720

1.09

2.06

2.6

3.3

127.70

125.68

g/l

2.77

1181

7528

All dysplastic lesions of the cervix uteri, vagina or vulva

460

4019

1.14

2.06

3.5

3.1

128.67

129.34

g/l

0.30

453

3916

Acetic acid derivatives and related substances

922

4374

1.10

2.06

2.9

4.0

131.32

127.09

g/l

6.64

890

4284

Other (seronegative) rheumatoid arthritis, wide

471

4156

1.14

2.05

3.6

3.2

124.75

127.84

g/l

2.38

459

4048

Drug-induced autoimmune haemolytic anaemia

3.72

2.05

6.0

2.3

127.57

127.81

g/l

—

Occupational exposure to risk-factors

621

1.38

2.05

3.6

3.4

131.46

129.77

g/l

0.28

607

Myasthenia gravis, drug-induced

3.65

2.04

4.1

3.4

115.29

128.67

g/l

—

Inflammation of lacrimal passages (acute and unspecified)

288

1.57

2.04

4.3

2.8

125.75

126.33

g/l

0.07

283

Crushing injury of head

3.31

2.03

1.6

3.8

122.50

121.96

g/l

—

Dental caries 1

2585

12504

1.06

2.03

4.0

3.3

128.32

129.26

g/l

1.24

2521

12236

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

952

5319

1.10

2.00

3.5

127.14

132.83

g/l

10.62

929

5191

Unspecified urinary incontinence

203

1680

1.22

2.00

3.2

2.9

125.96

126.95

g/l

0.25

191

1635

Congenital malformations of eye, ear, face and neck

130

1024

1.28

1.99

5.6

4.5

130.42

130.73

g/l

0.05

125

1001

Tracheo-bronchomalasia

3.43

1.98

3.7

4.8

120.71

134.24

g/l

—

Pedal cyclist injured in noncollision transport accidents

245

2064

1.20

1.98

3.0

3.6

130.64

130.90

g/l

0.07

239

2009

Nightmares

3.98

1.97

1.5

3.9

137.50

124.19

g/l

—

Allergic conjunctivitis

1127

11996

0.92

1.97

3.3

3.4

130.96

129.44

g/l

1.59

1100

11719

Maternal care for (suspected) damage to fetus from alcohol

3.10

1.97

7.9

2.6

134.88

128.78

g/l

—

Varicose veins

1798

12757

1.07

1.96

3.2

3.3

127.67

128.05

g/l

0.31

1739

12464

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

254

2150

1.19

1.96

3.1

3.3

123.57

130.94

g/l

5.41

246

2096

Benign lipomatous neoplasm of other sites/unspecified

228

1913

1.21

1.96

3.2

3.1

129.12

127.70

g/l

0.45

219

1865

Traumatic secondary and recurrent haemorrhage

3.52

1.96

1.1

2.1

145.29

130.05

g/l

—

Glaucoma secondary to drugs

2.47

1.95

4.3

3.0

136.08

133.87

g/l

0.10

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

2.45

1.94

5.3

2.8

125.08

132.75

g/l

0.52

Alzheimer’s disease, wide definition, excluding more controls

411

2446

1.15

1.94

2.5

3.0

126.82

125.18

g/l

0.81

404

2389

Autoimmune hyperthyroidism

124

975

1.29

1.94

3.2

2.6

132.38

129.78

g/l

0.64

117

952

Neurofibromatosis, type 2

3.42

1.94

2.6

6.9

142.57

130.27

g/l

—

Sacrococcygeal disorders, not elsewhere classified

414

1.45

1.94

2.9

2.7

127.76

128.46

g/l

0.09

400

Other/unspecified rheumatoid arthritis

309

2662

1.17

1.93

3.9

3.1

123.26

127.15

g/l

2.75

304

2593

Relapsing polychondritis

3.06

1.92

2.8

128.13

133.21

g/l

—

Dental caries 3

2706

13132

1.06

1.91

4.0

3.4

128.53

129.16

g/l

0.72

2636

12858

Other disorders of prostate

725

1.33

1.90

3.8

3.3

128.78

128.36

g/l

0.06

707

Digeorge syndrome

4.17

1.89

3.3

25.8

137.67

120.89

g/l

—

Disorders of conjunctiva

2151

17026

1.06

1.89

3.9

3.6

130.76

129.29

g/l

2.42

2096

16634

Haemophagocytic lymphohistiocytosis

3.40

1.88

51.3

4.3

115.57

128.65

g/l

—

Carcinoma in situ of oral cavity

2.78

1.87

1.9

3.6

132.00

130.06

g/l

—

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

580

1.37

1.87

6.6

2.7

123.59

131.04

g/l

2.09

565

Allergic rhinitis

626

5593

1.11

1.86

4.1

4.0

133.58

131.22

g/l

1.92

617

5469

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

155

1260

1.25

1.85

2.7

3.0

132.95

131.70

g/l

0.28

147

1220

Postmenopausal atrophic vaginitis

606

3278

1.12

1.84

2.8

3.1

128.34

125.48

g/l

2.91

592

3218

Lumbosacral root disorders, not elsewhere classified

220

0.44

1.84

2.4

3.0

123.90

128.38

g/l

—

214

Embedded teeth, including avohilmo

150

1215

1.24

1.82

5.6

3.5

126.18

133.11

g/l

3.46

140

1191

Other operation for atrial fibrillation

110

1.93

1.82

3.3

3.5

124.75

127.45

g/l

0.21

110

Congenital absence, atresia and stenosis of small intestine

3.68

1.81

15.8

14.4

120.67

131.06

g/l

—

Traumatic amputation of forearm

4.52

1.81

2.6

3.1

116.00

125.23

g/l

—

Other hypertrichosis

2.61

1.78

1.8

2.5

117.33

129.75

g/l

—

Kissing spine

3.13

1.77

2.3

3.9

138.14

128.92

g/l

—

Restless leg syndrome

280

2413

1.17

1.77

3.4

3.1

131.30

128.37

g/l

1.44

274

2350

Cholera

742

0.70

1.75

2.3

2.6

124.89

127.14

g/l

0.32

723

Benign neoplasm: Liver/bile ducts (ICD-9)

3.62

1.75

2.0

3.3

117.00

124.32

g/l

—

Contraceptive management

756

5816

0.91

1.74

4.5

3.5

131.54

132.40

g/l

0.49

734

5700

Other specified/unspecified disorders of bone/cartilage

501

1.38

1.74

4.1

3.0

130.76

g/l

0.00

496

Other hearing loss

738

6630

1.10

1.74

3.5

3.3

126.18

126.94

g/l

0.41

717

6476

Carcinoma in situ of breast, other/unspecified

228

0.47

1.73

2.5

2.4

127.55

127.36

g/l

0.01

218

Lethal midline granuloma

4.44

1.73

8.0

2.9

114.20

129.79

g/l

—

Other disorders of skin and subcutaneous tissue related to radiation

2.82

1.73

2.1

2.9

128.13

131.61

g/l

—

Chronic laryngitis and laryngotracheitis

249

2903

0.85

1.73

4.3

3.3

127.35

128.22

g/l

0.23

237

2822

Congenital malformations of genital organs

159

1298

1.23

1.71

4.0

4.8

128.22

130.24

g/l

0.60

154

1265

Malignant neoplasm, without specification of site

621

0.68

1.71

3.0

119.23

125.29

g/l

1.25

607

Other disorders of patella

360

3164

1.14

1.71

3.3

3.2

132.22

130.97

g/l

0.48

350

3104

Drug-induced acute pancreatitis

3.04

1.71

58.7

2.1

117.57

131.04

g/l

—

HSIL lesion of the vulva

269

1.52

1.68

3.1

2.6

124.00

128.87

g/l

0.87

263

Dental caries 3 and operation codes

2917

14295

1.05

1.66

4.0

3.3

128.56

129.37

g/l

1.10

2840

14003

Injury of blood vessels at shoulder and upper arm level

2.71

1.66

2.9

3.2

113.88

128.16

g/l

—

Aortic arch syndrome [Takayasu]

2.69

1.65

3.4

4.4

123.38

127.09

g/l

—

Vestibular neuronitis

209

1772

1.19

1.65

3.4

3.2

130.07

128.38

g/l

0.53

204

1725

120

961

1.26

1.64

2.6

3.0

132.70

131.74

g/l

0.21

120

937

Benign neoplasm: Skin of upper limb, including shoulder

329

1.46

1.63

3.1

2.7

127.26

129.75

g/l

0.28

322

Moderate mental retardation

1.92

1.61

4.7

7.6

128.18

131.88

g/l

0.41

Other sideroblastic anaemias

2.21

1.60

4.5

2.9

122.25

126.05

g/l

0.24

Porphyria cutanea tarda

3.70

1.58

1.8

2.1

121.20

131.60

g/l

—

Convalescence

107

852

1.27

1.57

7.5

2.5

121.84

130.34

g/l

2.90

101

825

Carcinoma in situ of larynx

2.80

1.57

2.6

2.5

134.86

124.63

g/l

—

Unspecified severe protein-energy malnutrition

2.80

1.57

5.7

6.1

122.71

125.04

g/l

—

Urethral discharge

3.62

1.57

5.4

3.3

151.40

131.20

g/l

—

Use of peginterferon beta-1a

2.51

1.56

2.5

3.9

139.88

134.24

g/l

—

Benign neoplasm of ovary

360

3189

1.14

1.56

2.8

3.1

125.48

128.26

g/l

1.76

348

3104

Abnormal findings in peritoneal fluid saliva

2.17

1.54

4.9

2.9

130.08

128.90

g/l

0.08

Tonsillectomy and adenotomy

1202

7830

1.07

1.53

3.5

3.9

134.04

132.06

g/l

2.41

1169

7642

Motor- or nonmotor-vehicle accident in traffic area

1.96

1.53

5.3

3.7

137.67

131.15

g/l

0.53

Ulcerative rectosigmoiditis

175

1472

1.20

1.52

4.9

3.1

130.70

131.11

g/l

0.08

168

1433

Torsion of testis

267

1.48

1.51

3.9

4.6

145.49

137.65

g/l

1.03

262

Behçet disease

2.35

1.51

2.4

3.0

126.00

130.09

g/l

—

Other puerperal infections

100

793

1.27

1.51

2.0

2.9

133.80

131.32

g/l

0.61

774

Other specified/unspecified disorders of middle ear and mastoid

2.53

1.51

3.1

5.6

130.44

129.92

g/l

—

Frostbite involving multiple body regions and unspecified frostbite

2.65

1.49

3.1

4.9

142.71

120.71

g/l

—

Myeloproliferative diseases

209

1791

1.18

1.49

2.7

3.0

125.72

127.94

g/l

0.63

199

1741

Disorders of sexual preference

2.47

1.48

3.3

4.3

128.11

132.92

g/l

—

Disorders of puberty

171

1.61

1.48

4.5

4.9

133.41

133.49

g/l

0.01

165

Ankylosis of teeth

2.94

1.48

9.0

2.3

128.33

140.45

g/l

—

Other female pelvic inflammatory diseases

316

2787

1.14

1.48

3.7

2.9

129.40

127.52

g/l

0.91

309

2721

Assault by drugs, medicaments and biological substances

2.92

1.47

4.7

4.4

133.67

129.82

g/l

—

Nutritional marasmus

2.92

1.47

4.0

5.0

127.00

122.77

g/l

—

Use of antiglaucoma preparations and miotics

217

1867

1.17

1.47

4.9

3.0

122.36

126.73

g/l

2.03

206

1824

Other congenital malformations of spinal cord

3.34

1.47

29.2

4.7

116.80

133.56

g/l

—

Mental and behavioural disorders due to cocaine

3.31

1.47

2.8

6.0

109.80

124.56

g/l

—

Myasthenia gravis

312

1.44

1.46

4.5

3.3

129.20

127.25

g/l

0.24

306

Disorders of synovium and tendon in diseases classified elsewhere

363

1.40

1.44

3.5

2.8

126.98

131.53

g/l

0.66

354

Nasal polyp

495

4490

1.11

1.44

3.2

3.5

132.44

129.52

g/l

2.35

484

4374

Caries in Clefts patients

103

1.79

1.43

13.1

7.5

122.56

131.50

g/l

0.70

103

Merkel cell carcinoma of skin

2.88

1.42

2.3

2.5

125.83

119.52

g/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

254

2218

1.16

1.42

2.6

3.2

123.70

128.36

g/l

2.75

247

2154

Disorders of vagus nerve

2.86

1.42

25.8

5.3

123.00

121.70

g/l

—

Benign neoplasm: Skin of upper limb, including shoulder

339

1.41

1.42

3.1

2.7

127.26

128.89

g/l

0.17

334

Primary open-angle glaucoma

890

8073

1.08

1.41

3.4

3.2

124.99

126.36

g/l

1.03

863

7877

Gestational diabetes (for exclusion)

519

3331

1.11

1.41

3.2

132.08

130.48

g/l

1.05

508

3248

Secondary sideroblastic anaemia

2.31

1.41

5.4

2.9

114.56

128.85

g/l

—

Lichen planus, including avohilmo

419

3773

1.12

1.41

3.5

3.2

127.73

128.26

g/l

0.19

411

3671

Diaper [napkin] dermatitis

2.79

1.40

10.8

17.0

132.67

132.91

g/l

—

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

3.21

1.40

4.8

2.5

115.60

121.12

g/l

—

Sequelae of injuries of neck and trunk

512

1.33

1.40

2.0

3.0

131.10

130.25

g/l

0.11

503

Ménière disease

231

2008

1.16

1.38

3.0

128.35

127.56

g/l

0.23

224

1957

Juvenile Open Angle Glaucoma

1.93

1.38

7.2

3.6

122.71

133.89

g/l

0.90

Poor fetal growth

156

1312

1.19

1.37

4.5

3.3

127.97

131.28

g/l

1.08

149

1280

Other and unspecified hypertrophic disorders of skin

1.84

1.37

1.8

2.8

134.88

129.67

g/l

0.43

Other crystal arthropathies

394

1.38

1.36

4.7

3.4

120.17

126.67

g/l

1.52

383

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

168

1426

1.19

1.36

6.3

2.9

130.48

131.22

g/l

0.16

161

1382

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

302

2676

1.14

1.35

4.0

3.3

131.15

129.19

g/l

0.85

291

2605

Fourth [trochlear] nerve palsy

429

1.35

1.34

4.3

3.1

129.12

127.84

g/l

0.14

422

Other osteochondropathies

149

1254

1.20

1.33

2.8

3.5

133.34

131.62

g/l

0.37

141

1225

Benign neoplasm: Pituitary gland, craniopharyngeal duct

111

909

1.23

1.32

4.5

3.0

132.17

129.38

g/l

0.68

105

883

Contact with machinery

268

2362

1.14

1.32

3.7

3.6

132.72

131.32

g/l

0.43

260

2307

Crystal arthropathies, rheuma endpoint

396

1.37

1.32

4.7

3.4

120.17

126.61

g/l

1.51

388

Benign neoplasm: Penis

2.45

1.32

1.8

3.1

143.88

127.51

g/l

—

Benign neoplasm of middle ear and respiratory system

191

1644

1.17

1.32

3.3

3.2

126.33

128.61

g/l

0.72

186

1597

Dysplastic lesion of the vulva of unknown severity

2.96

1.31

5.0

2.1

126.40

127.50

g/l

—

Oral leukoplakia and related diseases, including avohilmo

205

1775

1.16

1.31

3.8

3.0

127.79

128.53

g/l

0.17

200

1730

Other disorders of veins

949

8878

1.07

1.30

3.5

3.2

128.62

128.36

g/l

0.14

930

8679

Defect, injury or illness of lumbar spine

2.37

1.29

2.0

3.4

134.38

129.86

g/l

—

Seropositive rheumatoid arthritis, strict definition

342

3064

1.12

1.29

3.3

3.2

123.41

128.61

g/l

4.40

334

2981

Malignant neoplasm of cervix uteri

219

1.49

1.29

3.2

2.5

123.84

126.96

g/l

0.32

214

Atrophy of thyroid (acquired)

2.58

1.28

3.8

3.3

124.00

125.76

g/l

—

Photocontact dermatitis [berloque dermatitis]

2.58

1.28

4.3

5.2

135.67

121.64

g/l

—

Malignant neoplasm of rectum

242

2126

1.15

1.27

2.8

3.1

123.08

128.33

g/l

3.23

235

2067

Parapsoriasis

338

1.39

1.27

2.9

3.7

137.46

128.91

g/l

2.00

331

Disorders of puberty, other/unspecified

2.29

1.26

1.6

8.1

132.38

128.22

g/l

—

Radiodermatitis

2.29

1.25

2.3

2.4

123.87

130.24

g/l

—

Use of donepezil

548

4844

1.09

1.25

2.8

3.2

128.27

124.91

g/l

3.69

533

4725

Dental pulpitis 2, only avohilmo

2370

11628

1.05

1.24

3.9

3.3

128.19

129.04

g/l

1.00

2311

11380

Supervision of high-risk pregnancy

246

1694

0.88

1.24

2.2

3.0

133.53

129.80

g/l

2.21

238

1660

Medical treatment for female infertility

212

2422

0.87

1.23

2.6

3.3

131.61

130.76

g/l

0.25

204

2364

Endometriosis ASRM stages 1,2

288

2565

1.13

1.20

2.9

3.2

131.70

129.05

g/l

1.55

283

2497

Injury of blood vessels at forearm level

2.10

1.20

7.6

4.6

117.30

132.34

g/l

—

Heterophoria

155

1324

1.18

1.19

6.3

3.6

131.21

129.95

g/l

0.32

149

1291

Retinal detachment with retinal break

317

2847

1.12

1.18

4.7

3.2

125.51

128.79

g/l

1.77

310

2776

Delivery, wide proxy

732

4187

0.93

1.18

2.5

3.1

128.52

125.60

g/l

3.38

704

4094

Leiomyoma of uterus

1439

7769

1.06

1.18

3.2

3.1

127.80

126.77

g/l

1.06

1405

7590

Epidermolysis bullosa

2.65

1.18

8.4

14.6

114.60

126.40

g/l

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

233

1.45

1.17

6.5

2.9

119.88

130.36

g/l

2.37

228

Carcinoma in situ of larynx

2.51

1.17

2.6

3.5

134.86

124.60

g/l

—

Benign neoplasm: Pineal gland

2.59

1.17

1.8

5.1

134.00

132.95

g/l

—

Chronic drug-induced interstitial lung disorders

2.45

1.15

2.1

3.2

132.29

128.71

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

155

1330

1.18

1.15

2.7

3.2

132.95

129.19

g/l

1.25

147

1296

Diseases of thymus

2.09

1.15

5.4

3.7

133.13

129.10

g/l

—

Other hereditary haemolytic anaemias

1.76

1.14

3.3

3.6

138.73

128.03

g/l

0.70

Glaucoma, exfoliation

297

2665

1.12

1.14

3.4

3.0

126.21

125.93

g/l

0.08

285

2604

Lichen ruber planus, wide definition including periferal and oral lichen planus

482

4428

1.09

1.13

3.4

3.3

128.55

128.26

g/l

0.10

471

4322

Adenocarcinoma and papilloma adenocarcinoma of rectum

240

2128

1.14

1.13

2.6

3.2

123.74

128.26

g/l

2.46

233

2067

Lesion of sciatic nerve

115

965

1.20

1.12

3.0

126.60

126.36

g/l

0.04

110

943

Patellar tendinitis

209

1.46

1.12

2.9

3.5

134.47

132.77

g/l

0.15

202

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

910

5126

1.07

1.12

3.5

127.11

132.45

g/l

9.24

887

5005

Alzheimer’s disease (Late onset), excluding more controls

380

2299

1.11

1.12

2.5

3.0

127.03

124.92

g/l

1.13

373

2245

Onychogryphosis

2.04

1.12

2.9

2.6

122.38

127.39

g/l

—

Need for immunization against single bacterial diseases

2.30

1.11

35.6

24.7

133.86

124.25

g/l

—

2.46

1.10

14.0

4.4

129.60

138.38

g/l

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

244

1.42

1.10

4.3

3.3

138.53

135.02

g/l

0.37

239

Internal derangement of knee

933

8767

1.06

1.10

3.2

130.49

130.43

g/l

0.02

907

8588

Infections with a predominantly sexual mode of transmission

553

5112

1.08

1.09

4.0

3.4

128.23

131.74

g/l

3.32

542

4990

Dyslexia and other symbolic dysfunctions, not elsewhere classified

1.99

1.09

4.0

4.5

139.90

127.96

g/l

—

Carcinoma in situ of lip, oral cavity and pharynx

2.11

1.09

6.2

3.1

129.56

129.42

g/l

—

Erythrasma

2.23

1.09

4.4

4.6

124.71

130.82

g/l

—

Use of anticholinesterases

920

7015

1.07

1.08

2.5

3.2

128.16

125.26

g/l

4.26

898

6838

N06DA Anticholinesterases

920

7015

1.07

1.08

2.5

3.2

128.16

125.26

g/l

4.26

898

6838

Disorders of puberty, all

194

1.46

1.08

4.4

5.9

132.82

131.59

g/l

0.12

187

Acne varioliformis

2.21

1.08

4.7

2.2

105.00

127.61

g/l

—

Ovarian hyperstimulation (induction)

161

1.51

1.08

2.1

3.6

125.54

133.15

g/l

0.92

156

Mumps

442

0.71

1.08

3.5

2.9

132.63

131.68

g/l

0.08

435

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

805

1.22

1.07

4.0

3.0

122.15

130.63

g/l

3.38

780

Obstructed labour due to malposition and malpresentation of fetus

247

2611

0.89

1.07

3.1

3.3

132.71

129.73

g/l

1.55

236

2555

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

2.48

1.07

2.6

3.0

129.00

133.68

g/l

—

Palatinal maxillary operation

1.74

1.06

7.6

8.7

129.14

129.18

g/l

0.00

Other hyperalimentation

2.04

1.06

2.1

2.8

124.00

132.07

g/l

—

Procreative management

653

5131

1.08

1.06

5.9

3.9

129.21

132.23

g/l

2.61

627

5020

Optic atrophy

341

1.34

1.06

7.7

4.7

130.78

127.54

g/l

0.51

336

Internuclear ophthalmoplegia

1.96

1.04

2.2

3.4

120.30

130.64

g/l

—

Injury of muscle and tendon at lower leg level

353

3215

1.10

1.03

3.8

3.6

130.73

130.44

g/l

0.08

341

3146

Major anomalies of jaw size

413

1.30

1.02

4.2

3.9

132.08

129.96

g/l

0.30

405

Endometriosis ASRM stages 3,4

436

4010

1.09

1.02

3.0

3.1

128.61

127.70

g/l

0.45

430

3916

Haemorrhagic disorder due to circulating anticoagulants

232

1.41

1.01

3.3

120.75

125.40

g/l

0.55

227

Premenstrual syndrome

115

1.59

1.01

3.4

3.6

129.28

129.09

g/l

0.02

110

Thyroiditis, unspecified

240

1.40

1.01

3.5

2.7

132.27

127.49

g/l

0.56

234

Other cranial nerve disorders in other disorders

1.95

1.01

2.1

3.5

128.20

129.63

g/l

—

therapeutic use

571

0.76

1.00

3.9

2.7

124.23

128.03

g/l

0.51

559

Polypectomy (DHB20)

163

1425

1.15

0.99

3.2

3.3

130.59

129.65

g/l

0.21

157

1389

Iliotibial band syndrome

157

1.49

0.98

6.3

3.0

121.04

128.91

g/l

0.86

151

Chronic rhinitis, nasopharyngitis and pharyngitis

718

6741

1.07

0.98

3.8

3.6

131.14

129.44

g/l

1.33

710

6590

Burn and corrosion of wrist and hand

595

1.24

0.98

3.5

3.7

133.86

131.60

g/l

0.41

580

Carcinoma in situ of other and unspecified genital organs

259

1.37

0.97

3.3

2.5

121.06

127.71

g/l

1.11

249

Malignant neoplasm of other and unspecified male genital organs, excluding all cancers (controls excluding all cancers)

2.36

0.97

3.3

3.6

127.50

127.74

g/l

—

Hyperfunction of pituitary gland, other and/or unspecified

2.36

0.96

4.5

3.2

118.50

125.48

g/l

—

Operations 1 for CAVS

1.92

0.96

6.0

10.5

122.00

121.73

g/l

—

Cyst of spleen

2.34

0.96

11.0

3.6

119.83

135.78

g/l

—

Maternal care for cervical incompetence

557

0.77

0.96

2.0

2.6

135.21

128.24

g/l

1.55

543

Malignant neoplasm of rectosigmoid junction

304

1.34

0.95

3.6

3.4

124.15

127.64

g/l

0.41

299

Pleural plaque

269

2432

1.11

0.95

3.5

3.4

129.27

127.06

g/l

0.91

262

2362

Complications specific to multiple gestation

1.93

0.95

1.1

2.7

138.00

128.59

g/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

782

6521

0.94

0.95

3.0

3.1

129.12

128.60

g/l

0.29

757

6378

Spontaneous abortion

861

5527

1.06

0.95

2.9

3.1

128.90

127.99

g/l

0.63

837

5400

Colitis due to radiation

201

1.43

0.95

5.2

3.2

125.04

126.38

g/l

0.13

196

Sequelae of tuberculosis

357

1.31

0.94

4.6

3.0

121.43

122.78

g/l

0.18

348

Pollen allergy

264

2891

0.90

0.94

4.6

4.3

134.99

132.34

g/l

1.25

256

2835

Obstructed labour due to maternal pelvic abnormality

264

2384

1.11

0.93

2.8

3.3

132.56

127.96

g/l

3.40

258

2333

Bilateral sagittal split ramus osteotomy operation

428

1.27

0.93

2.5

3.1

138.20

132.24

g/l

1.32

419

Hypertensive encephalopathy

1.76

0.92

8.9

2.5

117.75

128.27

g/l

1.17

Maxillary retrognathism

244

1.37

0.92

2.2

5.5

142.58

132.92

g/l

1.69

237

Rhabdomyosarcoma, excluding all cancers (controls excluding all cancers)

2.18

0.92

25.7

10.8

112.83

130.21

g/l

—

False labour

438

2539

1.09

0.91

2.5

3.3

133.20

129.93

g/l

3.08

429

2479

Benign lipomatous neoplasm of of intra-abdominal organs

1.87

0.91

2.6

3.0

118.20

129.07

g/l

—

All dysplastic lesions of the cervix uteri

367

3365

1.09

0.90

3.3

3.2

128.67

129.58

g/l

0.37

361

3279

Exposure to ignition or melting of other clothing and apparel

1.95

0.90

3.3

4.3

140.12

130.09

g/l

—

Congenital malformations of spine and bony thorax

1.65

0.90

30.6

7.4

131.21

131.60

g/l

0.02

Maternal care for other known or suspected fetal problems

320

1870

1.10

0.90

3.0

3.2

131.26

130.73

g/l

0.17

309

1828

Myeloproliferative diseases (CML excluded)

182

1616

1.13

0.89

2.7

3.0

127.05

127.97

g/l

0.19

173

1573

Other sexually transmitted chlamydial diseases

729

0.81

0.89

2.9

2.8

130.73

136.35

g/l

1.13

711

Cleft lip and cleft lip and palate

1.64

0.89

11.1

5.8

121.93

130.97

g/l

0.57

Intermittent hydrarthrosis

2.07

0.89

8.5

4.2

137.17

133.60

g/l

—

Other orthopaedic follow-up care

108

925

1.18

0.88

2.8

2.7

131.96

130.79

g/l

0.21

103

898

Malignant neoplasm of breast, HER-positive

667

6984

0.94

0.88

2.5

3.1

124.68

126.55

g/l

1.58

646

6839

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

415

1.27

0.88

4.2

2.9

124.96

131.62

g/l

1.21

406

Dysplasia of cervi uteri

402

2870

1.09

0.87

3.2

127.93

127.71

g/l

0.07

396

2811

Erectile dysfunction

217

1952

1.12

0.87

6.1

3.6

125.83

128.58

g/l

0.87

209

1901

Benign neoplasm of ovary

360

3316

1.09

0.86

2.8

3.1

125.48

126.38

g/l

0.36

348

3236

Pityriasis rubra pilaris

2.01

0.86

3.5

3.2

122.00

128.84

g/l

—

Benign neoplasm: Skin of eyelid, including canthus

343

3156

1.09

0.85

4.0

3.1

128.10

129.68

g/l

0.62

336

3068

Malignant neoplasm of other and unspecified female genital organs

240

1.36

0.85

3.7

2.5

115.91

125.84

g/l

1.60

234

L02BA Anti-estrogens

275

3015

0.91

0.85

2.6

3.1

124.84

127.11

g/l

1.18

269

2948

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

1.63

0.84

2.4

3.5

123.07

127.53

g/l

0.39

Postpartum care and examination

149

1082

0.88

0.84

5.6

2.8

130.37

131.28

g/l

0.24

142

1058

Osteochondrodysplasia with defects of growth of tubular bones and spine

1.95

0.84

1.2

10.0

129.50

129.56

g/l

—

Calcium deposit in bursa

1.95

0.84

5.2

3.4

99.33

131.91

g/l

—

Mouth breathing

1017

9697

1.05

0.82

3.9

3.8

131.68

130.48

g/l

0.89

987

9470

Long labour

283

2704

0.91

0.82

3.4

3.2

132.36

129.65

g/l

1.51

270

2645

Disorders of orbit

756

1.19

0.82

3.1

3.0

130.60

128.34

g/l

0.47

732

Carcinoma in situ of oropharynx, excluding all cancers

1.92

0.82

2.2

3.2

130.50

129.91

g/l

—

Qualitative platelet defects

1.73

0.81

1.9

3.3

128.36

132.12

g/l

0.26

Use of bromocriptine

0.00

0.81

0.0

2.8

—

126.80

—

Congenital retinoschisis

1.73

0.81

12.5

5.4

125.13

128.54

g/l

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

678

5195

1.06

0.80

2.5

3.1

124.73

128.62

g/l

5.34

657

5074

Ulcer of vagina/vulva

358

1.27

0.78

3.1

2.6

127.64

127.41

g/l

0.03

350

All dysplastic lesions of the vagina

376

1.26

0.78

4.0

2.7

125.72

127.61

g/l

0.30

365

Artificial joint re-operation

166

1482

1.13

0.78

3.7

3.0

121.28

127.80

g/l

3.54

159

1445

Kaposi sarcoma, excluding all cancers (controls excluding all cancers)

2.27

0.78

4.6

2.3

131.60

128.52

g/l

—

Toxic erythema

2.26

0.78

2.4

4.1

118.60

127.83

g/l

—

Benign neoplasm: Pineal gland

2.25

0.77

1.8

3.1

134.00

133.87

g/l

—

Pregnancy examination and test

223

1258

1.11

0.77

2.6

3.0

131.99

131.11

g/l

0.28

214

1231

Cleft lip and palate

1.68

0.76

11.8

4.3

120.64

132.87

g/l

0.64

Intentional self-harm by drowning and submersion

2.17

0.76

5.8

2.2

126.00

134.88

g/l

—

Procedures for purposes other than remedying health state

324

1.28

0.76

2.8

2.4

128.98

129.86

g/l

0.09

317

Perioral dermatitis

271

1.30

0.75

11.7

3.3

131.80

128.07

g/l

0.72

266

Triptan medication for migraine, min. 3 purchases

1073

8104

1.05

0.75

3.1

3.4

132.66

130.40

g/l

3.33

1048

7919

Injury of blood vessels of thorax

1.68

0.75

1.9

3.9

120.56

130.22

g/l

—

Postpartum hemorraghe, parous women as controls

298

2833

0.92

0.75

2.9

130.48

131.04

g/l

0.18

291

2767

Kaposi sarcoma

2.09

0.74

4.6

2.8

131.60

127.04

g/l

—

Benign neoplasm: Spinal cord

237

1.33

0.74

2.6

3.3

128.19

127.30

g/l

0.08

232

Crushing injury of ankle and foot

1.72

0.74

1.5

4.2

132.20

129.45

g/l

—

Osteosarcoma

2.07

0.74

15.4

10.8

108.60

121.36

g/l

—

Eclampsia

2.05

0.74

4.4

1.8

115.80

139.36

g/l

—

Macular cyst

517

1.22

0.73

6.4

3.0

121.08

127.43

g/l

1.26

505

Benign neoplasm: Connective and other soft tissue of abdomen

1.80

0.73

2.7

2.3

127.71

128.67

g/l

—

Gastrointestinal stromal tumor and sarcoma

217

0.68

0.73

2.1

3.2

123.13

127.77

g/l

0.29

211

conjunctival scars

2.01

0.72

3.8

2.6

136.20

129.73

g/l

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

101

1.52

0.72

3.7

4.0

138.13

132.79

g/l

0.44

101

Traumatic amputation of lower leg

1.78

0.72

15.9

2.9

114.86

128.85

g/l

—

Exfoliative dermatitis

204

1.35

0.71

3.5

128.85

g/l

0.00

199

Lipodystrophy, not elsewhere classified

1.94

0.70

1.2

2.1

126.20

134.96

g/l

—

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers)

1.73

0.70

2.3

2.4

120.71

126.26

g/l

—

Selective deficiency of immunoglobulin A [IgA]y

1.68

0.70

7.1

7.5

115.60

128.36

g/l

—

Complications of labour and delivery

1133

6581

0.96

0.70

3.0

3.1

129.75

127.78

g/l

2.55

1107

6441

Primary open-angle glaucoma, strict

699

6634

1.05

0.70

3.4

3.2

124.81

126.53

g/l

1.20

678

6478

LeFortI or BSSRO operation

519

1.20

0.69

2.4

3.1

139.53

131.93

g/l

2.17

507

Other benign neoplasms of connective and other soft tissue

195

1770

1.11

0.69

3.3

3.0

125.20

131.35

g/l

3.29

187

1720

Severe mental retardation

1.68

0.68

1.4

15.3

136.29

125.14

g/l

—

Assault by other and unspecified firearm discharge

1.85

0.68

2.8

4.3

134.60

131.75

g/l

—

Malignant neoplasm of breast, HER-negative

399

4254

0.93

0.67

2.6

3.0

123.33

126.00

g/l

1.90

392

4155

Tuberous sclerosis 1

1.84

0.67

3.2

9.1

129.80

127.86

g/l

—

Sequelae of infectious and parasitic diseases

160

1441

1.12

0.67

4.8

3.1

125.96

129.60

g/l

1.30

160

1405

Benign neoplasm: Connective and other soft tissue of abdomen

1.63

0.66

2.7

3.5

127.71

129.64

g/l

—

Effects of air pressure and water pressure

1.65

0.66

1.7

3.9

134.70

133.34

g/l

—

Malignant melanoma

308

3311

0.93

0.65

2.9

3.2

127.30

128.08

g/l

0.23

299

3225

Drug-induced aplastic anaemia

1.79

0.65

6.8

2.5

117.60

126.69

g/l

—

Enterohaemorrhagic Escherichia coli infection

1.79

0.65

11.4

2.8

117.20

129.72

g/l

—

Other haemoglobinopathies

1.78

0.65

5.6

2.9

149.20

126.72

g/l

—

Use of galantamine

143

1589

0.89

0.64

2.0

3.0

130.83

124.59

g/l

3.17

138

1552

Other and/or unspecified nontoxic goitre

169

1532

1.11

0.64

2.7

3.1

128.82

126.64

g/l

0.60

163

1499

Other disorders of cornea

200

1829

1.10

0.63

3.9

3.0

123.77

129.21

g/l

2.49

192

1782

Functional disorders of polymorphonuclear neutrophils

0.00

0.63

0.0

3.8

—

133.60

—

Medicines for HER+ breast cancer

717

7312

0.95

0.62

2.6

3.1

124.47

126.72

g/l

2.23

696

7159

Pemphigus foliaceus

0.00

0.62

0.0

2.3

—

127.65

—

Malignant neoplasm of trachea, excluding all cancers (controls excluding all cancers)

0.00

0.62

0.0

2.6

—

132.00

—

Postpartum hemorraghe, all women as controls

298

3188

0.93

0.62

2.9

3.2

130.48

130.32

g/l

0.04

291

3114

Gonococcal infection

489

0.81

0.62

2.5

2.9

126.85

132.09

g/l

0.87

477

Polydactyly

0.00

0.62

0.0

23.2

—

122.68

—

Other chondrocalcinosis

245

1.29

0.62

4.4

3.4

117.90

124.02

g/l

1.06

240

Brain mixed glioma, excluding all cancers (controls excluding all cancers)

0.00

0.61

0.0

2.9

—

135.57

—

Brain mixed glioma

0.00

0.61

0.0

4.7

—

134.33

—

Other and unspecified disease of Bartholin gland

499

0.81

0.61

5.1

2.7

127.68

127.12

g/l

0.06

487

Carcinoma in situ of oral cavity and pharynx

1.86

0.61

2.2

3.0

130.50

130.62

g/l

—

Abrasion of teeth

534

4139

0.95

0.61

3.0

129.61

130.46

g/l

0.40

518

4030

Congenital deformities of feet

335

1.23

0.60

3.4

4.5

128.17

129.79

g/l

0.18

329

Type 1 diabetes, wide definition, subgroup 2

266

0.74

0.60

8.8

5.4

121.70

124.61

g/l

0.17

261

Family history of malignant neoplasm

166

1508

1.10

0.60

2.8

2.5

129.78

131.78

g/l

0.54

157

1473

Habitual aborter

174

1.33

0.60

3.0

3.5

125.57

130.00

g/l

0.37

169

Maternal care for known or suspected malpresentation of fetus

197

1603

0.91

0.59

2.8

3.3

131.91

130.64

g/l

0.41

192

1564

Cardiomyopathy due to drugs and other external agents

1.78

0.59

8.0

3.0

119.67

129.89

g/l

—

Hereditary spherocytosis

1.76

0.59

1.7

5.7

135.67

127.43

g/l

—

Benign neoplasm: Spinal cord

247

1.27

0.58

2.6

2.7

128.19

130.26

g/l

0.21

242

Unspecified lump in breast

260

2794

0.93

0.57

4.2

3.0

127.02

127.05

g/l

0.01

254

2726

Lipomatosis, not elsewhere classified

1.66

0.56

10.5

2.1

119.50

134.16

g/l

—

Granulosa cell carcinoma of ovary

1.66

0.56

3.2

2.4

134.67

128.11

g/l

—

Routine general health check-up of defined subpopulation

203

1.29

0.56

3.2

2.5

130.27

129.88

g/l

0.04

198

Exposure to uncontrolled fire in building or structure

116

1.40

0.56

3.1

3.2

130.00

129.96

g/l

0.00

116

Postpartum haemorrhage

298

2773

0.93

0.55

2.9

3.2

130.48

129.70

g/l

0.26

291

2715

Special screening examination for other diseases and disorders

159

1450

1.10

0.55

4.0

2.9

123.39

130.68

g/l

3.83

153

1410

Balanced rearrangements and structural markers, not elsewhere classified

1.60

0.55

3.7

4.0

138.33

131.34

g/l

—

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

1.52

0.55

3.1

137.55

129.58

g/l

0.92

Chondromalacia

469

1.18

0.54

3.7

3.2

136.60

129.91

g/l

1.55

463

Tinnitus

530

5049

1.05

0.54

3.6

3.5

131.84

129.19

g/l

2.11

517

4928

Mucosal proctocolitis

247

2298

1.08

0.54

4.8

3.3

126.72

131.64

g/l

2.44

240

2246

Other mosquito-borne viral fevers

1.58

0.54

1.3

3.2

125.67

128.33

g/l

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

741

1.14

0.53

2.9

2.8

122.34

131.34

g/l

2.84

719

Fenamates

382

2728

0.94

0.53

4.6

4.0

128.82

125.88

g/l

1.81

371

2671

Malignant neoplasm of oropharynx

296

1.23

0.53

3.3

3.1

130.11

128.40

g/l

0.19

291

Allergic colitis

286

1.23

0.53

13.1

8.9

129.74

131.29

g/l

0.19

279

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1163

9794

0.97

0.52

3.2

3.4

129.46

128.76

g/l

0.53

1124

9570

Oher contracture of tendon (sheath)

1.41

0.52

4.3

2.7

128.22

127.89

g/l

—

Other diseases of blood and blood-forming organs

146

1333

1.10

0.52

4.6

3.1

138.40

129.11

g/l

3.18

139

1295

Dislocation of lens

288

1.23

0.51

3.6

3.0

123.97

127.56

g/l

0.44

280

Acquired stenosis of external ear canal

179

0.71

0.51

6.7

3.5

123.15

128.71

g/l

0.38

174

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

168

1545

1.09

0.51

6.3

3.2

130.48

128.74

g/l

0.48

161

1508

Seronegative rheumatoid arthritis

257

2403

1.07

0.51

3.2

3.1

125.13

128.67

g/l

1.73

248

2353

Graves disease, strict definition

172

1583

1.09

0.51

2.7

3.0

132.95

128.80

g/l

1.73

166

1537

Other specified and unspecified disorders of eye and adnexa

689

1.14

0.50

3.4

3.0

131.56

127.56

g/l

0.92

674

Respiratory tuberculosis, not confirmed

869

1.12

0.50

4.0

3.1

122.37

125.60

g/l

0.77

848

Mandibular retrognathia AND surgery (BSSRO)

335

1.20

0.49

2.2

3.3

141.08

131.46

g/l

2.54

328

Benign neoplasm of eye and adnexa

189

2039

0.92

0.49

3.6

3.0

126.05

127.93

g/l

0.56

184

1981

Other disorders of breast

213

1981

1.08

0.49

2.7

2.9

130.87

127.34

g/l

1.79

208

1932

Malignant neoplasm of small intestine

429

1.18

0.48

8.8

3.3

121.56

127.04

g/l

0.91

423

Carcinoma in situ of other and unspecified genital organs

291

1.22

0.47

3.3

2.6

121.06

128.13

g/l

1.23

286

Other articular cartilage disorders

467

1.17

0.47

2.5

3.4

129.72

g/l

0.00

458

L02BG Aromatase inhibitors

572

5964

0.96

0.47

2.7

3.1

123.77

126.38

g/l

2.32

554

5835

L01XX Other antineoplastic agents

128

1170

1.10

0.46

3.2

3.0

120.97

127.25

g/l

2.08

120

1138

Early syphilis

209

0.76

0.46

3.5

3.3

122.44

132.42

g/l

0.92

204

Acanthosis nigricans

1.42

0.46

3.1

2.5

129.57

132.24

g/l

—

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

311

1.20

0.45

1.6

2.7

121.65

129.63

g/l

1.49

305

Antenatal screening

306

1826

0.94

0.45

2.7

2.9

132.99

130.20

g/l

1.73

300

1785

Traumatic amputation of shoulder and upper arm

1.69

0.44

34.6

3.0

122.00

132.00

g/l

—

Medical abortion

1404

7432

1.03

0.44

3.1

3.0

128.54

127.14

g/l

1.63

1368

7262

Macular pucker

355

3375

1.06

0.44

4.4

3.2

126.21

127.78

g/l

0.67

346

3280

Drug-induced interstitial lung disorders, unspecified

1.61

0.43

3.0

4.3

139.80

130.97

g/l

—

Malignant melanoma of skin

232

2468

0.94

0.43

3.1

126.67

127.92

g/l

0.34

224

2400

Alzheimer disease, including avohilmo

974

6822

1.03

0.43

2.6

3.2

127.34

125.23

g/l

2.47

947

6655

Adult-onset Still disease

1.43

0.43

5.4

2.2

112.63

133.74

g/l

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

623

1.13

0.42

4.5

3.1

120.77

125.11

g/l

1.02

610

Phlebitis and thrombophlebitis of femoral vein, drug-induced

0.00

0.42

0.0

2.7

—

131.12

—

Benign neoplasm: Respiratory system, unspecified

1.55

0.42

4.6

2.4

133.40

133.61

g/l

—

Chronic bullous disease of childhood

0.00

0.42

0.0

2.8

—

132.38

—

Schistosomiasis [bilharziasis]

0.00

0.42

0.0

6.0

—

130.40

—

Malignant neoplasm of tonsil

268

1.21

0.42

3.3

3.2

129.06

128.46

g/l

0.05

263

Chronic inflammatory disorders of orbit

1.54

0.42

1.6

4.5

144.20

127.82

g/l

—

Unspecified pneumoconiosis

0.00

0.42

0.0

5.5

—

118.44

—

Foreign body on external eye

325

3088

1.06

0.41

3.8

3.7

134.47

132.57

g/l

0.81

314

3021

Benign neoplasm of mesothelial tissue

0.00

0.41

0.0

4.2

—

128.35

—

Other specified diseases of spinal cord, drug-induced

0.00

0.41

0.0

3.6

—

125.17

—

Sequelae of other and unspecified infectious and parasitic diseases

101

919

1.10

0.41

5.3

3.2

126.30

132.13

g/l

1.84

101

902

Atopic dermatitis

1112

9747

0.97

0.41

3.5

3.7

131.41

130.99

g/l

0.26

1087

9524

Pemphigus erythematosus

0.00

0.41

0.0

3.1

—

125.50

—

Familial chondrocalcinosis

0.00

0.41

0.0

3.1

—

126.22

—

Other inflammation of vagina/vulva

427

1.15

0.40

1.9

2.9

131.98

129.66

g/l

0.35

420

Diving or jumping into water causing injury other than drowning or submersion

1.43

0.40

2.3

5.4

144.40

131.76

g/l

—

Benign neoplasm: Respiratory system, unspecified

1.42

0.39

4.6

3.3

133.40

130.78

g/l

—

Oesophagitis, drug-induced

1.41

0.39

4.6

3.7

122.80

125.83

g/l

—

Traumatic amputation of ankle and foot

1.41

0.39

1.0

2.7

122.00

131.39

g/l

—

Crushing injury of lower leg

1.41

0.39

3.2

2.6

131.40

128.42

g/l

—

Injury of nerves at forearm level

206

1.23

0.38

2.7

3.3

130.36

131.30

g/l

0.08

206

Hydatidiform mole

170

0.76

0.38

2.6

3.5

130.38

128.50

g/l

0.18

165

Varicose veins of other sites

141

1309

1.08

0.38

2.7

3.4

131.80

131.28

g/l

0.09

133

1277

Bacterial meningitis

630

1.12

0.37

3.2

3.1

126.70

129.87

g/l

0.57

617

Traumatic spondylopathy

1.46

0.36

3.0

2.8

136.83

126.36

g/l

—

Epiphora

395

1.15

0.35

2.4

3.0

135.16

126.13

g/l

3.16

385

Retrobulbar neuritis in diseases classified elsewhere

1.41

0.35

47.7

3.3

136.67

134.47

g/l

—

Toxic encephalopathy

1.40

0.35

4.7

2.8

144.83

125.61

g/l

—

Glaucoma-related operations

113

1221

0.92

0.35

3.5

3.0

127.25

125.99

g/l

0.22

106

1192

Other and unspecified cicatricial alopecia

1.39

0.35

1.7

2.7

122.50

130.05

g/l

—

Granulosa cell carcinoma of ovary, excluding all cancers (controls excluding all cancers)

1.39

0.35

3.2

2.5

134.67

132.05

g/l

—

Benign neoplasm: Skin of eyelid, including canthus

343

3284

1.05

0.35

4.0

3.3

128.10

127.70

g/l

0.12

336

3198

Aphakia

264

1.18

0.35

3.6

2.9

125.77

128.09

g/l

0.24

257

Non-small cell lung cancer

359

3741

0.96

0.34

3.4

3.3

122.31

127.56

g/l

4.43

354

3647

Female infertility

502

2990

1.04

0.33

2.8

3.1

129.85

127.94

g/l

1.16

492

2930

Chronic diseases of tonsils and adenoids

2009

12937

0.98

0.33

3.6

132.38

129.95

g/l

5.01

1961

12643

Cleft hard palate NOS

1.29

0.32

6.2

12.6

124.00

132.38

g/l

—

Reiter disease

0.70

0.31

3.0

3.7

126.14

129.19

g/l

—

Ectopic pregnancy

271

2589

1.05

0.31

2.5

3.4

128.10

128.16

g/l

0.01

262

2530

Migraine, single triptan purchase ok & required. ICD-code if available is included

1794

11931

1.02

0.31

3.1

3.5

132.50

130.41

g/l

3.94

1753

11663

Triptan medication for migraine, single purchase ok

1794

11931

1.02

0.31

3.1

3.5

132.50

130.41

g/l

3.94

1753

11663

Alzheimer’s disease (Early onset), excluding more controls

665

0.90

0.31

2.4

2.8

126.69

123.66

g/l

0.68

646

Congenital malformations of anterior segment of eye

129

1.25

0.31

4.3

4.9

131.19

129.84

g/l

0.08

124

Secondary malignant neoplasm of other and unspecified sites

282

0.84

0.30

3.5

3.2

117.88

125.68

g/l

1.04

276

Pedestrian injured in collision with heavy transport vehicle or bus

1.29

0.30

3.6

3.5

130.14

126.53

g/l

—

Spermatocele

186

1764

1.06

0.30

3.9

3.6

129.65

129.70

g/l

0.01

178

1722

Injury of blood vessels at neck level

1.26

0.30

2.6

3.3

126.43

133.39

g/l

—

Hypothyroidism, autoimmune, DX-based

1.26

0.30

4.1

3.7

138.86

130.43

g/l

—

Use of memantine

684

5795

1.03

0.30

2.4

3.2

127.92

124.89

g/l

3.49

667

5651

Use of other anti-dementia drugs

684

5795

1.03

0.30

2.4

3.2

127.92

124.89

g/l

3.49

667

5651

Maternal care for known or suspected abnormality of pelvic organs

327

2348

0.96

0.29

3.4

3.2

133.97

129.76

g/l

3.71

318

2292

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

887

0.92

0.29

4.0

2.8

120.59

128.45

g/l

2.95

868

Myocardial infarction, unclassifiable

629

5458

1.03

0.28

4.6

3.3

121.91

126.67

g/l

6.13

600

5325

Benign neoplasm: Skin of trunk

699

1.09

0.28

3.8

2.7

126.32

131.23

g/l

1.11

681

Respiratory tuberculosis, clinically confirmed

242

1.17

0.28

2.6

3.4

125.36

125.42

g/l

0.00

237

Overjet

325

1.14

0.28

16.1

7.3

126.05

129.38

g/l

0.48

315

Lagophthalmos

233

1.17

0.28

3.3

124.19

124.89

g/l

0.05

227

Generalized pustular psoriasis

1.27

0.28

2.4

4.4

132.13

131.13

g/l

—

Persons encountering health services in other circumstances

793

8114

0.98

0.28

4.5

3.3

127.86

129.55

g/l

1.25

761

7906

Normotensive glaucoma

197

1878

1.05

0.27

2.9

124.86

126.99

g/l

0.65

188

1830

Congenital lens malformations

1.22

0.27

9.4

6.3

125.87

131.53

g/l

—

Cleft palate

113

1.25

0.27

8.6

7.5

124.86

129.95

g/l

0.47

113

Deviated nasal septum

844

8249

1.02

0.27

3.6

3.5

132.93

130.28

g/l

2.89

825

8052

Scar conditions and fibrosis of skin

607

1.09

0.26

4.6

3.4

126.64

128.65

g/l

0.37

594

Other obstructed labour

108

1013

1.07

0.26

3.1

3.2

127.29

128.59

g/l

0.26

103

991

Pregnancy, childbirth and the puerperium

715

3832

0.98

0.25

2.5

3.2

126.43

125.45

g/l

0.62

693

3743

Acute hepatitis B

1.21

0.25

1.7

3.6

122.78

130.48

g/l

—

Chalazion

228

2187

1.04

0.25

3.0

3.2

131.67

129.50

g/l

0.76

219

2128

Retinal breaks without detachment

339

3279

1.04

0.24

3.9

3.2

128.51

129.24

g/l

0.24

333

3194

Vasomotor rhinitis (mode)

128

1353

0.94

0.24

3.1

131.89

128.24

g/l

1.36

122

1315

Malignant neoplasm of heart, mediastinum and pleura

233

0.85

0.24

6.2

4.0

122.30

125.66

g/l

0.29

226

Benign neoplasm: Ribs, sternum and clavicle

1.37

0.24

1.0

5.5

134.40

128.32

g/l

—

Malignant neoplasm of palate

1.37

0.24

1.8

2.8

119.60

127.57

g/l

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

510

4365

0.97

0.23

3.6

3.3

122.54

130.09

g/l

11.87

500

4249

Small kidney of unknown cause

1.30

0.23

8.2

3.7

116.60

129.77

g/l

—

Effects of other deprivation

1.30

0.23

6.6

3.6

118.00

133.00

g/l

—

Carcinoma in situ of other/unspecified male genital organs

0.00

0.22

0.0

4.0

—

115.64

—

Follow-up examination after treatment for malignant neoplasms

209

2175

0.96

0.22

3.2

3.0

122.68

128.01

g/l

2.77

197

2117

Plague

0.00

0.22

0.0

3.7

—

140.30

—

Acquired keratosis follicularis

0.00

0.22

0.0

7.7

—

127.30

—

Inhalation of gastric contents

1.23

0.22

5.4

3.0

156.40

132.73

g/l

—

Toxic myoneural disorders

0.00

0.22

0.0

3.0

—

130.90

—

Disorders of visual cortex

0.00

0.22

0.0

6.1

—

116.80

—

Fetal blood loss

0.00

0.22

0.0

13.4

—

127.73

—

Intestinal helminthiases, other/unspecified

0.00

0.22

0.0

2.6

—

123.18

—

Lesion of plantar nerve

120

1138

1.06

0.22

5.5

2.9

131.96

127.84

g/l

1.51

112

1117

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

0.22

0.0

3.2

—

129.20

—

Echinococcosis

0.00

0.22

0.0

7.1

—

122.30

—

Coccidioidomycosis

0.00

0.22

0.0

2.5

—

125.09

—

Benign neoplasm: Ureter

0.00

0.22

0.0

4.4

—

127.27

—

Benign neoplasm: Ureter

0.00

0.22

0.0

2.9

—

119.73

—

Glanders and melioidosis

0.00

0.22

0.0

2.2

—

130.64

—

Conjunctivitis

1791

15403

1.01

0.22

3.7

3.6

130.77

129.40

g/l

1.87

1748

15043

Lichen ruber moniliformis

0.00

0.22

0.0

1.8

—

131.92

—

Linear scleroderma

0.00

0.22

0.0

3.1

—

129.82

—

Disorders of conjunctiva in diseases classified elsewhere

0.00

0.21

0.0

5.1

—

132.67

—

Acquired ichthyosis

0.00

0.21

0.0

3.3

—

141.92

—

Plasmodium vivax malaria

0.00

0.21

0.0

3.5

—

131.85

—

Hydroxyapatite deposition disease

0.00

0.21

0.0

3.2

—

121.54

—

Other assisted single delivery

198

0.85

0.21

2.6

3.1

127.24

129.66

g/l

0.16

192

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

345

1.11

0.21

3.5

2.9

124.84

131.04

g/l

0.83

339

Defect, injury or illness of skull

0.00

0.20

0.0

4.0

—

133.57

—

Other congenital malformations of integument

0.00

0.20

0.0

9.4

—

131.14

—

Melanoma in situ of trunk

271

0.88

0.20

3.2

2.9

123.92

129.83

g/l

0.51

266

Single delivery by caesarean section

248

1485

0.96

0.20

2.8

3.7

130.83

128.54

g/l

0.94

241

1446

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

236

0.87

0.19

7.5

18.3

124.48

125.27

g/l

0.06

231

Melanoma in situ of trunk

270

0.88

0.19

3.2

3.5

123.92

127.94

g/l

0.31

265

Other obstetric trauma

520

1.08

0.19

3.4

2.7

130.73

130.50

g/l

0.03

506

Other acquired deformities of ankle and foot

137

1.18

0.19

3.7

3.0

130.44

126.81

g/l

0.38

131

Benign neoplasm: Cranial nerves

549

0.93

0.18

4.0

3.0

132.86

127.86

g/l

1.03

538

Meningitis, viral

1.19

0.18

2.0

3.5

129.43

131.42

g/l

—

Benign neoplasm: Vagina

195

1.13

0.17

3.1

2.6

129.36

128.05

g/l

0.09

189

Malignant neoplasm of prostate

1167

7465

0.99

0.17

3.6

126.56

129.22

g/l

3.53

1133

7283

Hallux rigidus

293

3009

0.97

0.17

2.4

3.3

128.38

127.95

g/l

0.13

285

2946

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

470

4422

1.02

0.17

2.6

3.1

123.97

127.93

g/l

4.27

462

4314

Female infertility, cervigal, vaginal, other or unspecified origin

442

2896

1.02

0.16

2.7

3.1

130.20

127.86

g/l

1.45

433

2836

Degenerative diseases of the nervous system

933

6926

1.01

0.16

2.8

3.2

126.85

125.55

g/l

1.08

911

6755

Other benign neoplasms of connective and other soft tissue

195

1890

1.03

0.16

3.3

3.1

125.20

129.15

g/l

1.62

187

1840

Use of rivastigmine

335

3420

0.98

0.15

2.2

3.1

126.99

125.05

g/l

1.03

328

3335

Noise effects on inner ear

851

0.95

0.15

3.9

3.4

133.18

130.10

g/l

0.55

830

Anti-inflammatory and antirheumatic products, non-steroids

929

4605

1.01

0.15

3.1

4.2

129.67

127.31

g/l

2.29

910

4508

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

802

1.05

0.14

2.9

122.34

129.10

g/l

1.82

784

Torsion of ovary, ovarian pedicle and fallopian tube

266

1.09

0.14

2.4

3.2

126.79

128.23

g/l

0.13

258

Infliximab

0.82

0.14

2.1

2.9

127.00

135.34

g/l

—

Alzheimer disease

800

6109

0.99

0.14

2.6

3.2

127.13

125.15

g/l

1.93

780

5959

Status post-ami

167

1411

0.97

0.13

4.2

2.7

123.22

126.87

g/l

1.53

161

1384

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

481

1.06

0.13

3.3

2.9

123.71

132.32

g/l

1.62

469

Contact with lifting and transmission devices, not elsewhere classified

323

0.93

0.12

3.2

3.3

141.27

129.78

g/l

1.80

318

Spinal enthesopathy

590

1.05

0.12

3.4

2.8

118.64

124.37

g/l

1.30

576

Other and unspecified degenerative diseases of nervous system

466

0.94

0.11

3.2

130.52

125.73

g/l

0.78

456

Brain glioblastoma

230

1.09

0.11

2.5

3.1

137.40

128.96

g/l

1.52

225

Other effects of reduced temperature

1.17

0.10

5.6

4.7

138.00

129.33

g/l

—

Other conditions related to polyarteritis nodosa

1.14

0.10

4.2

2.8

128.20

123.61

g/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

262

2572

1.02

0.10

3.2

3.1

128.45

132.07

g/l

1.78

256

2511

Chronic conjunctivitis

496

1.05

0.10

6.9

3.9

126.06

128.42

g/l

0.34

487

Other specified/unspecified disorders of ear

1.12

0.10

2.8

2.4

127.00

129.02

g/l

—

Type 1 diabetes, strict definition, subgroup 2

1.12

0.10

12.8

19.3

130.00

130.84

g/l

—

Oral lichen ruber planus wide, hypothyreosis or thyroxin

102

989

1.03

0.10

2.5

2.9

127.76

126.99

g/l

0.12

966

Labour and delivery complicated by fetal stress [distress]

275

1802

1.02

0.09

3.0

3.1

131.88

130.90

g/l

0.35

268

1764

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

420

0.95

0.08

4.8

3.0

123.35

126.57

g/l

0.42

412

Malignant neoplasm of head and neck

179

1755

1.02

0.08

2.7

3.2

122.82

128.07

g/l

2.19

174

1702

Sudden idiopathic hearing loss

211

2073

1.02

0.08

3.6

3.2

127.51

128.71

g/l

0.31

204

2017

malignant neoplasm of male genital organs

1209

7625

1.01

0.08

3.6

126.54

129.48

g/l

4.25

1175

7437

Discontinuity and dislocation of ear ossicles

1.05

0.07

2.3

3.3

134.75

128.24

g/l

—

Malignant neoplasm of gum

1.03

0.07

1.8

3.9

122.50

123.15

g/l

—

Cholinergic urticaria

1.03

0.07

1.8

3.6

132.88

131.46

g/l

—

Malignant neoplasm of breast, HER2-negative

1066

7883

0.99

0.07

2.6

3.1

124.17

126.77

g/l

3.94

1038

7711

Dental caries 3, only avohilmo

2668

13698

1.00

0.07

3.5

3.6

129.19

128.77

g/l

0.42

2597

13417

Malignant neoplasm of floor of mouth

1.05

0.07

1.8

3.1

123.67

129.06

g/l

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

387

3828

1.01

0.07

2.9

3.3

127.27

130.20

g/l

1.66

377

3722

Benign neoplasm: Vulva

334

1.05

0.07

4.3

2.6

121.57

127.86

g/l

0.96

318

Dental caries 1, only avohilmo

2556

13121

1.00

0.06

3.5

3.6

129.03

128.79

g/l

0.20

2490

12844

Presbycusis

340

3345

1.01

0.06

2.6

3.1

125.07

125.55

g/l

0.16

325

3274

Haemorrhagic and haematological disorders of fetus and newborn

310

1.05

0.06

19.9

16.9

122.76

126.81

g/l

0.50

301

Complications following abortion and ectopic and molar pregnancy

578

0.97

0.06

2.4

3.1

123.63

127.26

g/l

0.53

564

Benign neoplasm: Cranial nerves

527

0.97

0.06

4.0

2.8

132.86

130.22

g/l

0.43

512

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

320

3170

1.01

0.05

3.0

3.2

126.85

130.17

g/l

1.75

311

3081

Benign neoplasm of eye and adnexa

189

1913

0.99

0.05

3.6

3.0

126.05

130.27

g/l

1.85

184

1851

Pregnancy with abortive outcome

1450

7553

1.00

0.04

2.8

3.0

127.88

127.15

g/l

0.63

1418

7380

Malignant neoplasm of breast

1099

7959

1.00

0.04

2.5

3.1

124.23

126.86

g/l

4.13

1071

7784

Benign neoplasm: Skin of trunk

745

1.02

0.04

3.8

3.1

126.32

128.46

g/l

0.36

728

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

604

5041

1.00

0.03

3.5

3.3

122.60

130.07

g/l

13.19

587

4901

Neonatal jaundice from other and unspecified causes

251

0.96

0.03

26.1

18.7

122.12

126.24

g/l

0.45

244

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

359

3401

0.99

0.02

3.4

3.2

122.31

130.16

g/l

8.90

354

3310

Benign neoplasm: Other parts of oropharynx

152

1.06

0.02

5.8

3.4

131.75

130.20

g/l

0.10

152

Other deformity of hallux (acquired)

162

1.05

0.02

1.8

2.9

128.71

128.11

g/l

0.03

157

Injury of nerves and spinal cord at thorax level

1.08

0.02

2.8

3.7

129.40

131.13

g/l

—

Abnormal spermatozoa

295

2963

1.00

0.02

3.3

3.9

130.73

129.17

g/l

0.62

284

2890

Malignant neoplasm of tongue

372

1.02

0.01

2.6

3.3

119.13

127.12

g/l

1.03

367

Disorders of lacrimal system and orbit in diseases classified elsewhere

398

0.98

0.01

3.3

2.9

133.03

128.35

g/l

0.62

390

Propionic acid derivatives

915

4605

1.00

0.01

3.0

4.2

130.82

127.31

g/l

4.56

892

4508

Benign neoplasm: Prostate

134

1.05

0.00

1.6

3.4

131.21

125.96

g/l

0.39

129

Benign neoplasm: Bronchus and lung

246

0.97

0.00

5.0

3.1

123.79

128.10

g/l

0.38

241

Brain glioblastoma and astrocytoma

293

0.99

0.00

2.5

3.3

136.69

128.59

g/l

1.51

286

Other disorders of breast and lactation associated with childbirth

161

0.99

0.00

2.1

2.8

132.81

131.71

g/l

0.10

156

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

289

1.00

0.00

2.5

2.7

136.69

131.55

g/l

0.79

284

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

399

1.00

0.00

4.8

2.7

123.35

129.87

g/l

1.10

390

Dementia in Alzheimer disease

439

3752

1.00

0.00

2.7

3.2

127.27

124.41

g/l

2.12

433

3657

Malignant neoplasm of oral cavity

677

1.00

0.00

2.8

3.3

122.07

127.76

g/l

1.16

667

Injury of muscle and tendon at ankle and foot level

375

0.99

0.00

3.4

3.3

133.00

129.53

g/l

0.45

367

Carcinoma in situ of other/unspecified male genital organs

0.00

0.0

2.3

—

117.89

—

Immobility syndrome (paraplegic)

0.00

0.0

1.6

—

133.60

—

IPHG Phlebitis and thrombophlebitis of intracranial venous sinuses

0.00

0.0

1.4

—

150.60

—

Other drug-induced osteomalacia in adults

0.00

0.0

6.8

—

138.56

—

Benign neoplasm: Mesothelial tissue of pleura

0.00

0.0

1.4

—

128.00

—

Rabies

0.00

0.0

7.0

—

122.44

—

Anhidrosis

0.00

0.0

3.0

—

130.89

—

Adenocarcinomas of cervix

1.00

0.00

2.5

3.0

122.17

126.97

g/l

—

Diastrofic dysplasy

0.00

0.0

1.8

—

127.00

—

Blastomycosis

0.00

0.0

2.0

—

114.20

—

Ascariasis

0.00

0.0

4.4

—

129.57

—

Use of tolcapone

0.00

0.0

3.9

—

136.13

—

Neurological devices associated with adverse incidents

0.00

0.0

4.4

—

142.14

—

Erythema elevatum diutinum

0.00

0.0

4.2

—

134.00

—

Chlamydial lymphogranuloma (venereum)

0.00

0.0

4.6

—

121.63

—

Bilateral

0.00

0.0

3.0

—

136.83

—

Benign neoplasm: Vulva

350

1.00

0.00

4.3

2.5

121.57

126.95

g/l

0.77

342

Pedal cyclist injured in collision with train or tram

0.00

0.0

2.5

—

131.33

—

Carcinoma in situ, thyroid and other endocrine glands

0.00

0.0

4.3

—

129.14

—

Obstetric and gynaecological devices associated with adverse incidents

0.00

0.0

2.8

—

127.25

—

Assault by unspecified chemical or noxious substance

0.00

0.0

1.4

—

157.20

—

Other sex chromosome abnormalities, female phenotype, not elsewhere classified

0.00

0.0

2.8

—

132.33

—

Spotted fever [tick-borne rickettsioses]

0.00

0.0

2.1

—

126.88

—

Accident to nonpowered aircraft causing injury to occupant

0.00

0.0

3.2

—

118.67

—

Drug-induced chorea

0.00

0.0

2.4

—

120.25

—

Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons

0.00

0.0

1.0

—

154.00

—

Heredofamilial amyloidosis, unspecified

0.00

0.0

1.7

—

126.43

—

Deformity of orbit

0.00

0.0

2.0

—

138.40

—

Pseudomembranous colitis, drug-induced

0.00

0.0

2.1

—

137.43

—

Malignant neoplasm of meninges

0.00

0.0

2.6

—

135.67

—

Scleritis and episcleritis (ICD-9) only

0.00

0.0

4.8

—

125.50

—

Malignant neoplasm of placenta

0.00

0.0

2.0

—

131.60

—

Malignant neoplasm of trachea

0.00

0.0

2.7

—

140.33

—

Endometriosis of intestine

140

1.00

0.00

2.1

3.4

134.29

130.10

g/l

0.35

134

Laboratory evidence of human immunodeficiency virus [HIV]

0.00

0.0

2.8

—

137.25

—

Chronic thyroiditis

0.97

0.00

6.0

2.6

127.14

129.68

g/l

—

Delta-beta thalassaemia

0.00

0.0

5.5

—

129.88

—

Other congenital infectious and parasitic diseases

0.00

0.0

10.4

—

124.80

—

Scarlet fever

1.01

0.00

4.3

3.7

124.57

139.36

g/l

—

Congenital pneumonia

0.00

0.0

14.0

—

120.80

—

Intrauterine hypoxia

0.00

0.0

3.6

—

125.00

—

Chronic myeloid leukaemia

0.88

0.00

3.6

3.5

106.00

132.20

g/l

—

Familial dysautonomia

0.00

0.0

5.4

—

133.33

—

Strongyloidiasis

0.00

0.0

8.1

—

123.00

—

Other fluke infections

0.00

0.0

3.1

—

127.33

—

Trichuriasis

0.00

0.0

3.0

—

125.43

—

Other neonatal haemorrhages

0.00

0.0

13.1

—

126.43

—

Alcohol-induced pseudo-Cushing syndrome

0.00

0.0

1.6

—

124.20

—

Pulmonary haemorrhage originating in the perinatal period

0.00

0.0

3.0

—

134.17

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hemoglobin [Mass/volume] in Venous blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS